# ::snt Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice .
# ::tok Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice .
# ::alignments 7-8|0.2.0 4-5|0.2 3-4|0.1 2-3|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:28.108
(a / and 
      :op1 (a2 / ataxia) 
      :op2 (n / nerve 
            :mod (p / peripheral)) 
      :op3 (h / hypomyelination 
            :mod (m / mouse)))

# ::snt ADAM22 is a member of the ADAM gene family , but the fact that it is expressed only in the nervous systems makes it unique .
# ::tok ADAM22 is a member of the ADAM gene family , but the fact that it is expressed only in the nervous systems makes it unique .
# ::alignments 24-25|0.1.1 22-23|0.1 21-22|0.1.0.2 20-21|0.1.0.2.0 17-18|0.1.0.2.1 16-17|0.1.0 12-13|0.1.0.1 10-11|0 8-9|0.0.1 7-8|0.0.1.0 6-7|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 3-4|0.0.2+0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:29.895
(c / contrast-01 
      :ARG1 (h / have-org-role-91 
            :ARG0 (a / ADAM22) 
            :ARG1 (f2 / family 
                  :mod (g / gene)) 
            :ARG2 (m2 / member)) 
      :ARG2 (m / make-02 
            :ARG0 (e / express-01 
                  :ARG1 (o2 / organization 
                        :name (n2 / name 
                              :op1 "ADAM")) 
                  :condition-of (f / fact) 
                  :manner (s / system 
                        :ARG1-of (n / nervous-01) 
                        :mod (o / only))) 
            :ARG1 (u / unique)))

# ::snt ADAM22 's sequence similarity to other ADAMs suggests it to be an integrin binder and thus to have a role in cell-cell or cell-matrix interactions .
# ::tok ADAM22 's sequence similarity to other ADAMs suggests it to be an integrin binder and thus to have a role in cell-cell or cell-matrix interactions .
# ::alignments 24-25|0.2.2.0 22-23|0.2.2 19-20|0.1.1 15-16|0.1.0.0 14-15|0.1 13-14|0.1.0 12-13|0.1.0.1 7-8|0 6-7|0.2.1.0+0.2.1+0.2 5-6|0.2.0 3-4|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:30.985
(s / suggest-01 
      :ARG0 (s2 / similarity 
            :mod (s3 / sequence)) 
      :ARG1 (a / and 
            :op1 (b / bind-01 
                  :ARG0 (t / thus-far) 
                  :ARG1 (i2 / integrin)) 
            :op2 (r / role)) 
      :ARG2 (p / person 
            :mod (o2 / other) 
            :name (n / name 
                  :op1 "ADAMs") 
            :op1-of (o / or 
                  :op2 (i / interaction))))

# ::snt To elucidate the physiological functions of ADAM22 , we employed gene targeting to generate ADAM22 knockout mice .
# ::tok To elucidate the physiological functions of ADAM22 , we employed gene targeting to generate ADAM22 knockout mice .
# ::alignments 16-17|0.0.0.0.0.0 15-16|0.0.0.0.0 13-14|0.0.0.0 11-12|0.0.0 10-11|0.1 9-10|0 8-9|0.0 4-5|0.0.1.0 3-4|0.0.1.0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:31.428
(e / employ-01 
      :ARG0 (w / we 
            :ARG0-of (t / target-01 
                  :ARG1 (g / generate-01 
                        :ARG1 (k / knockout 
                              :mod-of (m / mouse)))) 
            :ARG0-of (e2 / elucidate-01 
                  :ARG1 (f / function-01 
                        :ARG1 (p / physiological)))) 
      :ARG1 (g2 / gene))

# ::snt ADAM22-deficient mice were produced in a good accordance with the Mendelian ratio and appeared normal at birth .
# ::tok ADAM22-deficient mice were produced in a good accordance with the Mendelian ratio and appeared normal at birth .
# ::alignments 16-17|0.0.1 14-15|0.1 13-14|0.0 12-13|0 11-12|0.0.0.0.0.0 10-11|0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 7-8|0.0.0.0.0 6-7|0.0.0.0.0.1 3-4|0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:31.541
(a2 / and 
      :op1 (a / appear-01 
            :ARG1 (m / mouse 
                  :ARG1-of (p / produce-01 
                        :ARG1-of (a3 / accord-02 
                              :ARG2 (r / ratio 
                                    :op1 (t / thing 
                                          :name (n2 / name 
                                                :op1 "Mendelian"))) 
                              :mod (g / good)))) 
            :time (b / birth-01)) 
      :op2 (n / normal-02))

# ::snt After one week , severe ataxia was observed , and all homozygotes died before weaning , probably due to convulsions .
# ::tok After one week , severe ataxia was observed , and all homozygotes died before weaning , probably due to convulsions .
# ::alignments 19-20|0.0.1.0.0.1.0.1 16-17|0 14-15|0.0.1.0.0.1.0 13-14|0.0.1.0.0.1 12-13|0.0.1.0.0 11-12|0.0.1.0.0.0 10-11|0.0.1.0.0.0.0 9-10|0.0.1.0 7-8|0.0 5-6|0.0.0 4-5|0.0.0.0 2-3|0.0.1.0.0.1.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:31.692
(p / probable 
      :ARG0-of (o / observe-01 
            :ARG1 (a3 / ataxia 
                  :mod (s / severe)) 
            :time (a4 / after 
                  :time-of (a2 / and 
                        :op1 (d / die-01 
                              :ARG1 (h / homozygot 
                                    :quant (a / all)) 
                              :time (b / before 
                                    :op1 (w / wean-01 
                                          :ARG0 (w2 / week) 
                                          :ARG1 (c / convulsion))))))))

# ::snt No major histological abnormalities were detected in the cerebral cortex or cerebellum of the homozygous mutants ; however , marked hypomyelination of the peripheral nerves was observed .
# ::tok No major histological abnormalities were detected in the cerebral cortex or cerebellum of the homozygous mutants ; however , marked hypomyelination of the peripheral nerves was observed .
# ::alignments 26-27|0.0.0 24-25|0.0.1 23-24|0.0.1.0 20-21|0.0 19-20|0 16-17|0.0.0.0 15-16|0.0.0.0.0.1.2 14-15|0.0.0.0.0.1.2.0 11-12|0.0.0.0.0.1.1 10-11|0.0.0.0.0.1 9-10|0.0.0.0.0.1.0 8-9|0.0.0.0.0.1.0.0 5-6|0.0.0.0.0 3-4|0.0.0.0.0.0 2-3|0.0.0.0.0.0.1 1-2|0.0.0.0.0.0.0 0-1|0.0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:32.330
(m / mark-01 
      :ARG1 (h / hypomyelination 
            :ARG1-of (o / observe-01 
                  :ARG0 (a / and 
                        :op1 (d / detect-01 
                              :ARG1 (a2 / abnormaliti 
                                    :ARG1-of (m3 / major-02) 
                                    :mod (h3 / histological)) 
                              :ARG2 (o2 / or 
                                    :op1 (c2 / cortex 
                                          :mod (c3 / cerebral)) 
                                    :op2 (c / cerebellum) 
                                    :poss (m2 / mutant 
                                          :mod (h2 / homozygou))) 
                              :polarity -))) 
            :poss (n / nerve 
                  :mod (p / peripheral))))

# ::snt The results of our study demonstrate that ADAM22 is closely involved in the correct functioning of the nervous system .
# ::tok The results of our study demonstrate that ADAM22 is closely involved in the correct functioning of the nervous system .
# ::alignments 18-19|0.1.1.0 17-18|0.1.1.0.0 14-15|0.1.1 13-14|0.1.1.1 10-11|0.1 9-10|0.1.2 7-8|0.1.0 5-6|0 4-5|0.0.0.0 3-4|0.0.0.0.0 1-2|0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:32.443
(d / demonstrate-01 
      :ARG0 (t / thing 
            :ARG2-of (r / result-01 
                  :ARG1 (s2 / study-01 
                        :ARG1 (w / we)))) 
      :ARG1 (i / involve-01 
            :ARG1 (a / ADAM22) 
            :ARG2 (f / function-01 
                  :ARG1 (s / system 
                        :ARG1-of (n / nervous-01)) 
                  :ARG1-of (c / correct-02)) 
            :manner (c2 / close)))

# ::snt Further analysis of ADAM22 will provide clues to understanding the mechanisms of human diseases such as epileptic seizures and peripheral neuropathy .
# ::tok Further analysis of ADAM22 will provide clues to understanding the mechanisms of human diseases such as epileptic seizures and peripheral neuropathy .
# ::alignments 20-21|0.2.1 19-20|0.2.1.0 18-19|0.2 17-18|0.2.0 16-17|0.2.0.0 14-15|0.1.0.0.0 13-14|0.0.0 12-13|0.0.0.0 10-11|0.0 8-9|0 6-7|0.1 5-6|0.1.0 1-2|0.1.0.0 0-1|0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:33.461
(u / understand-01 
      :ARG1 (m / mechanism 
            :quant-of (d / disease 
                  :mod (h / human))) 
      :ARG2 (c / clue 
            :ARG1-of (p2 / provide-01 
                  :ARG3 (a2 / analyze-01 
                        :ARG1 (s2 / such) 
                        :mod (f / further)))) 
      :op1-of (a / and 
            :op2 (s / seize-01 
                  :mod (e / epileptic)) 
            :op3 (n / neuropathy 
                  :mod (p / peripheral))))

# ::snt ADAM ( A Disintegrin And Metalloprotease ) is a family of membrane-spanning multi-domain proteins containing a metalloproteinase-like domain and a disintegrin-like domain .
# ::tok ADAM ( A Disintegrin And Metalloprotease ) is a family of membrane-spanning multi-domain proteins containing a metalloproteinase-like domain and a disintegrin-like domain .
# ::alignments 21-22|0.4 18-19|0 17-18|0.3 14-15|0.0 13-14|0.0.0 11-12|0.0.0.0 9-10|0.1.0 3-6|0.2.0.2+0.2.0.1+0.2.0.0+0.2.0+0.2 0-1|0.1.1.0+0.1.1+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:33.919
(a / and 
      :ARG1-of (c / contain-01 
            :ARG0 (p / protein 
                  :mod (m / membrane-spann))) 
      :op1 (o2 / organization 
            :domain-of (f / family) 
            :name (n2 / name 
                  :op1 "ADAM")) 
      :op2 (o / organization 
            :name (n / name 
                  :op1 "Disintegrin" 
                  :op2 "And" 
                  :op3 "Metalloprotease")) 
      :op3 (d2 / domain) 
      :op4 (d / domain))

# ::snt Currently , more than 30 ADAMs have been identified in mammals .
# ::tok Currently , more than 30 ADAMs have been identified in mammals .
# ::alignments 10-11|0.1 8-9|0 5-6|0.0.0.0+0.0.0+0.0 4-5|0.0.2 2-3|0.0.1 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:33.962
(i / identify-01 
      :ARG1 (p / person 
            :name (n / name 
                  :op1 "ADAMs") 
            :quant (m2 / more) 
            :quant 30) 
      :ARG2 (m / mammal) 
      :time (c / current))

# ::snt Their biological activities implicate ADAMs in fertilization , myogenesis and neurogenesis by proteolysis and adhesion .
# ::tok Their biological activities implicate ADAMs in fertilization , myogenesis and neurogenesis by proteolysis and adhesion .
# ::alignments 14-15|0.0.1 13-14|0.0 12-13|0.0.0 10-11|0.3.2 9-10|0.3 8-9|0.3.1 6-7|0.3.0 4-5|0.1.0.0+0.1.0+0.1 3-4|0 2-3|0.2 1-2|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:34.587
(i / implicate-01 
      :ARG0 (a2 / and 
            :op1 (p / proteolysi) 
            :op2 (a / adhesion)) 
      :ARG1 (p2 / person 
            :name (n2 / name 
                  :op1 "ADAMs")) 
      :ARG1-of (a4 / activity-06 
            :ARG0 (b / biology)) 
      :location (a3 / and 
            :op1 (f / fertilization) 
            :op2 (m / myogenesi) 
            :op3 (n / neurogenesi)))

# ::snt Some types of ADAM are catalytically active metalloproteases and shed the extracellular domains of membrane-bound growth factors or receptors [ 1,2 ] .
# ::tok Some types of ADAM are catalytically active metalloproteases and shed the extracellular domains of membrane-bound growth factors or receptors [ 1,2 ] .
# ::alignments 18-19|0.0.0.1 17-18|0.0.0 16-17|0.0.0.0 15-16|0.0.0.0.0 12-13|0.0 11-12|0.0.1 9-10|0 8-9|0.1 7-8|0.1.0 6-7|0.1.0.0 5-6|0.1.0.0.0 3-4|0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 1-2|0.1.0.1 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:34.958
(s / shed-01 
      :ARG1 (d / domain 
            :consist-of (o / or 
                  :op1 (f / factor 
                        :mod (g / grow-01 
                              :ARG1 (s2 / some))) 
                  :op2 (r / receptor)) 
            :mod (e / extracellular)) 
      :op2-of (a / and 
            :op1 (m / metalloproteas 
                  :ARG1-of (a2 / activity-06 
                        :mod (c / catalytically)) 
                  :domain (t / type 
                        :mod (o2 / organization 
                              :name (n / name 
                                    :op1 "ADAM"))))))

# ::snt For example , ADAM17 ( TACE ) has been shown to cleave several substrates , including tumour necrosis factor alpha [ 3,4 ] , heparin-binding epidermal growth factor-like growth factor [ 6,7 ] and transforming growth factor alpha [ 8 ] .
# ::tok For example , ADAM17 ( TACE ) has been shown to cleave several substrates , including tumour necrosis factor alpha [ 3,4 ] , heparin-binding epidermal growth factor-like growth factor [ 6,7 ] and transforming growth factor alpha [ 8 ] .
# ::alignments 39-40|0.1.1.1.0.0 36-37|0 35-36|0.1 34-35|0.0 33-34|0.0.1 29-30|0.1.1.1 28-29|0.1.1 26-27|0.1.1.1.0 25-26|0.1.1.1.0.1 24-25|0.1.0 19-20|0.0.0 18-19|0.1.1.0.0.0 17-18|0.1.1.0.0 16-17|0.1.1.0 13-14|0.0.1.1 12-13|0.0.1.1.0 11-12|0.0.1.0 9-10|0.0.1.0.1 3-4|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 1-2|0.0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:37.914
(f / factor 
      :ARG1-of (t / transform-01 
            :ARG0 (a2 / alpha) 
            :op2-of (a / and 
                  :ARG1-of (c / cleave-01 
                        :ARG0 (p / person 
                              :name (n2 / name 
                                    :op1 "ADAM17")) 
                        :ARG1-of (s3 / show-01 
                              :purpose (e2 / example))) 
                  :op1 (s / substrat 
                        :quant (s2 / several)))) 
      :mod (g / grow-01 
            :ARG0 (h / heparin-bind) 
            :ARG1-of (g2 / grow-01 
                  :ARG0 (t2 / tumour 
                        :mod-of (n / necrosi 
                              :mod-of (f3 / factor))) 
                  :mod-of (f2 / factor 
                        :ARG3-of (g3 / grow-01 
                              :ARG0 8 
                              :ARG1 (e / epidermal))))))

# ::snt Studies of ADAM17-null mice have revealed that ADAM17 is critical in embryogenesis and plays an essential role in the supply of growth factors [ 6,8 ] .
# ::tok Studies of ADAM17-null mice have revealed that ADAM17 is critical in embryogenesis and plays an essential role in the supply of growth factors [ 6,8 ] .
# ::alignments 22-23|0.1.0.1.0.0 21-22|0.1.0.1.0.0.0 19-20|0.1.0.1.0 16-17|0.1.0.1 15-16|0.1.0.1.1 13-14|0.1.0 12-13|0.1 11-12|0.1.0.0.0.0 9-10|0.1.0.0.0 7-8|0.1.0.0.1.0+0.1.0.0.1+0.1.0.0 5-6|0 3-4|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:38.537
(r2 / reveal-01 
      :ARG0 (s2 / study-01 
            :ARG1 (m / mouse)) 
      :ARG1 (a / and 
            :op1 (p / play-02 
                  :ARG0 (p2 / person 
                        :ARG1-of (c / critical-02 
                              :ARG2 (e2 / embryogenesi)) 
                        :name (n / name 
                              :op1 "ADAM17")) 
                  :ARG1 (r / role 
                        :ARG2-of (s / supply-01 
                              :ARG1 (f / factor 
                                    :mod (g / grow-01))) 
                        :mod (e / essential)))))

# ::snt ADAMs are also involved in cell-cell or cell-matrix adhesion through their interaction with integrins or syndecans .
# ::tok ADAMs are also involved in cell-cell or cell-matrix adhesion through their interaction with integrins or syndecans .
# ::alignments 15-16|0.0.0.0.1 14-15|0.0.0.0 13-14|0.0.0.0.0 11-12|0.0.0 8-9|0.0 6-7|0 3-4|0.0.1 2-3|0.0.1.1 0-1|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:39.546
(o2 / or 
      :op1 (a / adhesion 
            :ARG0-of (i2 / interact-01 
                  :ARG1 (o / or 
                        :op1 (i / integrin) 
                        :op2 (s / syndecan))) 
            :ARG2-of (i3 / involve-01 
                  :ARG1 (p / person 
                        :name (n / name 
                              :op1 "ADAMs")) 
                  :mod (a2 / also))))

# ::snt More than 10 ADAMs have been shown to support integrin-mediated cell adhesion in vitro [ 9 ] .
# ::tok More than 10 ADAMs have been shown to support integrin-mediated cell adhesion in vitro [ 9 ] .
# ::alignments 15-16|0.0 11-12|0.1.1 10-11|0.1.1.0 9-10|0.1.1.1 8-9|0.1 6-7|0 2-3|0.1.0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:39.791
(s2 / show-01 
      :ARG0 9 
      :ARG1 (s / support-01 
            :ARG0 (m / more-than 
                  :op1 10) 
            :ARG1 (a / adhesion 
                  :mod (c / cell) 
                  :mod (i / integrin-mediat))))

# ::snt It has been reported that ADAM2-null and ADAM3-null male mutants are infertile and their spermatozoa lack egg-binding abilities [ 10-12 ] .
# ::tok It has been reported that ADAM2-null and ADAM3-null male mutants are infertile and their spermatozoa lack egg-binding abilities [ 10-12 ] .
# ::alignments 17-18|0.1.0.0.1.1 16-17|0.1.0.0.1.1.0 15-16|0.1.0.0.1 14-15|0.1.0.0.1.0 12-13|0.1.0.0 11-12|0.1.0 9-10|0.1 8-9|0.0.0 6-7|0 5-6|0.0.1.0+0.0.1+0.0 3-4|0.1.0.0.0 0-1|0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:40.422
(a3 / and 
      :op1 (p / person 
            :mod (m2 / male) 
            :name (n / name 
                  :op1 "ADAM2-null")) 
      :op2 (m / mutant 
            :domain-of (i / infertile 
                  :op1-of (a2 / and 
                        :ARG0-of (r / report-01 
                              :ARG1 (i2 / it)) 
                        :op2 (l / lack-01 
                              :ARG0 (s / spermatozoon) 
                              :ARG1 (a / ability 
                                    :mod (e / egg-bind)))))))

# ::snt Both ADAM2 and ADAM3 are not metalloproteases because they lack catalytic site sequences in their metalloprotease domain .
# ::tok Both ADAM2 and ADAM3 are not metalloproteases because they lack catalytic site sequences in their metalloprotease domain .
# ::alignments 16-17|0.0.2 15-16|0.0.2.0 12-13|0.0.1 11-12|0.0.2.0.0 10-11|0.0.1.0 9-10|0.0 8-9|0.0.0 7-8|0 5-6|0.0.3 2-3|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:40.605
(c2 / cause-01 
      :ARG0 (l / lack-01 
            :ARG0 (t / they) 
            :ARG1 (s / sequence 
                  :mod (c / catalytic)) 
            :ARG2 (d / domain 
                  :mod (m / metalloprotease 
                        :poss (s2 / site))) 
            :polarity -) 
      :ARG1 (a / and 
            :mod (b / both)))

# ::snt These studies clearly showed that non-proteinase members of ADAMs also have significant roles in vivo .
# ::tok These studies clearly showed that non-proteinase members of ADAMs also have significant roles in vivo .
# ::alignments 14-15|0.1.1 12-13|0.1 11-12|0.1.0 9-10|0.2.0 8-9|0.0.0.1.0+0.0.0.1+0.0.0 6-7|0.0.0.0.1+0.0.0.0+0.0.0.0.0 3-4|0 2-3|0.2 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:41.569
(s2 / show-01 
      :ARG0 (s3 / study-01 
            :ARG0 (p / person 
                  :ARG1-of (h / have-org-role-91 
                        :ARG0 (p2 / person) 
                        :ARG2 (m / member)) 
                  :name (n / name 
                        :op1 "ADAMs")) 
            :mod (t / this)) 
      :ARG1 (r / role 
            :ARG1-of (s / significant-02) 
            :mod (v / vivo)) 
      :ARG1-of (c / clear-06 
            :ARG0 (a / also)))

# ::snt We have reported the findings of ADAM11 , ADAM22 and ADAM23 genes and their restricted expression in the human and murine nervous systems [ 13-15 ] .
# ::tok We have reported the findings of ADAM11 , ADAM22 and ADAM23 genes and their restricted expression in the human and murine nervous systems [ 13-15 ] .
# ::alignments 22-23|0.0.1 21-22|0.0.1.0 20-21|0.1 19-20|0 18-19|0.0.1.0.0 15-16|0.0 14-15|0.0.0 12-13|0.0.2 11-12|0.0.2.3 10-11|0.0.2.1 9-10|0.0.2.1.0 8-9|0.0.2.2 6-7|0.0.2.1.0.0 4-5|0.0.2.0+0.0.2.0.0 2-3|0.0.2.0.0.0 0-1|0.0.2.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:42.867
(a / and 
      :ARG1-of (e / express-01 
            :ARG1-of (r / restrict-01) 
            :ARG2 (s / system 
                  :ARG1-of (n / nervous-01 
                        :mod (h / human))) 
            :op3-of (a2 / and 
                  :ARG0-of (f / find-01 
                        :ARG1 (t / thing 
                              :ARG1-of (r2 / report-01 
                                    :ARG0 (w / we)))) 
                  :mod (a3 / ADAM23 
                        :op2-of (a4 / and 
                              :op1 (a6 / ADAM11))) 
                  :op1 (a5 / ADAM22) 
                  :op2 (g / gene))) 
      :op1 (m / murine))

# ::snt Sequence analysis suggests that they are not metalloproteases , since they all lack a catalytic motif .
# ::tok Sequence analysis suggests that they are not metalloproteases , since they all lack a catalytic motif .
# ::alignments 15-16|0.1.1.0.1 14-15|0.0.0 12-13|0.1.1.0 11-12|0.0.2 9-10|0.1.1 7-8|0.1 6-7|0.1.0 4-5|0.1.1.0.0 2-3|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:43.055
(s2 / suggest-01 
      :ARG0 (a2 / analyze-01 
            :ARG0 (c / catalytic) 
            :ARG1 (s3 / sequence) 
            :ARG2 (a / all)) 
      :ARG1 (m2 / metalloproteas 
            :polarity - 
            :time (s / since 
                  :op1 (l / lack-01 
                        :ARG0 (t / they) 
                        :ARG1 (m / motif)))))

# ::snt It has been reported that ADAM23 protein is localised to the cell surface [ 16 ] , interacts with alpha-v beta-3 integrin heterodimer [ 17 ] and the disruption of ADAM23 gene in the mouse results in premature death associated with ataxia and tremor [ 18 ] .
# ::tok It has been reported that ADAM23 protein is localised to the cell surface [ 16 ] , interacts with alpha-v beta-3 integrin heterodimer [ 17 ] and the disruption of ADAM23 gene in the mouse results in premature death associated with ataxia and tremor [ 18 ] .
# ::alignments 45-46|0.1.0.0 43-44|0.1.0.2.0.2 42-43|0.1.0.2.0 41-42|0.1.0.2.0.1 39-40|0.1.0.2 38-39|0.1.0 37-38|0.1.0.3 35-36|0+0.1 34-35|0.0 31-32|0.1.0.2.0.0.1.0 28-29|0.1.0.2.0.0.2 26-27|0.1.0.2.0.0 24-25|0.1.0.2.0.0.0.1.0 22-23|0.1.0.2.0.0.1.1 21-22|0.1.0.2.0.0.1.1.0 17-18|0.1.0.2.0.0.1 14-15|0.1.0.1 12-13|0.1.0.2.0.0.0.1.2 11-12|0.1.0.2.0.0.0.1.2.0 8-9|0.1.0.2.0.0.0.1 6-7|0.1.0.2.0.0.0.1.1 3-4|0.1.0.2.0.0.0 0-1|0.1.0.2.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:45.824
(r / result-01 
      :ARG1 (m / mouse) 
      :ARG2 (t2 / thing 
            :topic (d / die-01 
                  :ARG0 18 
                  :ARG1 16 
                  :ARG1-of (a3 / associate-01 
                        :ARG2 (a / and 
                              :op1 (a4 / and 
                                    :ARG0-of (r2 / report-01 
                                          :ARG1 (i3 / it) 
                                          :ARG2 (l / localize-01 
                                                :ARG0 17 
                                                :ARG1 (p2 / protein) 
                                                :ARG2 (s / surface 
                                                      :mod (c / cell)))) 
                                    :ARG2-of (i2 / interact-01 
                                          :ARG0 (g / gene) 
                                          :ARG1 (h / heterodim 
                                                :mod (i / integrin))) 
                                    :op1 (d2 / disruption)) 
                              :op2 (a2 / ataxia) 
                              :op3 (t / tremor))) 
                  :mod (p / premature))))

# ::snt Although the cause of death in this mouse is unknown , for these phenotypes , impaired cell-cell or cell-matrix interactions in the nervous system caused by loss of ADAM23 may be responsible .
# ::tok Although the cause of death in this mouse is unknown , for these phenotypes , impaired cell-cell or cell-matrix interactions in the nervous system caused by loss of ADAM23 may be responsible .
# ::alignments 31-32|0.0.0 29-30|0.0 26-27|0.1.0 24-25|0.1.0.0 23-24|0.1.1 22-23|0.1.1.0 19-20|0.1.0.0.0.1 17-18|0.1.0.0.0 15-16|0.1.0.0.0.1.0 13-14|0.1.0.0.0.0 12-13|0.1.0.0.0.0.0 9-10|0.2.0+0.2 7-8|0.3 6-7|0.3.0 4-5|0.1 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:46.668
(c2 / cause-01 
      :ARG0 (p / possible-01 
            :ARG1 (r / responsible-01)) 
      :ARG1 (d / die-01 
            :mod (l / loss 
                  :ARG0-of (c / cause-01 
                        :ARG1 (o / or 
                              :mod (p2 / phenotyp 
                                    :mod (t / this)) 
                              :op1 (i / interaction 
                                    :ARG1-of (i2 / impair-01))))) 
            :mod (s / system 
                  :ARG1-of (n / nervous-01))) 
      :ARG1-of (k / know-01 
            :polarity -) 
      :location (m / mouse 
            :mod (t2 / this)))

# ::snt ADAM22 and ADAM23 share highly homologous sequences in their extracellular domains .
# ::tok ADAM22 and ADAM23 share highly homologous sequences in their extracellular domains .
# ::alignments 10-11|0.0.1 9-10|0.0.1.0 6-7|0.0.0 5-6|0.0.0.0 4-5|0.0.0.0.0 3-4|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:46.759
(a / and 
      :op1 (s2 / share-01 
            :ARG1 (s / sequence 
                  :mod (h / homologou 
                        :degree (h2 / high))) 
            :ARG2 (d / domain 
                  :mod (e / extracellular))))

# ::snt Especially , it is evident in their putative integrin binding loop sequences , CR ( E/D ) AVN ( E/D ) CD , which is located centre of the disintegrin domain .
# ::tok Especially , it is evident in their putative integrin binding loop sequences , CR ( E/D ) AVN ( E/D ) CD , which is located centre of the disintegrin domain .
# ::alignments 30-31|0.0.0.0 29-30|0.0.0.0.0 26-27|0.0.0.0.1 25-26|0.0.0.0.1.0 21-22|0.0.0.0.1.0.0 17-18|0.0.0.0.1.0.0.0.0.0+0.0.0.0.1.0.0.0.0+0.0.0.0.1.0.0.0 13-14|0.0.0.0.2 11-12|0.0 10-11|0.0.2 9-10|0.0.0 7-8|0.0.1 4-5|0 0-1|0.0.0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:47.388
(e / evident 
      :location (s / sequence 
            :ARG0-of (b / binding-07 
                  :ARG1 (d / domain 
                        :mod (d2 / disintegrin) 
                        :poss (c / centre-left 
                              :ARG1-of (l / locate-01 
                                    :ARG0 (c2 / cd 
                                          :mod (o / organization 
                                                :name (n / name 
                                                      :op1 "AVN"))) 
                                    :ARG2 (e2 / especially))) 
                        :poss-of (c3 / cr))) 
            :mod (p / putative) 
            :mod (l2 / loop)))

# ::snt These findings led us to hypothesize that ADAM22 is an integrin binder and plays an important role in the nervous system , as does ADAM23 .
# ::tok These findings led us to hypothesize that ADAM22 is an integrin binder and plays an important role in the nervous system , as does ADAM23 .
# ::alignments 20-21|0.0.1.0.0.1 19-20|0.0.1.0.0.1.0 16-17|0.0.1.0.0 15-16|0.0.1.0.0.0 13-14|0.0.1.0 12-13|0.0.1 11-12|0.0 10-11|0 5-6|0.0.0 2-3|0.0.0.0 1-2|0.0.0.0.0.0+0.0.0.0.0 0-1|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:47.740
(i2 / integrin 
      :ARG1-of (b / bind-01 
            :ARG1-of (h / hypothesize-01 
                  :ARG1-of (l / lead-02 
                        :ARG0 (t / thing 
                              :ARG1-of (f / find-01) 
                              :mod (t2 / this)))) 
            :op1-of (a / and 
                  :op2 (p / play-02 
                        :ARG1 (r / role 
                              :mod (i / important) 
                              :mod (s / system 
                                    :ARG1-of (n / nervous-01)))))))

# ::snt To determine the physiological functions of ADAM22 , we generated and analysed Adam22 gene-targeted mice .
# ::tok To determine the physiological functions of ADAM22 , we generated and analysed Adam22 gene-targeted mice .
# ::alignments 14-15|0.0.1 13-14|0.0.1.0 10-11|0 9-10|0.0 8-9|0.0.0 4-5|0.0.0.0.0 3-4|0.0.0.0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:48.139
(a / and 
      :op1 (g2 / generate-01 
            :ARG0 (w / we 
                  :ARG0-of (d / determine-01 
                        :ARG1 (f / function-01 
                              :ARG1 (p / physiological)))) 
            :ARG1 (m / mouse 
                  :mod (g / gene-target))))

# ::snt Generation of ADAM22-deficient mice .
# ::tok Generation of ADAM22-deficient mice .
# ::alignments 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:48.148
(g / generation 
      :mod (m / mouse))

# ::snt Mice carrying a targeted mutation in their Adam22 gene were generated by homologous recombination ( Fig. 1A ) .
# ::tok Mice carrying a targeted mutation in their Adam22 gene were generated by homologous recombination ( Fig. 1A ) .
# ::alignments 15-16|0.1.0.0+0.1.0+0.1 13-14|0.0.0.0.0.0 12-13|0.0.0.0.0.0.0 10-11|0.0.0.0.0 8-9|0.0.1 7-8|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 4-5|0.0 3-4|0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:48.332
(t / target-01 
      :ARG0 (m / mutation 
            :ARG1-of (c3 / carry-01 
                  :ARG0 (m2 / mouse 
                        :ARG1-of (g / generate-01 
                              :ARG0 (r / recombination 
                                    :mod (h / homologou))))) 
            :location (g2 / gene 
                  :mod (c2 / country 
                        :name (n2 / name 
                              :op1 "Adam22")))) 
      :ARG1 (c / country 
            :name (n / name 
                  :op1 "Fig.")))

# ::snt Correct targeting events were confirmed by Southern blot analysis ( Fig. 1B ) .
# ::tok Correct targeting events were confirmed by Southern blot analysis ( Fig. 1B ) .
# ::alignments 10-11|0.0.0.0.0+0.0.0.0+0.0.0 8-9|0.0 7-8|0.0.2 6-7|0.0.1.0.0+0.0.1.0+0.0.1 4-5|0 2-3|0.1.0.0 1-2|0.1.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:48.614
(c2 / confirm-01 
      :ARG0 (a / analyze-01 
            :ARG0 (c / country 
                  :name (n / name 
                        :op1 "Fig.")) 
            :ARG1 (t / thing 
                  :name (n2 / name 
                        :op1 "Southern")) 
            :ARG1-of (b / blot-01)) 
      :ARG1 (c3 / correct-01 
            :ARG0-of (t2 / target-01 
                  :ARG1 (e / event))))

# ::snt Since the termination codon was introduced in exon 8 in the pro-protein domain , only the truncated form of the ADAM22 protein would be synthesized from this targeted allele .
# ::tok Since the termination codon was introduced in exon 8 in the pro-protein domain , only the truncated form of the ADAM22 protein would be synthesized from this targeted allele .
# ::alignments 28-29|0.1 27-28|0.1.0 26-27|0.1.1 24-25|0 21-22|0.0.3 17-18|0.0 16-17|0.0.1 14-15|0.0.2 12-13|0.0.0.1 8-9|0.0.1.0 7-8|0.0.0.2 5-6|0.0.0 3-4|0.0.0.0 2-3|0.0.0.0.0 0-1|0.0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:48.832
(s / synthesize-01 
      :ARG1 (f / form 
            :ARG0-of (i / introduce-02 
                  :ARG1 (c / codon 
                        :ARG1-of (t4 / terminate-01)) 
                  :ARG2 (d / domain) 
                  :manner (e / exon) 
                  :op1-of (s2 / since)) 
            :mod (t3 / truncate-01 
                  :ARG1 8) 
            :mod (o / only) 
            :poss (p / protein)) 
      :ARG2 (a / allele 
            :ARG1-of (t / target-01) 
            :mod (t2 / this)))

# ::snt Because a pro-protein domain is always removed in the mature functional ADAM-proteins by the Furin-like proteases and is thought to be non-functional itself , we considered that this truncated form of ADAM22 protein has no function .
# ::tok Because a pro-protein domain is always removed in the mature functional ADAM-proteins by the Furin-like proteases and is thought to be non-functional itself , we considered that this truncated form of ADAM22 protein has no function .
# ::alignments 35-36|0.1.3 34-35|0.1.3.1 32-33|0.1.3.0 31-32|0.1.3.0.0 29-30|0.1.3.0.1 28-29|0.1.3.0.1.0 27-28|0.1.3.0.1.1 25-26|0 24-25|0.0 18-19|0.1.2 16-17|0.1 15-16|0.1.1.0 14-15|0.1.3.0.1.0.0.0.0.0+0.1.3.0.1.0.0.0.0+0.1.3.0.1.0.0.0 11-12|0.1.1.2 10-11|0.1.1.2.0 9-10|0.1.3.0.1.0.0 6-7|0.1.1 5-6|0.1.1.3 3-4|0.1.1.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:49.264
(c / consider-01 
      :ARG0 (w / we) 
      :ARG1 (a2 / and 
            :ARG0-of (c2 / cause-01) 
            :op1 (r / remove-01 
                  :ARG0 (p2 / proteas) 
                  :ARG1 (d / domain) 
                  :time (a3 / adam-protein 
                        :mod (f3 / functional)) 
                  :time (a4 / always)) 
            :op2 (t3 / think-01) 
            :op3 (f / function-01 
                  :ARG1 (p / protein 
                        :mod (a / ADAM22) 
                        :mod-of (f2 / form 
                              :mod (t / truncate-01 
                                    :ARG1 (m / mature-02 
                                          :ARG1 (t4 / thing 
                                                :name (n / name 
                                                      :op1 "Furin-like")))) 
                              :mod (t2 / this))) 
                  :polarity -)))

# ::snt Absence of mature ADAM22 protein in homozygous mutants was confirmed by Western blot analysis using the specific antibody , which recognizes the cytoplasmic domain of the ADAM22 protein ( Fig. 1C ) .
# ::tok Absence of mature ADAM22 protein in homozygous mutants was confirmed by Western blot analysis using the specific antibody , which recognizes the cytoplasmic domain of the ADAM22 protein ( Fig. 1C ) .
# ::alignments 29-30|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 27-28|0 23-24|0.0 22-23|0.0.1 20-21|0.0.0 17-18|0.0.0.0 16-17|0.0.0.0.1 14-15|0.0.0.0.0 13-14|0.0.0.0.0.1.0 12-13|0.0.0.0.0.1.0.0 11-12|0.0.0.0.0.1.0.1.2+0.0.0.0.0.1.0.1.1.0+0.0.0.0.0.1.0.1.1+0.0.0.0.0.1.0.1 9-10|0.0.0.0.0.1 7-8|0.0.0.0.0.1.0.0.0 6-7|0.0.0.0.0.1.0.0.0.0 4-5|0.0.0.0.0.1.0.1.0 3-4|0.0.0.0.0.1.0.1.0.1 2-3|0.0.0.0.0.1.0.1.0.0 0-1|0.0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:51.682
(p / protein 
      :poss-of (d / domain 
            :ARG1-of (r / recognize-02 
                  :ARG0 (a / antibody 
                        :ARG1-of (u / use-01 
                              :ARG0 (c / country 
                                    :name (n / name 
                                          :op1 "Fig.")) 
                              :ARG1-of (c3 / confirm-01 
                                    :ARG0 (a2 / analyze-01 
                                          :ARG1 (b / blot-01 
                                                :ARG0 (m / mutant 
                                                      :mod (h / homozygou))) 
                                          :manner (w / world-region 
                                                :mod-of (p2 / protein 
                                                      :ARG1-of (m2 / mature-02) 
                                                      :mod (a3 / ADAM22)) 
                                                :name (n2 / name 
                                                      :op1 "West") 
                                                :wiki "Western_world"))) 
                              :ARG2 (a4 / absence)) 
                        :ARG1-of (s / specific-02))) 
            :mod (c2 / cytoplasmic)))

# ::snt Homozygous mutants showed no noticeable defects at birth and were indistinguishable from wild-type or heterozygous littermates during the first week .
# ::tok Homozygous mutants showed no noticeable defects at birth and were indistinguishable from wild-type or heterozygous littermates during the first week .
# ::alignments 19-20|0.1.0.0 15-16|0.1.2.1 14-15|0.1.2.0 13-14|0.1.2 10-11|0.2.0 8-9|0.2 7-8|0.1.0 5-6|0.1 4-5|0.1.1 3-4|0.2.0.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:52.088
(s / show-01 
      :ARG0 (m / mutant 
            :mod (h2 / homozygou)) 
      :ARG1 (d / defect-01 
            :ARG1 (b / birth-01 
                  :ARG1 (w / week)) 
            :mod (n / noticeable) 
            :op1-of (o / or 
                  :op2 (h / heterozygou) 
                  :op3 (l / littermat))) 
      :op1-of (a / and 
            :op2 (i / indistinguishable 
                  :polarity -)))

# ::snt At postnatal day 10 ( P10 ) , most of the homozygous mutants were distinguishable by abnormalities such as reduced body weight and uncoordinated movements of their limbs .
# ::tok At postnatal day 10 ( P10 ) , most of the homozygous mutants were distinguishable by abnormalities such as reduced body weight and uncoordinated movements of their limbs .
# ::alignments 27-28|0.0.1 24-25|0.0 23-24|0 22-23|0.0.4 21-22|0.0.4.0 20-21|0.0.4.0.2 19-20|0.0.4.0.1 17-18|0.0.4.0.1.1 16-17|0.0.4.0.0 14-15|0.0.3.1 12-13|0.0.0 11-12|0.0.0.0 8-9|0.0.4.0.1.0 3-4|0.0.2 2-3|0.0.3 1-2|0.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:52.894
(u / uncoordinat 
      :mod-of (m / move-01 
            :ARG0 (m2 / mutant 
                  :mod (h / homozygou)) 
            :ARG1 (l / limb) 
            :ARG2 10 
            :op1-of (d2 / day 
                  :mod (p / postnatal) 
                  :time-of (d / distinguishable)) 
            :op2-of (a / and 
                  :op1 (w / weight 
                        :example-of (a2 / abnormaliti) 
                        :mod (r / reduce-01 
                              :ARG0 (m3 / most) 
                              :ARG1 (s / such)) 
                        :part-of (b / body)))))

# ::snt After P10 , all homozygotes displayed severe ataxia ( Fig. 2 ) and began to die .
# ::tok After P10 , all homozygotes displayed severe ataxia ( Fig. 2 ) and began to die .
# ::alignments 15-16|0.1.1 13-14|0.1 12-13|0 10-11|0.1.1.0 9-10|0.1.0.0.0+0.1.0.0+0.1.0 7-8|0.0.1 6-7|0.0.1.0 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:53.976
(a / and 
      :op1 (d2 / display-01 
            :ARG0 (h / homozygot 
                  :quant (a3 / all)) 
            :ARG1 (a2 / ataxia 
                  :mod (s / severe))) 
      :op2 (b / begin-01 
            :ARG0 (c / country 
                  :name (n / name 
                        :op1 "Fig.")) 
            :ARG1 (d / die-01 
                  :ARG1 2)) 
      :time (a4 / after))

# ::snt To measure the survival rate and body weight of each genotype precisely , we backcrossed heterozygous male mutants to C57BL/6 females more than 6 times .
# ::tok To measure the survival rate and body weight of each genotype precisely , we backcrossed heterozygous male mutants to C57BL/6 females more than 6 times .
# ::alignments 23-24|0.3.0.4 21-22|0.3.0.1 20-21|0.3.0.2.0 19-20|0.3.0.2.1.0+0.3.0.2.1+0.3.0.2 17-18|0.0.0.0 16-17|0.3.0.0 15-16|0.0.0.0.0 13-14|0.0.0 11-12|0.1 10-11|0.3 9-10|0.3.1 7-8|0.2 6-7|0.2.0 5-6|0 4-5|0.3.0.3 3-4|0.3.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:55.227
(a / and 
      :ARG1-of (m4 / measure-01 
            :ARG0 (w / we 
                  :poss-of (m2 / mutant 
                        :mod (h / heterozygou)))) 
      :mod (p / precise) 
      :op1 (w2 / weight 
            :part-of (b / body)) 
      :op2 (g / genotype 
            :ARG0-of (s / survive-01 
                  :ARG1 (m3 / male) 
                  :ARG2 (m / more) 
                  :manner (t / thing 
                        :mod-of (f / female) 
                        :name (n / name 
                              :op1 "C57BL/6")) 
                  :mod-of (r / rate) 
                  :op1-of 6) 
            :mod (e / each)))

# ::snt The resulting ( N 6 ) heterozygous males and females were intercrossed and the produced offspring were analysed .
# ::tok The resulting ( N 6 ) heterozygous males and females were intercrossed and the produced offspring were analysed .
# ::alignments 15-16|0.3.1 14-15|0.3 12-13|0 11-12|0.2 9-10|0.1 8-9|0.2.0 7-8|0.0 6-7|0.0.1 4-5|0.3.2 3-4|0.3.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:55.419
(a / and 
      :op1 (m / male 
            :ARG1-of (r / result-01) 
            :mod (h / heterozygou)) 
      :op2 (f / female) 
      :op3 (i / intercross 
            :domain (a2 / and)) 
      :op4 (p / produce-01 
            :ARG0 (n / N) 
            :ARG1 (o / offspr) 
            :ARG2 6))

# ::snt The numbers of survivors of each genotype every 5 days are shown in Table 1 .
# ::tok The numbers of survivors of each genotype every 5 days are shown in Table 1 .
# ::alignments 14-15|0.0.0 13-14|0.0 11-12|0 9-10|0.1.1+0.1 8-9|0.1.0 7-8|0.1.1.0 6-7|0.2.0.0.0 5-6|0.2.0.0.0.0 3-4|0.2.0.0+0.2.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:55.850
(s / show-01 
      :ARG0 (t / table 
            :mod 1) 
      :ARG1 (t2 / temporal-quantity 
            :quant 5 
            :unit (d / day 
                  :mod (e / every))) 
      :ARG2 (n / number 
            :quant-of (p / person 
                  :ARG0-of (s2 / survive-01 
                        :ARG1 (g / genotype 
                              :mod (e2 / each))))))

# ::snt At P10 , the ratio of each genotype was in close accordance with the Mendelian ratio ( 20.5 % + / + , 55.1 % + / - , 24.4 % - / - ; n = 78 ) .
# ::tok At P10 , the ratio of each genotype was in close accordance with the Mendelian ratio ( 20.5 % + / + , 55.1 % + / - , 24.4 % - / - ; n = 78 ) .
# ::alignments 37-38|0.0.5 35-36|0.3 34-35|0 32-33|0.2 30-31|0.0.7 26-27|0.1 24-25|0.0.6 20-21|0.0.2.0.1 18-19|0.0.1 15-16|0.0.2 14-15|0.0.2.0.0.0+0.0.2.0.0+0.0.2.0 11-12|0.0 10-11|0.0.4 7-8|0.0.8 6-7|0.0.8.0 4-5|0.0.0 1-2|0.0.3.0.0+0.0.3.0+0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:56.463
(a / and 
      :op1 (a2 / accord-02 
            :ARG0 (r2 / ratio) 
            :ARG1 (p3 / percentage-entity) 
            :ARG2 (r / ratio 
                  :op1 (t / thing 
                        :name (n2 / name 
                              :op1 "Mendelian") 
                        :op1-of (s3 / slash))) 
            :location (c2 / country 
                  :name (n3 / name 
                        :op1 "P10")) 
            :manner (c / close) 
            :op1-of 78 
            :op1-of (p2 / percentage-entity) 
            :op1-of (p / percentage-entity) 
            :topic (g / genotype 
                  :mod (e / each))) 
      :op1-of (s2 / slash) 
      :op2 (s / slash) 
      :op3 (n / n))

# ::snt This result shows that ADAM22 is not essential for embryogenesis .
# ::tok This result shows that ADAM22 is not essential for embryogenesis .
# ::alignments 9-10|0.0.2 7-8|0.0 6-7|0.0.1 4-5|0.0.0 2-3|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:56.517
(s / show-01 
      :ARG1 (e2 / essential 
            :domain (a / ADAM22) 
            :polarity - 
            :purpose (e / embryogenesi)) 
      :ARG2-of (r / result-01 
            :mod (t / this)))

# ::snt At P10 , the average body weight of homozygous mutants was approximately half that of wild-type and heterozygous littermates ( Table 2 ) .
# ::tok At P10 , the average body weight of homozygous mutants was approximately half that of wild-type and heterozygous littermates ( Table 2 ) .
# ::alignments 21-22|0.3.0 20-21|0.3 18-19|0.2 17-18|0.1 16-17|0 13-14|0.2.0 12-13|0.3.0.0.0 11-12|0.3.0.0.0.0 9-10|0.3.0.0.1.0 8-9|0.3.0.0.1.0.0 6-7|0.3.0.0.1 5-6|0.3.0.0.1.1 4-5|0.3.0.0 1-2|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:56.843
(a / and 
      :op1 (c / country 
            :name (n / name 
                  :op1 "P10")) 
      :op2 (h / heterozygou) 
      :op3 (l / littermat 
            :mod (t2 / that)) 
      :op4 (t / table 
            :mod (2 / 2 
                  :ARG2-of (a3 / average-01 
                        :ARG0 (h2 / half 
                              :mod (a2 / approximately)) 
                        :ARG1 (w / weight 
                              :mod (m / mutant 
                                    :mod (h3 / homozygou)) 
                              :part-of (b / body))))))

# ::snt Homozygous mutants died one by one after P10 , and all homozygotes died before P20 .
# ::tok Homozygous mutants died one by one after P10 , and all homozygotes died before P20 .
# ::alignments 14-15|0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 13-14|0.2.1 12-13|0.2 11-12|0.2.0 10-11|0.2.0.0 9-10|0 6-7|0.2.0.0.0 2-3|0.0 1-2|0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:57.380
(a2 / and 
      :ARG1-of (d2 / die-01 
            :ARG0 (h2 / homozygou)) 
      :op1 (m / mutant) 
      :op2 (d / die-01 
            :ARG1 (h / homozygot 
                  :quant (a / all 
                        :op1-of (a3 / after))) 
            :time (b / before 
                  :op1 (t / thing 
                        :name (n / name 
                              :op1 "P20")))))

# ::snt Of more than 100 homozygotes we have produced , none have survived more than 25 days after birth .
# ::tok Of more than 100 homozygotes we have produced , none have survived more than 25 days after birth .
# ::alignments 17-18|0.2.0 16-17|0.2 15-16|0.2.1.1+0.2.1 14-15|0.2.1.0 12-13|0.2.0.1 11-12|0 9-10|0.1 7-8|0.0.0 5-6|0.0.0.0 4-5|0.0 3-4|0.2.0.0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:57.756
(s / survive-01 
      :ARG0 (h / homozygot 
            :ARG1-of (p / produce-01 
                  :ARG0 (w / we) 
                  :ARG2 (m2 / more))) 
      :ARG1 (n / none) 
      :time (a / after 
            :op1 (b / birth-01 
                  :ARG1 100 
                  :ARG2 (m / more)) 
            :quant (t / temporal-quantity 
                  :quant 25 
                  :unit (d / day))))

# ::snt Meanwhile , heterozygous mutants looked normal , were fertile , and survived for more than one year without obvious defects .
# ::tok Meanwhile , heterozygous mutants looked normal , were fertile , and survived for more than one year without obvious defects .
# ::alignments 19-20|0.2.0 18-19|0.2.0.1 16-17|0.2.0.0 13-14|0.2.0.2 11-12|0.2 10-11|0 8-9|0.1 5-6|0.0.0 4-5|0.0 3-4|0.0.0.0 2-3|0.0.0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:57.920
(a / and 
      :op1 (l / look-01 
            :ARG2 (n / normal-02 
                  :ARG1 (m2 / mutant 
                        :mod (h / heterozygou))) 
            :time (m3 / meanwhile)) 
      :op2 (f / fertile) 
      :op3 (s / survive-01 
            :prep-without (d / defect-01 
                  :ARG1 (y / year) 
                  :ARG1-of (o / obvious-01) 
                  :duration (m / more))))

# ::snt Histopathology of ADAM22-deficient mice .
# ::tok Histopathology of ADAM22-deficient mice .
# ::alignments 3-4|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:57.934
(m / mouse)

# ::snt We have reported the predominant expression of ADAM22 mRNA in the human and mouse brain by Northern blot analysis [ 13,14 ] .
# ::tok We have reported the predominant expression of ADAM22 mRNA in the human and mouse brain by Northern blot analysis [ 13,14 ] .
# ::alignments 18-19|0.1.0.0 17-18|0.1.0 16-17|0.1.0.0.1 14-15|0.1 13-14|0.1.1 12-13|0 11-12|0.1.0.0.0 7-9|0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 5-6|0.0.1 4-5|0.0.1.1 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:58.494
(a2 / and 
      :op1 (r / report-01 
            :ARG0 (w / we) 
            :ARG1 (e / express-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 (a3 / ADAM22) 
                              :op2 (m2 / mRNA))) 
                  :mod (p / predominant))) 
      :op2 (b2 / brain 
            :ARG0-of (b / blot-01 
                  :ARG1 (a / analyze-01 
                        :ARG1 (h / human) 
                        :mod "Northern_Ireland")) 
            :mod (m / mouse)))

# ::snt To determine the distribution of ADAM22 transcript in the adult mouse CNS precisely , in situ hybridisation analysis was performed using 35S-labeled RNA probe .
# ::tok To determine the distribution of ADAM22 transcript in the adult mouse CNS precisely , in situ hybridisation analysis was performed using 35S-labeled RNA probe .
# ::alignments 23-24|0.0.1.0.0 22-23|0.0.1.0.0.0 21-22|0.0.1.0.0.1 20-21|0.0.1.0 19-20|0.0.1.0.1 17-18|0.1 16-17|0.1.0 12-13|0.0.1.0.1.0 11-12|0.0.1.2.0+0.0.1.2+0.0.1 10-11|0.0.1.1 9-10|0.0.1.1.0 6-7|0.0.0.0+0.0.0 5-6|0.0.0.0.0 3-4|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:59.383
(d2 / determine-01 
      :ARG1 (d / distribute-01 
            :ARG1 (t / thing 
                  :ARG1-of (t2 / transcribe-01 
                        :ARG2 (a3 / ADAM22))) 
            :location (o / organization 
                  :ARG0-of (u / use-01 
                        :ARG1 (p / probe-01 
                              :ARG0 (r / rna) 
                              :mod 35s-label) 
                        :ARG1-of (p2 / perform-02 
                              :ARG0 (p3 / precise))) 
                  :mod (m / mouse 
                        :mod (a2 / adult)) 
                  :name (n / name 
                        :op1 "CNS"))) 
      :manner (a / analyze-01 
            :ARG1 (h / hybridisation)))

# ::snt As shown in Fig. 3 , ADAM22 mRNA was expressed throughout the adult mouse CNS .
# ::tok As shown in Fig. 3 , ADAM22 mRNA was expressed throughout the adult mouse CNS .
# ::alignments 14-15|0.1.0 13-14|0.1.0.0 12-13|0.1.0.0.0 10-11|0.1 9-10|0 6-8|0.0.0.1+0.0.0.0+0.0.0+0.0 4-5|0.1.0.1 3-4|0.2.0.0.0+0.2.0.0+0.2.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:59.566
(e / express-01 
      :ARG1 (t2 / thing 
            :name (n / name 
                  :op1 (a2 / ADAM22) 
                  :op2 (m2 / mRNA))) 
      :ARG2 (t / throughout 
            :op1 (c / cn 
                  :mod (m / mouse 
                        :mod (a / adult)) 
                  :mod-of 3)) 
      :time (s / show-01 
            :ARG0 (c2 / country 
                  :name (n2 / name 
                        :op1 "Fig."))))

# ::snt Strong signal was detected in the cerebellar granule cells and hippocampal formation .
# ::tok Strong signal was detected in the cerebellar granule cells and hippocampal formation .
# ::alignments 11-12|0.1.1 10-11|0.1.1.0 9-10|0.1 8-9|0.1.0 7-8|0.1.0.0 6-7|0.1.0.0.0 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:59.771
(d / detect-01 
      :ARG1 (s / signal 
            :mod (s2 / strong)) 
      :location (a / and 
            :op1 (c / cell 
                  :mod (g / granule 
                        :mod (c2 / cerebellar))) 
            :op2 (f / form-01 
                  :ARG0 (h / hippocampal))))

# ::snt In the spinal cord , hybridisation signal was restricted to the grey matter .
# ::tok In the spinal cord , hybridisation signal was restricted to the grey matter .
# ::alignments 12-13|0.1 11-12|0.1.0 8-9|0 6-7|0.0 5-6|0.0.0 3-4|0.2 2-3|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:21:59.863
(r / restrict-01 
      :ARG1 (s / signal 
            :mod (h / hybridisation)) 
      :ARG2 (m / matter 
            :mod (g / grey)) 
      :location (c / cord 
            :mod (s2 / spinal)))

# ::snt The distribution of ADAM22 transcripts in the CNS was quite similar with that of ADAM11 , whose neuronal expression has been reported [ 19 ] .
# ::tok The distribution of ADAM22 transcripts in the CNS was quite similar with that of ADAM11 , whose neuronal expression has been reported [ 19 ] .
# ::alignments 23-24|0.0.0.0.0.0 21-22|0.0 18-19|0 17-18|0.1 12-13|0.0.0.0.0.1.0 10-11|0.0.0.0.0.1 9-10|0.0.0.0.0.1.1 7-8|0.0.0.1.0+0.0.0.1+0.0.0 4-5|0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:00.159
(e / express-01 
      :ARG1-of (r / report-01 
            :ARG0 (o / organization 
                  :location-of (t2 / transcript 
                        :ARG1-of (d / distribute-01 
                              :ARG0 19 
                              :ARG1-of (r2 / resemble-01 
                                    :ARG2 (t / that) 
                                    :degree (q / quite)))) 
                  :name (n2 / name 
                        :op1 "CNS"))) 
      :mod (n / neuronal))

# ::snt These results suggest that the ADAM22 mRNA expression is neuronal in the mouse CNS .
# ::tok These results suggest that the ADAM22 mRNA expression is neuronal in the mouse CNS .
# ::alignments 13-14|0.1.0.1.1.0+0.1.0.1.1+0.1.0.1 12-13|0.1.0.1.0 9-10|0.1 7-8|0.1.0 5-7|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 2-3|0 1-2|0.0.0+0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:00.290
(s / suggest-01 
      :ARG0 (t2 / thing 
            :ARG2-of (r / result-01) 
            :mod (t3 / this)) 
      :ARG1 (n2 / neuronal 
            :domain (e / express-01 
                  :ARG0 (t / thing 
                        :name (n3 / name 
                              :op1 (a / ADAM22) 
                              :op2 (m2 / mRNA))) 
                  :poss-of (o / organization 
                        :mod (m / mouse) 
                        :name (n / name 
                              :op1 "CNS")))))

# ::snt Based on the mRNA distribution pattern , we performed immunohistopathological analysis of the cerebellum and hippocampus extensively .
# ::tok Based on the mRNA distribution pattern , we performed immunohistopathological analysis of the cerebellum and hippocampus extensively .
# ::alignments 16-17|0.0.0.0.1 15-16|0.0.0.0.0.0.1.0 14-15|0.0.0.0.0.0.1 13-14|0.0.0.0.0.0.0.0 10-11|0.0.0.0.0.0.0 8-9|0.0.0.0.0.0 7-8|0.0.0.0.0 5-6|0.0.0 4-5|0.0 3-4|0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:01.025
(m / mrna 
      :ARG1-of (d / distribute-01 
            :ARG0 (p2 / pattern 
                  :ARG2-of (b / base-02 
                        :ARG0 (w / we 
                              :ARG0-of (p / perform-02 
                                    :ARG1 (a2 / analyze-01 
                                          :ARG1 (c / cerebellum)) 
                                    :op1-of (a / and 
                                          :op2 (h / hippocampu)))) 
                        :ARG1 (e / extensive)))))

# ::snt Despite the high level of expression of ADAM22 mRNAs in the cerebellar granule cells , granule cell layer was normally formed and Purkinje cell morphology ( calbindin-staining ) of the mutant mouse looked intact ( Figs. 4A -- D ) .
# ::tok Despite the high level of expression of ADAM22 mRNAs in the cerebellar granule cells , granule cell layer was normally formed and Purkinje cell morphology ( calbindin-staining ) of the mutant mouse looked intact ( Figs. 4A -- D ) .
# ::alignments 38-39|0.0.1.0 35-36|0.2.2.2.0.0 33-34|0.2.1 32-33|0.2 31-32|0.2.0 30-31|0.2.0.0 26-27|0.2.2.0 24-25|0.1 23-24|0.1.0 22-23|0.1.0.0 21-22|0 20-21|0.0 19-20|0.0.1 17-18|0.0.0 16-17|0.0.0.0 15-16|0.0.0.1 13-14|0.2.2.1.0 12-13|0.2.2.1.0.0 11-12|0.2.2.1.0.1 8-9|0.2.2.1 5-6|0.2.2 3-4|0.2.2.2 2-3|0.2.2.2.0 0-1|0.2.2.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:01.886
(a / and 
      :op1 (f2 / form-01 
            :ARG1 (l2 / layer 
                  :mod (c3 / cell) 
                  :mod (g / granule)) 
            :ARG1-of (n / normal-02 
                  :ARG0 (d / D))) 
      :op2 (m3 / morphology 
            :mod (c2 / cell 
                  :mod (p / purkinje))) 
      :op3 (l / look-01 
            :ARG0 (m / mouse 
                  :mod (m2 / mutant)) 
            :ARG1 (i / intact) 
            :ARG2-of (e / express-01 
                  :ARG0 (c / calbindin-stain) 
                  :ARG1 (m4 / mrna 
                        :location (c4 / cell 
                              :mod (g2 / granule) 
                              :mod (c5 / cerebellar) 
                              :poss-of (d2 / despite))) 
                  :mod-of (l3 / level 
                        :ARG1-of (h / high-02 
                              :ARG0 (f / fig.))))))

# ::snt Hippocampal formation was also normally formed ( Figs. 4I -- J ) .
# ::tok Hippocampal formation was also normally formed ( Figs. 4I -- J ) .
# ::alignments 10-11|0.1.0.1+0.1.0.0.0+0.1.0.0+0.1.0 7-8|0.0 5-6|0 4-5|0.2 3-4|0.3 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:01.979
(f2 / form-01 
      :ARG0 (f / fig.) 
      :ARG1 (f3 / form-01 
            :ARG1 (a / aircraft-type 
                  :name (n / name 
                        :op1 "J-10") 
                  :wiki "Chengdu_J-10")) 
      :ARG1-of (n2 / normal-02) 
      :mod (a2 / also))

# ::snt These results suggest that neuronal cell migration was not impaired in the mutant mouse .
# ::tok These results suggest that neuronal cell migration was not impaired in the mutant mouse .
# ::alignments 13-14|0.1.1 12-13|0.1.1.0 9-10|0.1 8-9|0.1.2 6-7|0.1.0 5-6|0.1.0.0 4-5|0.1.0.0.0 2-3|0 1-2|0.0.0+0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:02.125
(s / suggest-01 
      :ARG0 (t / thing 
            :ARG2-of (r / result-01) 
            :mod (t2 / this)) 
      :ARG1 (i / impair-01 
            :ARG1 (m3 / migration 
                  :mod (c / cell 
                        :mod (n / neuronal))) 
            :location (m / mouse 
                  :mod (m2 / mutant)) 
            :polarity -))

# ::snt Myelin-formation detected by MBP ( myelin basic protein ) staining of the mutant in the cerebellum ( Fig. 4H ) and spinal cord ( Fig. 4L ) was also indistinguishable with the wild-type littermate ( Figs. 4G , K ) .
# ::tok Myelin-formation detected by MBP ( myelin basic protein ) staining of the mutant in the cerebellum ( Fig. 4H ) and spinal cord ( Fig. 4L ) was also indistinguishable with the wild-type littermate ( Figs. 4G , K ) .
# ::alignments 38-39|0.1.1 35-36|0.1.0.1 33-34|0.3.1 29-30|0.3 28-29|0.3.2 22-23|0.3.0 21-22|0.3.0.0 20-21|0 17-18|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 15-16|0.0.0 12-13|0.0 9-10|0.1.0 7-8|0.2 6-7|0.2.0 5-6|0.2.1 3-4|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:02.638
(a2 / and 
      :example-of (m / mutant 
            :location (c3 / cerebellum)) 
      :op1 (d / detect-01 
            :ARG0 (s2 / stain-01 
                  :ARG0 (o / organization 
                        :name (n2 / name 
                              :op1 "MBP")) 
                  :ARG1 (f / fig.)) 
            :ARG1 (k / k 
                  :mod (c2 / country 
                        :name (n / name 
                              :op1 "Fig.")))) 
      :op2 (p / protein 
            :mod (b / basic) 
            :mod (m2 / myelin)) 
      :op3 (i / indistinguishable 
            :domain (c / cord 
                  :mod (s / spinal)) 
            :domain (l / littermate) 
            :mod (a / also)))

# ::snt In summary , we could not find any signs of abnormalities in the mutant mouse brain by the light microscopic examination .
# ::tok In summary , we could not find any signs of abnormalities in the mutant mouse brain by the light microscopic examination .
# ::alignments 20-21|0.0.2 19-20|0.0.2.0 18-19|0.0.2.2 15-16|0.0.2.1 14-15|0.0.2.1.1 13-14|0.0.2.1.0 10-11|0.0.1.1 8-9|0.0.1 7-8|0.0.1.0 6-7|0.0 5-6|0.1 4-5|0 3-4|0.0.0 1-2|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:03.432
(p / possible-01 
      :ARG1 (f / find-01 
            :ARG0 (w / we) 
            :ARG1 (s / sign 
                  :mod (a2 / any 
                        :mod-of (s2 / summary)) 
                  :topic (a / abnormaliti)) 
            :ARG2-of (e / examine-01 
                  :ARG0 (m / microscopic) 
                  :ARG1 (b / brain 
                        :mod (m3 / mutant) 
                        :part-of (m2 / mouse)) 
                  :ARG1-of (l / light-06))) 
      :polarity -)

# ::snt Next , the spinal cord and peripheral nerves of each genotype were analysed by toluidine blue stain , which reveals myelin formation .
# ::tok Next , the spinal cord and peripheral nerves of each genotype were analysed by toluidine blue stain , which reveals myelin formation .
# ::alignments 21-22|0.2.0.0 20-21|0.2.0.0.1 19-20|0.2.0 16-17|0.2 15-16|0.2.1 10-11|0.0.1 9-10|0.0.1.0 7-8|0.1 6-7|0.1.0 5-6|0 4-5|0.0 3-4|0.0.0 0-1|0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:03.573
(a / and 
      :op1 (c / cord 
            :mod (s2 / spinal) 
            :poss (g / genotype 
                  :mod (e / each))) 
      :op2 (n / nerve 
            :mod (p / peripheral)) 
      :op3 (s / stain-01 
            :ARG0-of (r / reveal-01 
                  :ARG1 (f / form-01 
                        :ARG0 (n2 / next) 
                        :ARG1 (m / myelin))) 
            :mod (b / blue)))

# ::snt Surprisingly , lack of myelin or thin myelin was observed in the sciatic nerves ( Fig. 5B ) and trigeminal nerves ( Fig. 5D ) in homozygous mutants .
# ::tok Surprisingly , lack of myelin or thin myelin was observed in the sciatic nerves ( Fig. 5B ) and trigeminal nerves ( Fig. 5D ) in homozygous mutants .
# ::alignments 27-28|0.1.2.0.1 26-27|0.1.2.0.1.0 20-21|0.0.2 19-20|0.0.2.0 18-19|0.0 15-16|0.0.1.0.0+0.0.1.0+0.0.1 13-14|0.0.0 12-13|0.0.0.0 9-10|0 7-8|0.1.2 6-7|0.1.2.0 5-6|0.1 4-5|0.1.1 2-3|0.1.0 0-1|0.1.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:04.242
(o / observe-01 
      :ARG0 (a / and 
            :op1 (n3 / nerve 
                  :mod (s / sciatic)) 
            :op2 (c / country 
                  :name (n2 / name 
                        :op1 "Fig.")) 
            :op3 (n / nerve 
                  :mod (t / trigeminal))) 
      :ARG1 (o2 / or 
            :ARG1-of (l / lack-01) 
            :op1 (m3 / myelin) 
            :op2 (m2 / myelin 
                  :ARG1-of (t2 / thin-03 
                        :ARG0 (s2 / surprisingly) 
                        :ARG2 (m / mutant 
                              :mod (h / homozygou))))))

# ::snt Because no lesions were observed in the spinal cord ( Fig. 5F ) , it was suggested that Schwann cell specific myelination defect occurred in the homozygous mice .
# ::tok Because no lesions were observed in the spinal cord ( Fig. 5F ) , it was suggested that Schwann cell specific myelination defect occurred in the homozygous mice .
# ::alignments 27-28|0.1.1 26-27|0.1.1.0 23-24|0.1 22-23|0.1.0 21-22|0.1.0.1 20-21|0.1.0.1.0 19-20|0.2.0.0 18-19|0.1.0.0 16-17|0 10-11|0.0.0.0+0.0.0+0.0 8-9|0.2.0.2 7-8|0.2.0.2.0 4-5|0.2.0 2-3|0.2.0.1 1-2|0.1.0.2 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:05.169
(s3 / suggest-01 
      :ARG0 (c2 / country 
            :name (n / name 
                  :op1 "Fig.")) 
      :ARG1 (o / occur-01 
            :ARG0 (d / defect-01 
                  :ARG0 (s2 / schwann) 
                  :ARG1 (m2 / myelination 
                        :ARG1-of (s / specific-02)) 
                  :ARG2 -) 
            :ARG1 (m / mouse 
                  :mod (h / homozygou))) 
      :ARG1-of (c4 / cause-01 
            :ARG0 (o2 / observe-01 
                  :ARG0 (c / cell) 
                  :ARG1 (l / lesion) 
                  :ARG2 (c3 / cord 
                        :mod (s4 / spinal)))))

# ::snt To analyse the state of myelinating Schwann cells and axons , electron microscopic ( EM ) analysis of the sciatic nerve was performed ( Fig. 6 ) .
# ::tok To analyse the state of myelinating Schwann cells and axons , electron microscopic ( EM ) analysis of the sciatic nerve was performed ( Fig. 6 ) .
# ::alignments 25-26|0.0.0.0.0 24-25|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 22-23|0.0.0 20-21|0.0.0.0.1 19-20|0.0.0.0.1.0 16-17|0.0.0.0 14-15|0.0.2.0.0+0.0.2.0+0.0.2 12-13|0.0.0.0.3 11-12|0.0.0.0.2 9-10|0 8-9|0.0 7-8|0.0.1.0 6-7|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 5-6|0.0.1.1 3-4|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:05.911
(a2 / axon 
      :op2-of (a3 / and 
            :ARG0-of (p / perform-02 
                  :ARG1 (a / analyze-01 
                        :ARG0 6 
                        :ARG1 (n2 / nerve 
                              :mod (s / sciatic)) 
                        :manner (e / electron) 
                        :mod (m / microscopic)) 
                  :ARG2 (c / country 
                        :name (n / name 
                              :op1 "Fig."))) 
            :op1 (s2 / state 
                  :mod (c2 / cell 
                        :mod (t / thing 
                              :name (n4 / name 
                                    :op1 "Schwann"))) 
                  :poss (m2 / myelinat)) 
            :op3 (o / organization 
                  :name (n3 / name 
                        :op1 "EM"))))

# ::snt Schwann cells formed thin or no myelin in the homozygous mutant ( Fig. 6B ) .
# ::tok Schwann cells formed thin or no myelin in the homozygous mutant ( Fig. 6B ) .
# ::alignments 12-13|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 10-11|0.2 9-10|0.2.0 6-7|0.1.1 5-6|0.1.1.0 4-5|0.1 3-4|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0.1.0+0.0.0.1+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:06.307
(f / form-01 
      :ARG0 (c2 / cell 
            :mod (t2 / thing 
                  :domain (c / country 
                        :name (n / name 
                              :op1 "Fig.")) 
                  :name (n2 / name 
                        :op1 "Schwann"))) 
      :ARG1 (o / or 
            :op1 (t / thin-03) 
            :op2 (m2 / myelin 
                  :polarity -)) 
      :time (m / mutant 
            :mod (h / homozygou)))

# ::snt In contrast , heterozygous mice showed complete myelination ( Fig. 6A ) .
# ::tok In contrast , heterozygous mice showed complete myelination ( Fig. 6A ) .
# ::alignments 9-10|0.0.0.0+0.0.0+0.0 7-8|0.1.1 6-7|0.1.1.0 5-6|0.1 4-5|0.1.0 3-4|0.1.0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:06.396
(c3 / contrast-01 
      :ARG0 (c / country 
            :name (n / name 
                  :op1 "Fig.")) 
      :ARG1 (s / show-01 
            :ARG0 (m2 / mouse 
                  :mod (h / heterozygou)) 
            :ARG1 (m / myelination 
                  :ARG1-of (c2 / complete-02))))

# ::snt Morphology of the axons looked normal in each genotype .
# ::tok Morphology of the axons looked normal in each genotype .
# ::alignments 8-9|0.3 7-8|0.3.0 5-6|0.2 4-5|0 3-4|0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:06.489
(l / look-01 
      :ARG0 (m / morphology) 
      :ARG1 (a / axon) 
      :ARG2 (n / normal-02) 
      :manner (g / genotype 
            :mod (e / each)))

# ::snt Immunohistochemical analysis of the sciatic nerve showed that increased number of nuclei ( Fig. 7B ) and reduced staining of MBP ( Fig. 7D ) were remarkable in the homozygous mutant .
# ::tok Immunohistochemical analysis of the sciatic nerve showed that increased number of nuclei ( Fig. 7B ) and reduced staining of MBP ( Fig. 7D ) were remarkable in the homozygous mutant .
# ::alignments 30-31|0.1.1 29-30|0.1.1.0 26-27|0.1 18-19|0.1.2.0 17-18|0.1.2.0.0 16-17|0.1.2 13-15|0.1.0.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 11-12|0.1.0.1 9-10|0.1.0 8-9|0.1.0.0 6-7|0 5-6|0.0.0 4-5|0.0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:06.877
(s2 / show-01 
      :ARG0 (a2 / analyze-01 
            :ARG1 (n4 / nerve 
                  :mod (s3 / sciatic))) 
      :ARG1 (r / remarkable-02 
            :ARG1 (n3 / number 
                  :ARG1-of (i / increase-01 
                        :ARG2 (t / thing 
                              :name (n / name 
                                    :op1 (f / Fig.) 
                                    :op2 7B))) 
                  :quant-of (n2 / nucleus)) 
            :location (m / mutant 
                  :mod (h / homozygou)) 
            :op2-of (a / and 
                  :op1 (s / stain-01 
                        :ARG1-of (r2 / reduce-01)))))

# ::snt The Schwann cell marker , S100 staining signal was intensely observed in the homozygote as well as wild-type ( Figs. 7E , F ) .
# ::tok The Schwann cell marker , S100 staining signal was intensely observed in the homozygote as well as wild-type ( Figs. 7E , F ) .
# ::alignments 22-23|0.0.1.0.1.1+0.0.1.0.1.0.0+0.0.1.0.1.0+0.0.1.0.1 19-20|0.0.1.0.0 13-14|0.0.1.1 10-11|0.0.1 9-10|0.0.1.2 7-8|0 6-7|0.0 5-6|0.0.0 3-4|0.0.1.0 2-3|0.0.1.0.2 1-2|0.0.1.0.2.0.0.0+0.0.1.0.2.0.0+0.0.1.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:07.609
(s / signal 
      :ARG1-of (s2 / stain-01 
            :ARG0 (s3 / S100) 
            :ARG2 (o / observe-01 
                  :ARG1 (m / mark-01 
                        :ARG0 (f / fig.) 
                        :ARG1 (a / aircraft-type 
                              :name (n / name 
                                    :op1 "F22") 
                              :wiki "Lockheed_Martin_F-22_Raptor") 
                        :mod (c / cell 
                              :mod (t / thing 
                                    :name (n2 / name 
                                          :op1 "Schwann")))) 
                  :ARG2 (h / homozygote) 
                  :manner (i / intensely))))

# ::snt These results suggest that proliferation of the Schwann cells was not impaired but differentiation is severely delayed in the ADAM22-deficient mice .
# ::tok These results suggest that proliferation of the Schwann cells was not impaired but differentiation is severely delayed in the ADAM22-deficient mice .
# ::alignments 20-21|0.2.1 16-17|0.2 15-16|0.2.2 13-14|0.2.0 12-13|0 11-12|0.0 10-11|0.0.1 8-9|0.0.0.0 7-8|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 4-5|0.0.0 2-3|0.1 1-2|0.1.0.0+0.1.0 0-1|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:07.857
(c / contrast-01 
      :ARG1 (i / impair-01 
            :ARG1 (p / proliferate-01 
                  :ARG0 (c2 / cell 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "Schwann")))) 
            :polarity -) 
      :ARG1-of (s2 / suggest-01 
            :ARG0 (t2 / thing 
                  :ARG2-of (r / result-01) 
                  :mod (t3 / this))) 
      :ARG2 (d / delay-01 
            :ARG1 (d2 / differentiation) 
            :location (m / mouse) 
            :manner (s / severe)))

# ::snt Novel ADAM22 transcript variants isolated from the peripheral nervous system .
# ::tok Novel ADAM22 transcript variants isolated from the peripheral nervous system .
# ::alignments 9-10|0.0.1 8-9|0.0.1.0 7-8|0.0.1.1 4-5|0.0 3-4|0 2-3|0.1.0+0.1 0-2|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:07.906
(v / variant 
      :ARG0-of (i / isolate-01 
            :ARG1 (p2 / person 
                  :name (n2 / name 
                        :op1 "Novel" 
                        :op2 "ADAM22")) 
            :ARG2 (s / system 
                  :ARG1-of (n / nervous-01) 
                  :mod (p / peripheral))) 
      :mod (t / thing 
            :ARG1-of (t2 / transcribe-01)))

# ::snt In the case of human ADAM22 , isolation of five splicing variants and existence of two terminating exons have been reported [ 13,20,21 ] .
# ::tok In the case of human ADAM22 , isolation of five splicing variants and existence of two terminating exons have been reported [ 13,20,21 ] .
# ::alignments 20-21|0 17-18|0.0.1.0 16-17|0.0.1.0.0 15-16|0.0.1.0.1 13-14|0.0.1 12-13|0.0 11-12|0.0.0.0 10-11|0.0.0.0.0 9-10|0.0.1.0.0.0.0 7-8|0.0.0 5-6|0.0.1.0.0.0.1 4-5|0.0.1.0.0.0.1.0 2-3|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:08.067
(r / report-01 
      :ARG1 (a / and 
            :op1 (i / isolate-01 
                  :ARG1 (v / variant 
                        :ARG1-of (s / splice-01))) 
            :op2 (e2 / exist-01 
                  :ARG1 (e / exon 
                        :ARG1-of (t / terminate-01 
                              :purpose (c / case-03 
                                    :ARG0 5 
                                    :ARG1 (a2 / ADAM22 
                                          :mod (h / human)))) 
                        :quant 2))))

# ::snt However , the latter terminating exon ( exon 31 ) of the mouse species has not been identified yet .
# ::tok However , the latter terminating exon ( exon 31 ) of the mouse species has not been identified yet .
# ::alignments 18-19|0.0.0 17-18|0.0.0.0 15-16|0.0.0.0.3 13-14|0.0.0.0.1 12-13|0.0.0.0.1.0 8-9|0.0.0.0.0 7-8|0 5-6|0.0.0.0.2 4-5|0.0 3-4|0.0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:08.470
(e / exon 
      :ARG2-of (t / terminate-01 
            :ARG0 (y / yet 
                  :time-of (i / identify-01 
                        :ARG0 31 
                        :ARG1 (s / species 
                              :mod (m / mouse)) 
                        :ARG2 (e2 / exon 
                              :mod (l / latter)) 
                        :polarity -))))

# ::snt To isolate the long form of mouse ADAM22 transcripts , at first , we sought the mouse genome by BLAST homology search .
# ::tok To isolate the long form of mouse ADAM22 transcripts , at first , we sought the mouse genome by BLAST homology search .
# ::alignments 21-22|0.2 20-21|0.3.0.0.0 19-20|0.2.0.0.0+0.2.0.0+0.2.0 17-18|0.1 16-17|0.1.0 14-15|0 13-14|0.0 8-9|0.3.0.2 7-8|0.3.0.2.0 6-7|0.3.0.1 4-5|0.3.0 3-4|0.3.0.0 1-2|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:08.951
(s2 / seek-01 
      :ARG0 (w / we) 
      :ARG1 (g / genome 
            :mod (m / mouse)) 
      :ARG2 (s / search-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "BLAST"))) 
      :condition (i / isolate-01 
            :ARG1 (f / form 
                  :ARG1-of (l / long-03 
                        :ARG0 (h / homology)) 
                  :consist (m2 / mouse) 
                  :mod (t / transcript 
                        :mod (a / ADAM22)))))

# ::snt Search results showed that the mouse genome contig NT_039297 contained most of the mouse Adam22 gene .
# ::tok Search results showed that the mouse genome contig NT_039297 contained most of the mouse Adam22 gene .
# ::alignments 15-16|0.1.1 13-14|0.1.1.0 10-11|0.1.2 9-10|0.1 8-9|0.1.0 7-8|0.1.0.0 6-7|0.1.0.1 5-6|0.0.0.0.0 2-3|0 1-2|0.0.0+0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:09.311
(s / show-01 
      :ARG0 (t / thing 
            :ARG2-of (r / result-01 
                  :ARG1 (s2 / search-01 
                        :ARG1 (m3 / mouse)))) 
      :ARG1 (c / contain-01 
            :ARG0 (n / nt_039297 
                  :mod (c2 / contig) 
                  :mod (g2 / genome)) 
            :ARG1 (g / gene 
                  :mod (m / mouse)) 
            :degree (m2 / most)))

# ::snt In this contig sequence , we found putative exons 30 and 31 , those sequences were quite similar to human ADAM22 isoform 1 ( GenBank # NM_021723 ) .
# ::tok In this contig sequence , we found putative exons 30 and 31 , those sequences were quite similar to human ADAM22 isoform 1 ( GenBank # NM_021723 ) .
# ::alignments 26-27|0.0.0.1.1.1.2 24-25|0.0.1.0+0.0.1+0.0 22-23|0.0.0.0 21-22|0.0.0.1.1.0.1 19-20|0.0.0.1.1.0.1.0 17-18|0.0.0.1.1.0 16-17|0.0.0.1.1.0.2 14-15|0.0.0.1.1 11-12|0.0.0.1.1.0.0 10-11|0 9-10|0.0.2 8-9|0.0.0.1.1.1.1.0 7-8|0.0.0.1.1.1.1 6-7|0.0.0.1.1.1 5-6|0.0.0.1.1.1.0 3-4|0.0.0.1 2-3|0.0.0.1.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:10.204
(a / and 
      :op1 (p / person 
            :mod (t / this 
                  :mod 1 
                  :mod-of (s2 / sequence 
                        :mod (c / contig) 
                        :poss (s / sequence 
                              :ARG1-of (r / resemble-01 
                                    :ARG0 31 
                                    :ARG2 (i / isoform 
                                          :mod (h / human)) 
                                    :degree (q / quite)) 
                              :ARG2-of (f / find-01 
                                    :ARG0 (w / we) 
                                    :ARG1 (p2 / putative 
                                          :mod (e / exon)) 
                                    :op1-of (n / nm_021723))))) 
            :name (n2 / name 
                  :op1 "GenBank") 
            :quant 30))

# ::snt To confirm existence of transcripts , we designed primers on the putative exon 31 and performed RT-PCR using mouse cerebellum mRNA as a template .
# ::tok To confirm existence of transcripts , we designed primers on the putative exon 31 and performed RT-PCR using mouse cerebellum mRNA as a template .
# ::alignments 23-24|0.2.0.0.1 20-21|0.2.0.0.0 19-20|0.2.0.0.0.0 18-19|0.1.1.0 17-18|0.2.0.0 16-17|0.2.0.1.0+0.2.0.1+0.2.0 15-16|0.2 14-15|0 13-14|0.0.1.0 12-13|0.0.0 11-12|0.0.1.2 8-9|0.1.1 7-8|0.1 6-7|0.1.0 4-5|0.0.1.1 2-3|0.0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:11.564
(a / and 
      :condition (c2 / confirm-01 
            :ARG0 (e / exon) 
            :ARG1 (e2 / exist-01 
                  :ARG0 31 
                  :ARG1 (t3 / transcript) 
                  :ARG2 (p2 / putative))) 
      :op1 (d / design-01 
            :ARG0 (w / we) 
            :ARG1 (p3 / primer 
                  :mod (m2 / mouse))) 
      :op2 (p / perform-02 
            :ARG1 (t2 / thing 
                  :ARG0-of (u / use-01 
                        :ARG1 (m / mrna 
                              :mod (c / cerebellum)) 
                        :ARG2 (t / template)) 
                  :name (n / name 
                        :op1 "RT-PCR")) 
            :ARG0 w))

# ::snt TA-cloning of the amplified fragments and sequencing analysis showed that 5 of 8 clones were type 1 isoform ( G01 ) , 2 clones were type 3 isoform ( G03 ) and 1 clone ( G08 ) contained a novel exon between exons 29 and 30 .
# ::tok TA-cloning of the amplified fragments and sequencing analysis showed that 5 of 8 clones were type 1 isoform ( G01 ) , 2 clones were type 3 isoform ( G03 ) and 1 clone ( G08 ) contained a novel exon between exons 29 and 30 .
# ::alignments 45-46|0.1.1.0.1 44-45|0.0.0.0 43-44|0.1.1.0.2 42-43|0.1.0.0 40-41|0.1.2.1 39-40|0.1.2.1.0 37-38|0.1.2 33-34|0.1.2.0 32-33|0.0.0.2.0 31-32|0.1 26-27|0.0.0.1.0 25-26|0.1.1.0.0 23-24|0.1.1.0 22-23|0.1.1.0.3 17-18|0.1.1 16-17|0.0.0.1.1.0 15-16|0.1.1.1 13-14|0.1.0 12-13|0.1.0.1 10-11|0.1.0.2 8-9|0 7-8|0.0.0.2 6-7|0.0.0.2.1 5-6|0.0.0 4-5|0.0.0.1 3-4|0.0.0.1.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:14.888
(s / show-01 
      :ARG0 (t3 / ta-clon 
            :op1-of (a4 / and 
                  :op1-of (a / and) 
                  :op2 (f / fragment-01 
                        :ARG0 3 
                        :ARG1 (a5 / amplify-01 
                              :ARG1 1)) 
                  :op3 (a3 / analyze-01 
                        :ARG0 1 
                        :ARG1 (s2 / sequence)))) 
      :ARG1 (a2 / and 
            :op1 (c4 / clone-01 
                  :ARG1 (e / exon) 
                  :quant 8 
                  :quant 5) 
            :op2 (i / isoform 
                  :ARG0-of (c3 / clone-01 
                        :ARG1 (t / type) 
                        :ARG2 30 
                        :op1-of 29 
                        :quant 2) 
                  :mod (t2 / type)) 
            :op3 (c / contain-01 
                  :ARG0 (c2 / clone) 
                  :ARG1 (e2 / exon 
                        :mod (n / novel)))))

# ::snt Next , we performed RT-PCR analysis of mRNAs purified from several adult mouse tissues , such as the spinal cord , dorsal root ganglion ( DRG ) , sciatic nerve and cultured primary Schwann cells .
# ::tok Next , we performed RT-PCR analysis of mRNAs purified from several adult mouse tissues , such as the spinal cord , dorsal root ganglion ( DRG ) , sciatic nerve and cultured primary Schwann cells .
# ::alignments 34-35|0.1 33-34|0.1.0.0.0+0.1.0.0+0.1.0 32-33|0.1.1 31-32|0 30-31|0.1.2 29-30|0.1.2.0.0.0 28-29|0.1.2.0.0.0.0 23-24|0.1.2.2 22-23|0.1.2.2.0 21-22|0.1.2.2.1 19-20|0.1.2.1 18-19|0.1.2.1.0 15-16|0.1.2.0.0.1.0.2 13-14|0.1.2.0 12-13|0.1.2.0.1 11-12|0.1.2.0.1.0 10-11|0.1.2.0.2 8-9|0.1.2.0.0 7-8|0.1.2.0.0.1 5-6|0.1.2.0.0.1.0 4-5|0.1.2.0.0.1.0.1.0.0+0.1.2.0.0.1.0.1.0+0.1.2.0.0.1.0.1 3-4|0.1.2.0.0.1.0.0 2-3|0.1.2.0.0.1.0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:16.313
(c2 / culture-01 
      :ARG0 (n4 / next) 
      :ARG1 (c / cell 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "Schwann")) 
            :mod (p / primary) 
            :op3-of (a / and 
                  :example-of (t2 / tissue 
                        :ARG2-of (p2 / purify-01 
                              :ARG0 (n2 / nerve 
                                    :mod (s / sciatic)) 
                              :ARG1 (m2 / mrna 
                                    :ARG1-of (a3 / analyze-01 
                                          :ARG1-of (p3 / perform-02 
                                                :ARG0 (w / we)) 
                                          :ARG2 (t3 / thing 
                                                :name (n3 / name 
                                                      :op1 "RT-PCR")) 
                                          :op1-of (s3 / such)))) 
                        :mod (m / mouse 
                              :mod (a2 / adult)) 
                        :quant (s4 / several)) 
                  :op1 (c3 / cord 
                        :mod (s2 / spinal)) 
                  :op2 (g / ganglion 
                        :mod (r / root) 
                        :mod (d / dorsal)))))

# ::snt Interestingly , multiple DNA fragments were amplified from each tissue ( Fig. 8 ) , and length of major fragments in each lane was different .
# ::tok Interestingly , multiple DNA fragments were amplified from each tissue ( Fig. 8 ) , and length of major fragments in each lane was different .
# ::alignments 24-25|0.1 22-23|0.1.0.0.1 21-22|0.1.0.0.1.1 19-20|0.1.0.0 18-19|0.1.0.0.2 16-17|0.1.0 15-16|0 12-13|0.1.0.0.0 11-12|0.1.0.0.1.0.0.0+0.1.0.0.1.0.0+0.1.0.0.1.0 9-10|0.0.1 8-9|0.0.1.0 6-7|0.0 4-5|0.0.0 3-4|0.0.0.0 2-3|0.0.0.0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:16.789
(a / and 
      :op1 (a2 / amplify-01 
            :ARG1 (f2 / fragment-01 
                  :ARG1 (d2 / DNA 
                        :quant (m2 / multiple))) 
            :ARG2 (t / tissue 
                  :mod (e2 / each)) 
            :manner (i / interesting)) 
      :op2 (d / differ-02 
            :ARG1 (l2 / length 
                  :mod (f / fragment-01 
                        :ARG0 8 
                        :ARG1 (l / lane-01 
                              :ARG0 (c / country 
                                    :name (n / name 
                                          :op1 "Fig.")) 
                              :mod (e / each)) 
                        :ARG1-of (m / major-02)))))

# ::snt For example , length of major amplified PCR fragments from the sciatic nerve ( Fig. 8A , lane 5 ) and cultured Schwann cells ( lane 6 ) were almost identical , and were shorter than those from other tissues .
# ::tok For example , length of major amplified PCR fragments from the sciatic nerve ( Fig. 8A , lane 5 ) and cultured Schwann cells ( lane 6 ) were almost identical , and were shorter than those from other tissues .
# ::alignments 39-40|0.1.0.2.0.0 38-39|0.1.0.2.0 34-35|0.2 32-33|0.1.1 30-31|0.1.0 29-30|0.1.0.4 26-27|0.0.0.0.0.0 25-26|0.1.0.3 23-24|0.1.0.1 22-23|0.1.0.1.0 21-22|0.1 20-21|0 18-19|0.1.0.0 17-18|0.1.0.2 14-15|0.1.0.3.0.0.0+0.1.0.3.0.0+0.1.0.3.0 12-13|0.0.1 11-12|0.0.1.0 8-9|0.0 6-8|0.0.0.0.1.1+0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 5-6|0.0.0.0.0 3-4|0.0.0 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:17.307
(a3 / and 
      :op1 (f / fragment-01 
            :ARG0 (l3 / length 
                  :poss (t2 / thing 
                        :ARG1-of (m / major-02 
                              :ARG0 6) 
                        :name (n3 / name 
                              :op1 (a4 / amplified) 
                              :op2 (p / PCR)))) 
            :ARG2 (n2 / nerve 
                  :mod (s3 / sciatic)) 
            :purpose (e / example)) 
      :op2 (c2 / culture-01 
            :ARG1 (i / identical-01 
                  :ARG0 5 
                  :ARG1 (c / cell 
                        :mod (s2 / schwann)) 
                  :ARG1-of (l2 / lane-01 
                        :ARG0 (o / other 
                              :mod-of (t / tissue))) 
                  :ARG2 (l / lane-01 
                        :ARG1 (c3 / country 
                              :name (n / name 
                                    :op1 "Fig."))) 
                  :degree (a2 / almost)) 
            :op1-of (a / and)) 
      :op3 (s / short))

# ::snt In contrast , major fragments from the DRG ( lane 4 ) were longer than others .
# ::tok In contrast , major fragments from the DRG ( lane 4 ) were longer than others .
# ::alignments 15-16|0.0.0.1.0 13-14|0.0.0.1 10-11|0.0.0.0 9-10|0.0 4-5|0.0.0 3-4|0.0.0.2 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:17.392
(c / contrast-01 
      :ARG1 (l2 / lane-01 
            :ARG1 (f / fragment-01 
                  :ARG1 4 
                  :ARG1-of (l / long-03 
                        :ARG2 (o / other)) 
                  :ARG1-of (m / major-02))))

# ::snt We performed TA-cloning and sequencing to analyse exon organization of the amplified transcripts ( Fig. 8C ) .
# ::tok We performed TA-cloning and sequencing to analyse exon organization of the amplified transcripts ( Fig. 8C ) .
# ::alignments 14-15|0.1.0.0+0.1.0+0.1 12-13|0.0.2.0 11-12|0.0.2 8-9|0.0.3 7-8|0.0.3.0 3-4|0 2-3|0.0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:18.074
(a2 / and 
      :ARG1-of (p / perform-02 
            :ARG0 (w / we) 
            :ARG2 (t2 / ta-clon) 
            :ARG2-of (a / amplify-01 
                  :ARG1 (t / transcript)) 
            :manner (o / organization 
                  :mod (e / exon))) 
      :op1 (c / country 
            :name (n / name 
                  :op1 "Fig.")))

# ::snt Forty seven clones were isolated in total and were classified in 16 independent clones ( G01 -- G23 ) .
# ::tok Forty seven clones were isolated in total and were classified in 16 independent clones ( G01 -- G23 ) .
# ::alignments 13-14|0.1 12-13|0.1.0.0+0.1.0 11-12|0.1.2 9-10|0.0 7-8|0 6-7|0.0.0.0.0 4-5|0.0.0.0 2-3|0.0.0 1-2|0.0.0.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:18.152
(a / and 
      :op1 (c2 / classify-01 
            :ARG1 (c3 / clone-01 
                  :ARG1-of (i / isolate-01 
                        :ARG1-of (t / total-01)) 
                  :quant 7)) 
      :op2 (c / clone-01 
            :ARG0-of (d / depend-01 
                  :polarity -) 
            :ARG1 (f / forty) 
            :quant 16))

# ::snt Comparison with the genomic sequence revealed the existence of 8 novel exons ( exons 27S , 27L , 29.1 , 29.3 , 29.5 , 29.7 , 30 and 31 ) .
# ::tok Comparison with the genomic sequence revealed the existence of 8 novel exons ( exons 27S , 27L , 29.1 , 29.3 , 29.5 , 29.7 , 30 and 31 ) .
# ::alignments 28-29|0.1.0 27-28|0.5 26-27|0.2 14-15|0.4 11-12|0.1.1 10-11|0.1.1.0 9-10|0.1.1.1 7-8|0.1 5-6|0 4-5|0.3 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:18.567
(r / reveal-01 
      :ARG0 (c / comparison) 
      :ARG1 (e2 / exist-01 
            :ARG0 31 
            :ARG2 (e / exon 
                  :mod (n / novel) 
                  :quant 8)) 
      :ARG2 30 
      :manner (s / sequence) 
      :op1-of 27 
      :op1-of (a / and))

# ::snt These novel exons were flanked by well-defined introns that obey the GT-AG rule .
# ::tok These novel exons were flanked by well-defined introns that obey the GT-AG rule .
# ::alignments 12-13|0.0.0.0 11-12|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 9-10|0.0.0 7-8|0.0 6-7|0.0.1 4-5|0 2-3|0.1 1-2|0.1.0 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:18.623
(f / flank-01 
      :ARG0 (i / intron 
            :ARG0-of (o / obey-01 
                  :ARG1 (r / rule-03 
                        :ARG0 (t / thing 
                              :name (n / name 
                                    :op1 "GT-AG")))) 
            :mod (w / well-defin)) 
      :ARG1 (e / exon 
            :mod (n2 / novel) 
            :mod (t2 / this)))

# ::snt Exon organization of each clone was shown in Fig. 8C .
# ::tok Exon organization of each clone was shown in Fig. 8C .
# ::alignments 8-10|0.0.0.1+0.0.0.0+0.0.0+0.0 6-7|0 4-5|0.1.1 3-4|0.1.1.0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:18.828
(s / show-01 
      :ARG0 (t / thing 
            :name (n / name 
                  :op1 (f / Fig.) 
                  :op2 8C)) 
      :ARG1 (o / organization 
            :mod (e2 / exon) 
            :part-of (c / clone 
                  :mod (e / each))))

# ::snt Characteristic feature of ADAM22 transcripts is tissue specific insertion or skipping of exons .
# ::tok Characteristic feature of ADAM22 transcripts is tissue specific insertion or skipping of exons .
# ::alignments 12-13|0.0 10-11|0.2.0 9-10|0.2 8-9|0 7-8|0.1 6-7|0.2.0.1 4-5|0.2.0.0.1 1-2|0.2.0.0 0-1|0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:19.093
(i / insert-01 
      :ARG1 (e / exon) 
      :ARG1-of (s2 / specific-02) 
      :op1-of (o / or 
            :op2 (s / skip-01 
                  :ARG0 (f / feature 
                        :mod (c / characteristic) 
                        :mod (t2 / transcript)) 
                  :ARG1 (t / tissue))))

# ::snt Because the number of nucleotides of exons 26 , 27 , 27L , 29.3 , 29.5 and 29.7 is a multiple of 3 , insertion or skipping of these exons will not change the downstream reading frame .
# ::tok Because the number of nucleotides of exons 26 , 27 , 27L , 29.3 , 29.5 and 29.7 is a multiple of 3 , insertion or skipping of these exons will not change the downstream reading frame .
# ::alignments 36-37|0.0.0.1 35-36|0.0.0.1.0 34-35|0.0.0.1.1 32-33|0.0.0 31-32|0.0.0.0.0 29-30|0.0.0.3.0.1 28-29|0.0.0.3.0.1.0 26-27|0.0.0.3.1 25-26|0.0.0.3 24-25|0.0.0.3.0 22-23|0.0.0.1.0.0 20-21|0.0.0.2 16-17|0 9-10|0.0.0.0 7-8|0.0.0.3.1.0.0 6-7|0.0.0.3.0.0 4-5|0.0.0.3.1.0 2-3|0.0.0.3.1.0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:19.518
(a / and 
      :ARG0-of (c2 / cause-01 
            :ARG1 (c / change-01 
                  :ARG0 (2 / 27 
                        :mod -) 
                  :ARG1 (f / frame 
                        :mod (r / read-01 
                              :ARG1 3) 
                        :mod (d / downstream)) 
                  :condition (m / multiple) 
                  :op3-of (o / or 
                        :op1 (i / insert-01 
                              :ARG0 (e2 / exon) 
                              :ARG1 (e / exon 
                                    :mod (t / this))) 
                        :op2 (s / skip-01 
                              :ARG0 (n / nucleotid 
                                    :mod 26 
                                    :quant (n2 / number)))))))

# ::snt Known peptide motives were not found in the newly isolated sequences .
# ::tok Known peptide motives were not found in the newly isolated sequences .
# ::alignments 10-11|0.1 9-10|0.1.0 8-9|0.1.0.0 5-6|0 4-5|0.2 2-3|0.0 1-2|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:19.604
(f / find-01 
      :ARG1 (m / motive 
            :mod (p / peptide) 
            :mod (k / know-01)) 
      :location (s / sequence 
            :ARG1-of (i / isolate-01 
                  :degree (n / newly))) 
      :polarity -)

# ::snt This RT-PCR analysis is summarized as follows : ADAM22 transcripts were roughly subdivided in 3 groups , CNS-form ( containing exon 27 ) , DRG-form ( containing exon 27L ) and Schwann-cell-form ( skipping exon 26 and 27 ) .
# ::tok This RT-PCR analysis is summarized as follows : ADAM22 transcripts were roughly subdivided in 3 groups , CNS-form ( containing exon 27 ) , DRG-form ( containing exon 27L ) and Schwann-cell-form ( skipping exon 26 and 27 ) .
# ::alignments 37-38|0.1.0 36-37|0.1.1.0.0.2.1.0 35-36|0.1.1.0.0.2.4.0.0 34-35|0.1.1.0.0.2.4 33-34|0.1.1.0.0.2.4.0 31-32|0.1.1.0.0.2.3.0.0+0.1.1.0.0.2.3.0+0.1.1.0.0.2.3 30-31|0.1.1.0.0.2 27-28|0.1.1.0.0.2.1.0.0.0 26-27|0.1.1.0.0.2.1.0.0 24-25|0.1.1.0.0.2.2.0.0+0.1.1.0.0.2.2.0+0.1.1.0.0.2.2 21-22|0.0.0 20-21|0.1.1.0.0.2.1.1 19-20|0.1.1.0.0.2.1 17-18|0.1.1.0.0.2.0.0.0+0.1.1.0.0.2.0.0+0.1.1.0.0.2.0 15-16|0.1.1.0.0.0 14-15|0.1.1.0.0.0.0 12-13|0.1.1.0.0 11-12|0.1.1.0.0.1 9-10|0.1.1.0 8-9|0.1.1 6-7|0.1 4-5|0 2-3|0.0 1-2|0.0.1.0.0+0.0.1.0+0.0.1 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:20.668
(s3 / summarize-01 
      :ARG1 (a4 / analyze-01 
            :ARG0 27 
            :ARG1 (t2 / thing 
                  :name (n4 / name 
                        :op1 "RT-PCR")) 
            :mod (t3 / this)) 
      :concession (f / follow-01 
            :ARG0 27 
            :ARG1 (a3 / ADAM22 
                  :mod-of (t / transcript 
                        :ARG1-of (s2 / subdivide-01 
                              :ARG3 (g / group 
                                    :quant 3) 
                              :degree (r / roughly) 
                              :op1-of (a2 / and 
                                    :op2 (p3 / person 
                                          :name (n3 / name 
                                                :op1 "CNS-form")) 
                                    :op3 (c2 / contain-01 
                                          :ARG0 (a / and 
                                                :ARG0-of (c / contain-01 
                                                      :ARG1 (e2 / exon))) 
                                          :ARG1 (e3 / exon)) 
                                    :op4 (p2 / person 
                                          :name (n2 / name 
                                                :op1 "DRG-form")) 
                                    :op5 (p / person 
                                          :name (n / name 
                                                :op1 "Schwann-cell-form")) 
                                    :op6 (e / exon 
                                          :ARG1-of (s / skip-01 
                                                :ARG0 26))))))))

# ::snt From these results , we concluded that ADAM22 is expressed in a cell-type specific manner , and plays an essential role in myelinogenesis in the PNS .
# ::tok From these results , we concluded that ADAM22 is expressed in a cell-type specific manner , and plays an essential role in myelinogenesis in the PNS .
# ::alignments 25-26|0.1.1.0.2.0.0+0.1.1.0.2.0+0.1.1.0.2 22-23|0.1.1.0.1 20-21|0.1.1.0 19-20|0.1.1.0.0 17-18|0.1.1 16-17|0.1 14-15|0.1.0.0 13-14|0.1.0.0.0 9-10|0.1.0 5-6|0 4-5|0.0 2-3|0.0.0+0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:21.009
(c / conclude-01 
      :ARG0 (w / we 
            :ARG0-of (r2 / result-01 
                  :ARG2 (t / thing 
                        :mod (t2 / this)))) 
      :ARG1 (a / and 
            :op1 (e2 / express-01 
                  :ARG2 (m2 / manner 
                        :ARG1-of (s / specific-02))) 
            :op2 (p / play-02 
                  :ARG1 (r / role 
                        :mod (e / essential) 
                        :mod (m / myelinogenesi) 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "PNS"))))))

# ::snt In the present study , we examined the function of ADAM22 by generating mice that lacked the Adam22 gene .
# ::tok In the present study , we examined the function of ADAM22 by generating mice that lacked the Adam22 gene .
# ::alignments 18-19|0.0.0.0.0.0 15-16|0.0.0.0.0 13-14|0.0.0.0 12-13|0.0.0 8-9|0.1 6-7|0 5-6|0.0 3-4|0.0.1 2-3|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:21.071
(e / examine-01 
      :ARG0 (w / we 
            :ARG0-of (g2 / generate-01 
                  :ARG1 (m / mouse 
                        :ARG0-of (l / lack-01 
                              :ARG1 (g / gene)))) 
            :ARG0-of (s / study-01 
                  :time (p / present))) 
      :ARG1 (f / function-01))

# ::snt ADAM22-deficient mice exhibited severe ataxia and premature death .
# ::tok ADAM22-deficient mice exhibited severe ataxia and premature death .
# ::alignments 7-8|0.1.0 6-7|0.1.0.0 5-6|0.1 4-5|0.2 3-4|0.2.0 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:21.364
(e / exhibit-01 
      :ARG0 (m / mouse) 
      :ARG1 (a / and 
            :op1 (d / die-01 
                  :mod (p / premature))) 
      :ARG2 (a2 / ataxia 
            :mod (s / severe)))

# ::snt In contrast , heterozygous mutants were healthy , fertile and survived more than 1 year without obvious abnormalities .
# ::tok In contrast , heterozygous mutants were healthy , fertile and survived more than 1 year without obvious abnormalities .
# ::alignments 17-18|0.1.1 16-17|0.1.1.0 14-15|0.1.2 13-14|0.1.1.0.0.0 11-12|0.1.1.1 10-11|0.1 9-10|0 8-9|0.0 6-7|0.1.0.0 4-5|0.1.0 3-4|0.1.0.1 1-2|0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:21.543
(a2 / and 
      :op1 (f / fertile) 
      :op2 (s / survive-01 
            :ARG1 (m2 / mutant 
                  :domain-of (h / healthy) 
                  :mod (h2 / heterozygou)) 
            :prep-without (a / abnormaliti 
                  :ARG1-of (o / obvious-01 
                        :ARG1-of (c / contrast-01 
                              :ARG0 1)) 
                  :quant (m / more)) 
            :time (y / year)))

# ::snt The cause of death in the homozygous mutants is not clear ; however , it is likely to be due to multiple seizures .
# ::tok The cause of death in the homozygous mutants is not clear ; however , it is likely to be due to multiple seizures .
# ::alignments 22-23|0 21-22|0.1 16-17|0.0.0.0.2 11-12|0.0 10-11|0.0.0.0.1 9-10|0.0.0.0.1.0 7-8|0.0.0 6-7|0.0.0.1 3-4|0.0.0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:21.739
(s / seize-01 
      :ARG1 (a / and 
            :op1 (m2 / mutant 
                  :ARG0-of (c2 / cause-01 
                        :ARG1 (d / die-01) 
                        :ARG1-of (c / clear-06 
                              :polarity -) 
                        :ARG1-of (l / likely-01)) 
                  :mod (h / homozygou))) 
      :quant (m / multiple))

# ::snt This is because convulsive seizures were occasionally observed in homozygotes , after which the suffered mice appeared exhausted and , in most cases , died on the next day .
# ::tok This is because convulsive seizures were occasionally observed in homozygotes , after which the suffered mice appeared exhausted and , in most cases , died on the next day .
# ::alignments 28-29|0.1.1 27-28|0.1.1.0 24-25|0.1 22-23|0.0.0.0.0 21-22|0.0.0.0.0.0 18-19|0 17-18|0.0.0 16-17|0.0 15-16|0.0.0.0 14-15|0.0.0.0.1 11-12|0.0.1 9-10|0.1.0 7-8|0.1.0.0 6-7|0.1.0.0.2 4-5|0.1.0.0.1 3-4|0.1.0.0.1.0 2-3|0.1.0.0.0 0-1|0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:22.212
(a / and 
      :op1 (a2 / appear-01 
            :ARG1 (e / exhaust-01 
                  :ARG1 (m2 / mouse 
                        :ARG1-of (c / case-03 
                              :quant (m / most)) 
                        :ARG1-of (s / suffer-01))) 
            :time (a3 / after)) 
      :op2 (d2 / die-01 
            :ARG1 (h / homozygot 
                  :location-of (o / observe-01 
                        :ARG0-of (c3 / cause-01 
                              :ARG1 (t / this)) 
                        :ARG1 (s2 / seize-01 
                              :mod (c2 / convulsive)) 
                        :frequency (o2 / occasional))) 
            :time (d / day 
                  :mod (n / next))))

# ::snt It is known that cortical dysplasia resulting from aberrant brain development causes seizure syndrome [ 22 ] .
# ::tok It is known that cortical dysplasia resulting from aberrant brain development causes seizure syndrome [ 22 ] .
# ::alignments 15-16|0.0.0.1.0 13-14|0.0.0.0 12-13|0.0.0.1.2 11-12|0 10-11|0.0.0.1 9-10|0.0.0.1.1 8-9|0.0.1.0 6-7|0.0.0 5-6|0.0 4-5|0.0.1 2-3|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:22.442
(c / cause-01 
      :ARG0 (d2 / dysplasia 
            :ARG1-of (r / result-01 
                  :ARG0 (s / syndrome) 
                  :ARG2 (d / develop-02 
                        :ARG0 22 
                        :ARG1 (b / brain) 
                        :ARG1-of (s2 / seize-01))) 
            :mod (c2 / cortical 
                  :mod (a / aberrant))) 
      :ARG1 (k / know-02 
            :ARG1 (i / it)))

# ::snt For example , mice lacking the neuron-specific activator of cyclin 5 , p35 , exhibit seizures and a severe neuronal migration defect [ 23 ] .
# ::tok For example , mice lacking the neuron-specific activator of cyclin 5 , p35 , exhibit seizures and a severe neuronal migration defect [ 23 ] .
# ::alignments 23-24|0.0 21-22|0.2.1.3 20-21|0.2.1.3.0 19-20|0.2.1.3.0.0 18-19|0.2.1.3.1 16-17|0.2.1 15-16|0.2 14-15|0 12-13|0.2.1.2 10-11|0.2.0 9-10|0.2.1.1 7-8|0.2.1.0.0 4-5|0.2.1.0 3-4|0.2.1.0.1 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:23.239
(e / exhibit-01 
      :ARG0 23 
      :ARG1 (e2 / example) 
      :ARG1-of (s2 / seize-01 
            :ARG0 5 
            :op4-of (a / and 
                  :op1 (l / lack-01 
                        :ARG1 (a2 / activator) 
                        :ARG2 (m2 / mouse)) 
                  :op2 (c / cyclin) 
                  :op3 (p / p35) 
                  :op5 (d / defect-01 
                        :ARG1 (m / migration 
                              :mod (n / neuronal)) 
                        :mod (s / severe)))))

# ::snt Because ADAM22 protein is expressed on the cell surface and is likely to be involved in cell-cell or cell-matrix interactions , we hypothesized that depletion of ADAM22 would generate aberrant neuronal migration .
# ::tok Because ADAM22 protein is expressed on the cell surface and is likely to be involved in cell-cell or cell-matrix interactions , we hypothesized that depletion of ADAM22 would generate aberrant neuronal migration .
# ::alignments 31-32|0.0.1.0.4 30-31|0.0.1.0.1.1.1 29-30|0.0.0 28-29|0.0.1.0.1.1 24-25|0.0.1.0.1.1.0 22-23|0.0.1.0.1 21-22|0.0.1.0.1.0 19-20|0.1 17-18|0 14-15|0.0 11-12|0.0.1 9-10|0.0.1.0 8-9|0.0.1.0.3 7-8|0.0.1.0.3.0 4-5|0.0.1.0.2 2-3|0.0.1.0.2.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:23.890
(o / or 
      :ARG2-of (i2 / involve-01 
            :ARG1 (a / aberrant) 
            :ARG1-of (l / likely-01 
                  :op3-of (a2 / and 
                        :ARG0-of (c2 / cause-01) 
                        :condition-of (h / hypothesize-01 
                              :ARG0 (w / we) 
                              :ARG1 (g / generate-01 
                                    :ARG0 (d / depletion) 
                                    :ARG1 (n / neuronal))) 
                        :op1 (e / express-01 
                              :ARG1 (p / protein)) 
                        :op2 (s / surface 
                              :mod (c / cell)) 
                        :op4 (m / migration)))) 
      :op1 (i / interaction))

# ::snt Histochemical analysis was performed to verify this hypothesis .
# ::tok Histochemical analysis was performed to verify this hypothesis .
# ::alignments 7-8|0.0.1 6-7|0.0.1.0 5-6|0.0 3-4|0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:23.915
(p / perform-02 
      :ARG1 (v / verify-01 
            :ARG0 (a / analyze-01) 
            :ARG1 (h / hypothesi 
                  :mod (t / this))))

# ::snt However , no marked abnormalities were observed in the mutant mouse brain , ruling out a critical role for ADAM22 in neuronal migration .
# ::tok However , no marked abnormalities were observed in the mutant mouse brain , ruling out a critical role for ADAM22 in neuronal migration .
# ::alignments 22-23|0.0.0.0.1 21-22|0.0.0.0.1.0 17-18|0.0.0.0 16-17|0.0.0.0.0 13-14|0.0.0 11-12|0.1 10-11|0.1.1 9-10|0.1.0 6-7|0 4-5|0.0 3-4|0.0.1 2-3|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:24.079
(o / observe-01 
      :ARG1 (a / abnormaliti 
            :ARG0-of (r2 / rule-03 
                  :ARG1 (r / role 
                        :ARG1-of (c / critical-02) 
                        :mod (m / migration 
                              :mod (n / neuronal)))) 
            :ARG1-of (m4 / mark-01)) 
      :ARG2 (b / brain 
            :mod (m3 / mutant) 
            :part-of (m2 / mouse)) 
      :polarity -)

# ::snt Another possible explanation is that the premature death in first 2 weeks of life is caused by the dysfunction of the autonomic nervous system .
# ::tok Another possible explanation is that the premature death in first 2 weeks of life is caused by the dysfunction of the autonomic nervous system .
# ::alignments 23-24|0.0.0 22-23|0.0.0.0 21-22|0.0.0.1 18-19|0.0 15-16|0 13-14|0.0.0.0.0.0.0 11-12|0.1.0.0.0+0.1.0.0 10-11|0.1.0 7-8|0.1 6-7|0.1.1 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:24.394
(c / cause-01 
      :ARG0 (d / dysfunction 
            :mod (s / system 
                  :ARG1-of (n / nervous-01 
                        :ARG2-of (p2 / possible-01 
                              :ARG1 (e / explain-01 
                                    :ARG1 (l / life) 
                                    :mod (a2 / another)))) 
                  :mod (a / autonomic))) 
      :ARG1 (d2 / die-01 
            :ARG2 (2 / 2 
                  :quant-of (t / temporal-quantity 
                        :unit (w / week))) 
            :mod (p / premature)))

# ::snt Especially , nerves which control the breathing would be very important , because the respiration system undergoes significant maturation in the first 2 -- 3 weeks after birth .
# ::tok Especially , nerves which control the breathing would be very important , because the respiration system undergoes significant maturation in the first 2 -- 3 weeks after birth .
# ::alignments 27-28|0.1 26-27|0.1.1 25-26|0.1.1.0.1+0.1.1.0 24-25|0.1.1.0.0 22-23|0.0 18-19|0.2.0.0.0.0.1 17-18|0.2.0.0.0.0.1.0 16-17|0.2.0.0.0.0 15-16|0.2.0.0.0.0.0 14-15|0.2.0.0.0.0.0.0 12-13|0.2.0.0.0 10-11|0.2.0.0 9-10|0.2.0.0.1 6-7|0 4-5|0.2 2-3|0.2.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:24.908
(b2 / breathe-01 
      :ARG0 2 
      :ARG1-of (b / birth-01 
            :ARG0 (e / especially) 
            :op1-of (a / after 
                  :duration (t / temporal-quantity 
                        :quant 3 
                        :unit (w / week)))) 
      :ARG1-of (c2 / control-01 
            :ARG0 (n / nerve 
                  :domain-of (i / important 
                        :ARG1-of (c / cause-01 
                              :ARG0 (u / undergo-28 
                                    :ARG0 (s2 / system 
                                          :mod (r / respiration)) 
                                    :ARG1 (m / maturation 
                                          :ARG1-of (s / significant-02)))) 
                        :degree (v / very)))))

# ::snt For example , the myelin-deficient ( MD ) rat , which carries a point mutation in the proteolipid protein ( PLP ) gene , exhibits ataxia , tremor , dysmyelination and dies at approximately postnatal day 21 .
# ::tok For example , the myelin-deficient ( MD ) rat , which carries a point mutation in the proteolipid protein ( PLP ) gene , exhibits ataxia , tremor , dysmyelination and dies at approximately postnatal day 21 .
# ::alignments 36-37|0.1.4.0.0.1 35-36|0.3 34-35|0.3.0 33-34|0.3.0.0 31-32|0.1.4 30-31|0.1 29-30|0.1.3 27-28|0.1.2 25-26|0.2 24-25|0 22-23|0.0 18-19|0.0.0 14-15|0.1.4.0.0.0 13-14|0.1.4.1 11-12|0.1.4.0.0 8-9|0.1.4.0 6-7|0.1.1.0.0+0.1.1.0+0.1.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:26.620
(e / exhibit-01 
      :ARG0 (g / gene 
            :mod (p2 / protein)) 
      :ARG1 (a2 / and 
            :location-of (e2 / example) 
            :op1 (c2 / country 
                  :name (n / name 
                        :op1 "MD")) 
            :op2 (t / tremor) 
            :op3 (d3 / dysmyelination) 
            :op4 (d2 / die-01 
                  :ARG0 (r / rat 
                        :ARG0-of (c / carry-out-03 
                              :ARG1 (m / mutation) 
                              :ARG2 21)) 
                  :ARG1 (p3 / point))) 
      :ARG2 (a3 / ataxia) 
      :time (d / day 
            :mod (p / postnatal 
                  :mod (a / approximately))))

# ::snt In MD rat , early death is caused by the dysfunction of the brain stem which is essential for autonomic control of respiration during hypoxia [ 24 ] .
# ::tok In MD rat , early death is caused by the dysfunction of the brain stem which is essential for autonomic control of respiration during hypoxia [ 24 ] .
# ::alignments 26-27|0.1.0 24-25|0.0.0.0.0.2 22-23|0.0.0.0.0.1 20-21|0.0.0.0.0 19-20|0.0.0.0.0.0 17-18|0.0.0.0 14-15|0.0.0 13-14|0.2.1 10-11|0.0 7-8|0 5-6|0.1 4-5|0.1.1 2-3|0.2 1-2|0.2.0.0.0+0.2.0.0+0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:26.823
(c2 / cause-01 
      :ARG0 (d / dysfunction 
            :poss (s / stem 
                  :domain-of (e / essential 
                        :purpose (c / control-01 
                              :ARG0 (a / autonomic) 
                              :ARG1 (r / respiration) 
                              :ARG2 (h / hypoxia))))) 
      :ARG1 (d2 / die-01 
            :ARG1 24 
            :time (e2 / early)) 
      :location (r2 / rat 
            :mod (c3 / country 
                  :name (n / name 
                        :op1 "MD")) 
            :name-of (b / brain)))

# ::snt Further study is needed to verify the cause of death in ADAM22-deficient mice .
# ::tok Further study is needed to verify the cause of death in ADAM22-deficient mice .
# ::alignments 12-13|0.1.0.0.0 9-10|0.1.0.0 7-8|0.1.0 5-6|0.1 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:26.860
(n / need-01 
      :ARG1 (s / study-01 
            :mod (f / further)) 
      :purpose (v / verify-01 
            :ARG1 (c / cause-01 
                  :ARG1 (d / die-01 
                        :ARG1 (m / mouse)))))

# ::snt Another interesting phenotype observed in ADAM22-deficient mice was hypomyelinogenesis .
# ::tok Another interesting phenotype observed in ADAM22-deficient mice was hypomyelinogenesis .
# ::alignments 8-9|0 6-7|0.0.0.0 3-4|0.0.0 2-3|0.0 1-2|0.0.1 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:26.910
(h / hypomyelinogenesi 
      :domain (p / phenotype 
            :ARG1-of (o / observe-01 
                  :ARG0 (m / mouse)) 
            :ARG2-of (i / interest-01) 
            :mod (a / another)))

# ::snt Histopathological analysis revealed marked hypomyelination in the sciatic and trigeminal nerves .
# ::tok Histopathological analysis revealed marked hypomyelination in the sciatic and trigeminal nerves .
# ::alignments 10-11|0.2.2 9-10|0.2.1 8-9|0.2 7-8|0.2.0 4-5|0.1 3-4|0.1.0 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:26.965
(r / reveal-01 
      :ARG0 (a2 / analyze-01) 
      :ARG1 (h / hypomyelination 
            :ARG1-of (m / mark-01)) 
      :op1-of (a / and 
            :op2 (s / sciatic) 
            :op3 (t / trigeminal) 
            :op4 (n / nerve)))

# ::snt However , myelin formation in the spinal cord and the brain was normal .
# ::tok However , myelin formation in the spinal cord and the brain was normal .
# ::alignments 12-13|0.0 10-11|0.2 8-9|0 7-8|0.1.1 6-7|0.1.1.0 3-4|0.1 2-3|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:27.037
(a / and 
      :ARG1-of (n / normal-02) 
      :op1 (f / form-01 
            :ARG1 (m / myelin) 
            :ARG2 (c / cord 
                  :mod (s / spinal))) 
      :op2 (b / brain))

# ::snt It was therefore evident that hypomyelinogenesis occurred specifically in the peripheral nerves in the knockout mice , suggesting Schwann cell dysfunction .
# ::tok It was therefore evident that hypomyelinogenesis occurred specifically in the peripheral nerves in the knockout mice , suggesting Schwann cell dysfunction .
# ::alignments 20-21|0.0.0.3.0 19-20|0.0.0.3.0.0 18-19|0.0.0.3.0.0.0.0.0+0.0.0.3.0.0.0.0+0.0.0.3.0.0.0 17-18|0.0.0.3 15-16|0.0.0.1.0 14-15|0.0.0.1.0.0 11-12|0.0.0.2 10-11|0.0.0.2.0 7-8|0.0.0.1 6-7|0.0.0 5-6|0.0.0.0 3-4|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:27.379
(e / evident 
      :domain (i / it 
            :ARG1-of (o / occur-01 
                  :ARG0 (h / hypomyelinogenesi) 
                  :manner (s2 / specific-02 
                        :ARG1 (m / mouse 
                              :mod (k / knockout))) 
                  :manner (n2 / nerve 
                        :mod (p / peripheral)) 
                  :purpose (s / suggest-01 
                        :ARG1 (d / dysfunction 
                              :mod (c / cell 
                                    :mod (t / thing 
                                          :name (n / name 
                                                :op1 "Schwann"))))))))

# ::snt In the mutant sciatic nerve , the density of pro-myelinating Schwann cells ( S100-positive , MBP-negative ) was markedly higher than that seen in heterozygotes .
# ::tok In the mutant sciatic nerve , the density of pro-myelinating Schwann cells ( S100-positive , MBP-negative ) was markedly higher than that seen in heterozygotes .
# ::alignments 24-25|0.0 22-23|0 21-22|0.1 19-20|0.1.0 18-19|0.2 11-12|0.1.0.0.0 10-11|0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 9-10|0.1.0.0.0.1 7-8|0.1.0.0 4-5|0.3.0 3-4|0.3.0.0 2-3|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:27.631
(s / see-01 
      :ARG0 (h / heterozygot) 
      :ARG1 (t / that 
            :compared-to-of (h2 / high-02 
                  :compared-to (d / density 
                        :mod (c / cell 
                              :mod (t2 / thing 
                                    :name (n / name 
                                          :op1 "Schwann")) 
                              :mod (p / pro-myelinat))))) 
      :ARG2 (m / markedly) 
      :op1-of (m2 / mutant 
            :mod-of (n2 / nerve 
                  :mod (s2 / sciatic))))

# ::snt Higher pro-myelinating Schwann cell density and marked delay in myelin formation indicate that ADAM22 plays an important role in Schwann cell differentiation , but not in proliferation .
# ::tok Higher pro-myelinating Schwann cell density and marked delay in myelin formation indicate that ADAM22 plays an important role in Schwann cell differentiation , but not in proliferation .
# ::alignments 26-27|0.0.0.1.0 24-25|0.0.0.0.0 23-24|0 21-22|0.0.0.1.1.0.1 20-21|0.0.0.1.1.0.1.0 17-18|0.0.0.1.1.0 16-17|0.0.0.1.1.0.0 14-15|0.0.0.1.1 11-12|0.0.0.1.1.1 10-11|0.0.0.0 9-10|0.0.0.0.1 7-8|0.0.0 6-7|0.0 5-6|0.0.0.1 4-5|0.0.0.1.1.1.0 3-4|0.0.0.1.1.1.0.1 2-3|0.0.0.1.1.1.0.0.0.0.0+0.0.0.1.1.1.0.0.0.0+0.0.0.1.1.1.0.0.0 1-2|0.1 0-1|0.0.0.1.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:28.702
(c / contrast-01 
      :ARG0-of (m2 / mark-01 
            :ARG1 (d2 / delay-01 
                  :ARG1 (f / form-01 
                        :ARG0 - 
                        :ARG1 (m / myelin)) 
                  :op1-of (a / and 
                        :ARG0-of (p / proliferate-01) 
                        :ARG0-of (p2 / play-02 
                              :ARG1 (r / role 
                                    :mod (i / important) 
                                    :mod (d / differentiation 
                                          :mod (c2 / cell))) 
                              :ARG1-of (i2 / indicate-01 
                                    :ARG0 (d3 / density 
                                          :ARG0-of (h / high-02 
                                                :ARG1 (t / thing 
                                                      :name (n / name 
                                                            :op1 "Schwann"))) 
                                          :mod (c3 / cell))))))) 
      :ARG1 (p3 / pro-myelinat))

# ::snt Investigations on why hypomyelinogenesis occurred in ADAM22-deficient mice centre on integrin .
# ::tok Investigations on why hypomyelinogenesis occurred in ADAM22-deficient mice centre on integrin .
# ::alignments 10-11|0.0.1 8-9|0.0 7-8|0 4-5|0.0.0 3-4|0.0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:28.729
(m / mouse 
      :mod-of (c / centre-left 
            :ARG1-of (o / occur-01 
                  :ARG0 (h / hypomyelinogenesi) 
                  :topic-of (i2 / investigation)) 
            :location (i / integrin)))

# ::snt This is because several ADAMs have been shown to interact with integrins via disintegrin domains [ 9 ] , and it has been suggested that alpha-6 beta-1 integrin on the Schwann cell plays an important role in myelin formation [ 25 ] .
# ::tok This is because several ADAMs have been shown to interact with integrins via disintegrin domains [ 9 ] , and it has been suggested that alpha-6 beta-1 integrin on the Schwann cell plays an important role in myelin formation [ 25 ] .
# ::alignments 40-41|0.2.0.1.0.0.0 38-39|0 37-38|0.1 35-36|0.2 34-35|0.2.1 32-33|0.2.0 31-32|0.2.0.0.0 30-31|0.2.0.0.0.0.0.0+0.2.0.0.0.0.0+0.2.0.0.0.0 27-28|0.2.0.0 23-24|0.2.0.1 19-20|0.2.0.1.0 16-17|0.0 14-15|0.2.0.1.0.1 13-14|0.2.0.1.0.1.0 11-12|0.2.0.1.0.0.2.1 9-10|0.2.0.1.0.0.2 7-8|0.2.0.1.0.0 4-5|0.2.0.1.0.0.2.0 3-4|0.2.0.1.0.0.2.0.0 2-3|0.2.0.1.0.0.1 0-1|0.2.0.1.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:30.206
(f / form-01 
      :ARG0 9 
      :ARG1 (m / myelin) 
      :ARG2 (r / role 
            :ARG1-of (p / play-02 
                  :ARG0 (i2 / integrin 
                        :location (c / cell 
                              :location (t / thing 
                                    :name (n / name 
                                          :op1 "Schwann")))) 
                  :ARG1-of (s / suggest-01 
                        :op2-of (a / and 
                              :ARG1-of (s2 / show-01 
                                    :ARG0 25 
                                    :ARG0-of (c2 / cause-01 
                                          :ARG1 (t2 / this)) 
                                    :ARG2 (i4 / interact-01 
                                          :ARG0 (a2 / adam 
                                                :quant (s3 / several)) 
                                          :ARG1 (i3 / integrin))) 
                              :op1 (d / domain 
                                    :mod (d2 / disintegrin))))) 
            :mod (i / important)))

# ::snt In addition , laminin-2 is a key player in peripheral myelin formation , because laminin-2 deficiency causes dysmyelination in mice and humans , and its receptors , alpha-6 beta-1 integrin and dystroglycan , are also shown to be deeply involved in myelin formation [ 26,27 ] .
# ::tok In addition , laminin-2 is a key player in peripheral myelin formation , because laminin-2 deficiency causes dysmyelination in mice and humans , and its receptors , alpha-6 beta-1 integrin and dystroglycan , are also shown to be deeply involved in myelin formation [ 26,27 ] .
# ::alignments 42-43|0.0.1 41-42|0.0.1.0 39-40|0.0.3.1.0 38-39|0.0.3.1.0.2 35-36|0.0.3.1 34-35|0.0.3.1.1 31-32|0.0.3.1.0.0.0.1 30-31|0.0.3.1.0.0.0 29-30|0.0.3.1.0.0.0.0 25-26|0.0.3.1.0.0 23-24|0.0.3 21-22|0.1 20-21|0 19-20|0.0.2 17-18|0.0.3.1.0.1 16-17|0.0 15-16|0.0.0 13-14|0.0.3.0 11-12|0.0.3.0.0.0.0 10-11|0.0.3.0.0.0.0.0 9-10|0.0.3.0.0.0.0.1 7-8|0.0.3.0.0.0+0.0.3.0.0 6-7|0.0.3.0.0.1 1-2|0.0.3.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:31.565
(a4 / and 
      :ARG1-of (c / cause-01 
            :ARG0 (d4 / deficiency) 
            :ARG2 (f / form-01 
                  :ARG1 (m / myelin)) 
            :location (m2 / mouse) 
            :op1-of (a3 / and 
                  :ARG0-of (c2 / cause-01 
                        :ARG1 (t / thing 
                              :ARG0-of (p2 / play-12 
                                    :ARG1 (f2 / form-01 
                                          :ARG1 (m3 / myelin) 
                                          :mod (p / peripheral))) 
                              :ARG1-of (k / key-02 
                                    :ARG2 (a5 / addition)))) 
                  :op2 (s / show-01 
                        :ARG1 (i / involve-01 
                              :ARG0 (r / receptor 
                                    :op1-of (a2 / and 
                                          :op2 (i2 / integrin) 
                                          :op3 (d2 / dystroglycan))) 
                              :ARG1 (d3 / dysmyelination) 
                              :ARG1-of (d / deep-02)) 
                        :mod (a / also)))) 
      :op1 (h / human))

# ::snt The conditional knockout studies of beta-1 integrin and laminin gamma-1 in Schwann cell suggested that both laminin-2 and integrins are essential for segregation of large bundles of axons in the early stage of myelin formation [ 25,28 ] .
# ::tok The conditional knockout studies of beta-1 integrin and laminin gamma-1 in Schwann cell suggested that both laminin-2 and integrins are essential for segregation of large bundles of axons in the early stage of myelin formation [ 25,28 ] .
# ::alignments 34-35|0.0.0 33-34|0.0.0.0 31-32|0.3.3 30-31|0.3.3.0 27-28|0.0.1.0 25-26|0.0.1 24-25|0.0.1.2 22-23|0.0.1.1 20-21|0.3.0 18-19|0.3.2 17-18|0.3 15-16|0.3.1 13-14|0 12-13|0.0 11-12|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 8-9|0.2 7-8|0.1 6-7|0.1.1 3-4|0.1.0 2-3|0.1.0.0 1-2|0.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:32.376
(s3 / suggest-01 
      :ARG0 (c / cell 
            :ARG0-of (f / form-01 
                  :ARG1 (m / myelin)) 
            :ARG0-of (b / bundle-01 
                  :ARG1 (a / axon) 
                  :ARG1-of (s2 / segregate-01) 
                  :mod (l / large))) 
      :ARG1 (a3 / and 
            :ARG1-of (s4 / study-01 
                  :ARG0 (k / knockout) 
                  :location (t / thing 
                        :name (n / name 
                              :op1 "Schwann")) 
                  :mod (c2 / conditional)) 
            :op1 (i2 / integrin)) 
      :manner (l2 / laminin) 
      :op1-of (a2 / and 
            :domain-of (e2 / essential) 
            :mod (b2 / both) 
            :op2 (i / integrin) 
            :op3 (s / stage 
                  :mod (e / early))))

# ::snt In contrast , the phenotype seen in the ADAM22-deficient mice was quite different : for example , unsorted bundles of axons were not seen in nerves and roots .
# ::tok In contrast , the phenotype seen in the ADAM22-deficient mice was quite different : for example , unsorted bundles of axons were not seen in nerves and roots .
# ::alignments 27-28|0.4 26-27|0 25-26|0.3 23-24|0.1 22-23|0.1.1 20-21|0.1.0.1 18-19|0.1.0 17-18|0.1.0.2 15-16|0.1.2 12-13|0.2.0 11-12|0.2.0.0 9-10|0.2.1 5-6|0.2 4-5|0.1.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:32.729
(a / and 
      :ARG2-of (c / contrast-01) 
      :location-of (s / see-01 
            :ARG1 (b / bundle-01 
                  :ARG0 (p / phenotype) 
                  :ARG1 (a2 / axon) 
                  :mod (u / unsort)) 
            :polarity - 
            :purpose (e / example)) 
      :op1 (s2 / see-01 
            :ARG1 (d / differ-02 
                  :degree (q / quite)) 
            :location (m / mouse)) 
      :op2 (n / nerve) 
      :op3 (r / root))

# ::snt We assume that ADAM22 partially modulates integrin-mediated signals or is involved at a later stage of myelin formation .
# ::tok We assume that ADAM22 partially modulates integrin-mediated signals or is involved at a later stage of myelin formation .
# ::alignments 17-18|0.0 16-17|0 14-15|0.0.0 13-14|0.0.0.1 10-11|0.0.0.0 8-9|0.0.0.0.0 7-8|0.0.0.0.0.0.0 6-7|0.0.0.0.0.0.0.0 5-6|0.0.0.0.0.0 4-5|0.0.0.0.0.0.2 1-2|0.0.0.0.0.0.1 0-1|0.0.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:32.850
(m / myelin 
      :ARG1-of (f / form-01 
            :part (s / stage 
                  :ARG2-of (i / involve-01 
                        :op2-of (o / or 
                              :op1 (m2 / modulate-01 
                                    :ARG1 (s2 / signal 
                                          :mod (i2 / integrin-mediat)) 
                                    :ARG1-of (a / assume-02 
                                          :ARG0 (w / we)) 
                                    :manner (p / partial)))) 
                  :time (l / late))))

# ::snt In summary , we generated ADAM22-deficient mice and proved that ADAM22 plays an essential role in both the CNS and the PNS .
# ::tok In summary , we generated ADAM22-deficient mice and proved that ADAM22 plays an essential role in both the CNS and the PNS .
# ::alignments 21-22|0.0.0.0.0+0.0.0.0+0.0.0 19-20|0 18-19|0.2.0.0+0.2.0+0.2 16-17|0.0 14-15|0.1.0.0.0.0 13-14|0.1.0.0.0.0.0 11-12|0.1.0.0.0 8-9|0.1.0.0 7-8|0.1.2 6-7|0.1.1 4-5|0.1 3-4|0.1.0 1-2|0.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:32.970
(a / and 
      :mod (b / both 
            :op1 (o / organization 
                  :name (n / name 
                        :op1 "PNS"))) 
      :op1 (g / generate-01 
            :ARG0 (w / we 
                  :ARG0-of (p2 / prove-01 
                        :ARG1 (p / play-02 
                              :ARG1 (r / role 
                                    :mod (e / essential))))) 
            :ARG1 (m / mouse) 
            :op1-of (a2 / and) 
            :prep-in (s / summary)) 
      :op2 (o2 / organization 
            :name (n2 / name 
                  :op1 "CNS")))

# ::snt The results of this study suggest that ADAM22 is involved in human diseases such as epilepsy and peripheral neuropathy .
# ::tok The results of this study suggest that ADAM22 is involved in human diseases such as epilepsy and peripheral neuropathy .
# ::alignments 18-19|0.1.1.0.2 17-18|0.1.1.0.2.0 16-17|0.1.1.0 15-16|0.1.1.0.1 13-14|0.1.1.0.0 12-13|0.1.1 11-12|0.1.1.1 9-10|0.1 7-8|0.1.0 5-6|0 4-5|0.0.0.0 3-4|0.0.0.0.0 1-2|0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:33.484
(s2 / suggest-01 
      :ARG0 (t2 / thing 
            :ARG2-of (r / result-01 
                  :ARG1 (s3 / study-01 
                        :mod (t / this)))) 
      :ARG1 (i / involve-01 
            :ARG1 (a2 / ADAM22) 
            :ARG2 (d / disease 
                  :example (a / and 
                        :op1 (s / such) 
                        :op2 (e / epilepsy) 
                        :op3 (n / neuropathy 
                              :mod (p / peripheral))) 
                  :mod (h / human))))

# ::snt The human ADAM22 gene is relatively large , at 300 kb in length , and is comprised of more than 30 exons .
# ::tok The human ADAM22 gene is relatively large , at 300 kb in length , and is comprised of more than 30 exons .
# ::alignments 21-22|0.0.2.0 20-21|0.0.2.0.1 18-19|0.0.2 16-17|0.0 14-15|0 12-13|0.0.1.0 10-11|0.0.1 9-10|0.0.2.0.0 6-7|0.0.0.0 5-6|0.0.0.0.0 3-4|0.0.0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:33.738
(a / and 
      :op1 (c / comprise-01 
            :ARG0 (g / gene 
                  :domain-of (l2 / large 
                        :mod (r / relative)) 
                  :mod (h / human)) 
            :ARG1 (k / kb 
                  :location (l / length)) 
            :ARG2 (m / more 
                  :quant-of (e / exon 
                        :poss-of 300 
                        :quant 30))))

# ::snt It is assigned on 7q21 , where several chromosomal aberrations that are accompanied by neurological disorders have been identified [ 29,30 ] .
# ::tok It is assigned on 7q21 , where several chromosomal aberrations that are accompanied by neurological disorders have been identified [ 29,30 ] .
# ::alignments 18-19|0.1.1.0 15-16|0.1.0 14-15|0.1.0.0 12-13|0.1 9-10|0.1.1 8-9|0.1.1.1 7-8|0.1.1.2 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:33.905
(a3 / assign-01 
      :ARG1 (i2 / it) 
      :ARG2 (a / accompany-01 
            :ARG0 (d / disorder 
                  :mod (n / neurological)) 
            :ARG1 (a2 / aberration 
                  :ARG1-of (i / identify-01) 
                  :mod (c / chromosomal) 
                  :quant (s / several))))

# ::snt Further detailed molecular function analysis of ADAM22 may lead to progress in uncovering the mechanisms that underlie certain human neurological diseases .
# ::tok Further detailed molecular function analysis of ADAM22 may lead to progress in uncovering the mechanisms that underlie certain human neurological diseases .
# ::alignments 20-21|0.0.2.0.0.0.0 19-20|0.0.1 18-19|0.0.1.0 17-18|0.0.2.0.0.0.0.0 16-17|0.0.2.0.0.0 14-15|0.0.2.0.0 12-13|0.0.2.0 10-11|0.0.2 8-9|0.0 7-8|0 4-5|0.0.0 3-4|0.0.0.0 2-3|0.0.0.2 1-2|0.0.0.1 0-1|0.0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:34.004
(p2 / possible-01 
      :ARG1 (l / lead-03 
            :ARG0 (a / analyze-01 
                  :ARG1 (f / function-01) 
                  :ARG1-of (d2 / detail-01) 
                  :manner (m2 / molecule) 
                  :mod (f2 / further)) 
            :ARG1 (n / neurological 
                  :mod (h / human)) 
            :ARG2 (p / progress-01 
                  :ARG1 (u2 / uncover-01 
                        :ARG1 (m / mechanism 
                              :ARG0-of (u / underlie-01 
                                    :ARG1 (d / disease 
                                          :mod (c / certain))))))))

# ::snt Construction of an Adam22 gene-targeting vector .
# ::tok Construction of an Adam22 gene-targeting vector .
# ::alignments 5-6|0.1 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:34.019
(c / construct-01 
      :ARG1 (a / Adam22) 
      :ARG2 (v / vector))

# ::snt The 18-kb genomic DNA fragments covering exons 5 , 6 , 7 , 8 and 9 of the Adam22 gene were amplified from C57BL/6 genomic DNA by PCR using Expand Hi-Fidelity enzyme mix ( Roche Diagnostics ) and primers designed for each exon .
# ::tok The 18-kb genomic DNA fragments covering exons 5 , 6 , 7 , 8 and 9 of the Adam22 gene were amplified from C57BL/6 genomic DNA by PCR using Expand Hi-Fidelity enzyme mix ( Roche Diagnostics ) and primers designed for each exon .
# ::alignments 42-43|0 41-42|0.1 39-40|0.0 38-39|0.0.0 37-38|0.0.2 34-36|0.0.2.0.2.0.0.0.1+0.0.2.0.2.0.0.0.0+0.0.2.0.2.0.0.0+0.0.2.0.2.0.0 32-33|0.0.2.0.0 31-32|0.0.2.0.0.2 29-31|0.0.2.0.0.0.0.1+0.0.2.0.0.0.0.0+0.0.2.0.0.0.0+0.0.2.0.0.0 28-29|0.0.2.0 25-26|0.0.2.0.2.1 23-24|0.0.2.0.2.1.0.0.0+0.0.2.0.2.1.0.0+0.0.2.0.2.1.0 21-22|0.0.2.0.2 19-20|0.0.2.0.3 15-16|0.0.1 14-15|0.0.2.0.2.0.2.0 13-14|0.0.3 11-12|0.0.2.0.0.1 9-10|0.0.2.0.0.3 7-8|0.0.2.0.1 6-7|0.0.2.0.2.0.2.0.0 5-6|0.0.2.0.2.0.2 4-5|0.0.2.0.2.0 3-4|0.0.2.0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:36.925
(e / exon 
      :ARG3-of (d / design-01 
            :ARG1 (p / primer) 
            :op1-of 9 
            :op1-of (a / and 
                  :ARG0-of (u / use-01 
                        :ARG1 (m / mix-01 
                              :ARG1 (t / thing 
                                    :name (n2 / name 
                                          :op1 (e4 / Expand) 
                                          :op2 (h / Hi-Fidelity))) 
                              :ARG2 7 
                              :mod (e3 / enzyme) 
                              :op1-of 6) 
                        :ARG2 5 
                        :manner-of (a2 / amplify-01 
                              :ARG1 (f / fragment-01 
                                    :ARG0 (o / organization 
                                          :name (n / name 
                                                :op1 "Roche" 
                                                :op2 "Diagnostics")) 
                                    :ARG1 (d3 / DNA) 
                                    :ARG2-of (c / cover-01 
                                          :ARG1 (a3 / and 
                                                :op1 (e5 / exon)))) 
                              :ARG2 (d2 / DNA 
                                    :mod (t2 / thing 
                                          :name (n3 / name 
                                                :op1 "C57BL/6")))) 
                        :topic-of (g / gene))) 
            :op1-of 8) 
      :mod (e2 / each))

# ::snt To generate a mutation in the mouse Adam22 gene , we inserted the PGKneo cassette into exon 8 of the Adam22 gene .
# ::tok To generate a mutation in the mouse Adam22 gene , we inserted the PGKneo cassette into exon 8 of the Adam22 gene .
# ::alignments 21-22|0.2 17-18|0.0.0.0.1 16-17|0.3 14-15|0.1 13-14|0.1.0.0.0+0.1.0.0+0.1.0 11-12|0 10-11|0.0 8-9|0.0.0.0.0 6-7|0.0.0.0.0.0 3-4|0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:37.117
(i / insert-01 
      :ARG0 (w / we 
            :ARG0-of (g3 / generate-01 
                  :ARG1 (m2 / mutation 
                        :location (g2 / gene 
                              :mod (m / mouse)) 
                        :mod 8))) 
      :ARG1 (c / cassette 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "PGKneo"))) 
      :ARG2 (g / gene) 
      :location (e / exon))

# ::snt The final targeting construct consisted of a 10.5-kb genomic DNA fragment that was interrupted by the insertion of the PGKneo cassette and contained a MC1/TK cassette as a negative selection marker against random integration [ 5 ] .
# ::tok The final targeting construct consisted of a 10.5-kb genomic DNA fragment that was interrupted by the insertion of the PGKneo cassette and contained a MC1/TK cassette as a negative selection marker against random integration [ 5 ] .
# ::alignments 35-36|0.1.1.0 33-34|0.1.0 32-33|0.0.1 30-31|0.1.1.2 29-30|0.1.1.2.0 28-29|0.1.1.2.1 25-26|0.1.1.1 22-23|0.1.1 21-22|0.1 20-21|0.0.0.1.0.0 19-20|0.0.0.1.0.0.0.0.0+0.0.0.1.0.0.0.0+0.0.0.1.0.0.0 16-17|0.0.0.1.0 13-14|0.0.0.1 10-11|0.0.0 9-10|0.0.0.0 4-5|0 3-4|0.0 2-3|0.0.2 1-2|0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:37.450
(c4 / consist-01 
      :ARG1 (c5 / construct-01 
            :ARG0-of (f / fragment-01 
                  :ARG1 (d / DNA) 
                  :ARG1-of (i3 / interrupt-01 
                        :ARG0 (i2 / insert-01 
                              :ARG1 (c3 / cassette 
                                    :mod (t / thing 
                                          :name (n2 / name 
                                                :op1 "PGKneo")))))) 
            :ARG1 (r / random) 
            :ARG1-of (t2 / target-01) 
            :mod (f2 / final)) 
      :ARG2 (a / and 
            :ARG1-of (i / integrate-01) 
            :op1 (c2 / contain-01 
                  :ARG0 5 
                  :ARG1 (c / cassette) 
                  :ARG2 (m / mark-01 
                        :ARG1-of (s / select-01) 
                        :mod (n / negative)))))

# ::snt Generation of Adam22 deficient mice .
# ::tok Generation of Adam22 deficient mice .
# ::alignments 4-5|0 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:37.461
(m / mouse 
      :mod (a / Adam22 
            :consist (g / generation)))

# ::snt The linearised targeting vector was electroporated into TT2 embryonic stem ( ES ) cells [ 31 ] .
# ::tok The linearised targeting vector was electroporated into TT2 embryonic stem ( ES ) cells [ 31 ] .
# ::alignments 15-16|0.3 13-14|0.1.0.0 11-12|0.4 9-10|0.1.0 8-9|0.2 3-4|0.1 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:37.542
(t / target-01 
      :ARG0 (l / linearise) 
      :ARG1 (v / vector 
            :mod-of (s / stem 
                  :mod-of (c / cell))) 
      :ARG2 (e2 / embryonic) 
      :op1-of 31 
      :op1-of (e / e))

# ::snt Homologous recombinants were selected by PCR .
# ::tok Homologous recombinants were selected by PCR .
# ::alignments 5-6|0.0 3-4|0 0-2|0.1.0.1+0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:37.570
(s / select-01 
      :ARG0 (p / PCR) 
      :ARG1 (t / thing 
            :name (n / name 
                  :op1 (h / Homologous) 
                  :op2 (r / recombinants))))

# ::snt The extracted genomic DNA from each clone was amplified using the forward primer AGN2 : 5 ' - GCCTGCTTGCCGAATATCATGGTGGAAAAT-3 ' in the PGKneo cassette , and the reverse primer MFP065R : 5 ' - ACTATTTCTGTGATGAGGGCACAGCATC-3 ' outside the targeting vector .
# ::tok The extracted genomic DNA from each clone was amplified using the forward primer AGN2 : 5 ' - GCCTGCTTGCCGAATATCATGGTGGAAAAT-3 ' in the PGKneo cassette , and the reverse primer MFP065R : 5 ' - ACTATTTCTGTGATGAGGGCACAGCATC-3 ' outside the targeting vector .
# ::alignments 39-40|0.0.0.1.0 38-39|0.0.0.1 36-37|0.0.0.0.1.1 31-32|0.0.0.0.1.0 29-30|0.0 28-29|0.0.1 27-28|0.0.0 25-26|0 23-24|0.0.2.0 22-23|0.0.2.1.0+0.0.2.1+0.0.2 15-16|0.0.0.0.2.0.0 13-14|0.0.0.0.0.1.0+0.0.0.0.0.1+0.0.0.0.0 12-13|0.0.0.0.0.0 11-12|0.0.0.0.0.2.1 9-10|0.0.0.0 8-9|0.0.0.0.1 6-7|0.0.0.0.0.2 5-6|0.0.0.0.0.2.0 3-4|0.0.0.0.2 1-2|0.0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:38.496
(a / and 
      :op1 (m / MFP065R 
            :ARG1-of (r / reverse-01 
                  :purpose (u / use-01 
                        :ARG1 (c2 / country 
                              :mod (p2 / primer) 
                              :name (n2 / name 
                                    :op1 "AGN2") 
                              :poss (c3 / clone 
                                    :mod (e / each) 
                                    :mod (f / forward))) 
                        :ARG1-of (a2 / amplify-01 
                              :ARG2 5 
                              :op1-of (o / outside)) 
                        :ARG2 (d / DNA 
                              :ARG1-of (e2 / extract-01 
                                    :ARG0 5))) 
                  :purpose (t / target-01 
                        :ARG1 (v / vector))) 
            :mod (p / primer) 
            :quant-of (t2 / thing 
                  :mod-of (c / cassette) 
                  :name (n / name 
                        :op1 "PGKneo"))))

# ::snt Homologous recombined DNA was efficiently amplified by 35 cycles of the following amplification steps ( 94 C -30 s and 68 C -5 min ) .
# ::tok Homologous recombined DNA was efficiently amplified by 35 cycles of the following amplification steps ( 94 C -30 s and 68 C -5 min ) .
# ::alignments 23-24|0.2 20-23|0.0.0.0.2+0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 19-20|0 18-19|0.1 15-18|0.0.1.0.2+0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 13-14|0.0.2.0.0 12-13|0.0.2.0.0.0 11-12|0.0.2.0.0.1 8-9|0.0.2.0 7-8|0.0.2.0.1 5-6|0.0.2 4-5|0.0 2-3|0.0.2.1 1-2|0.0.2.2 0-1|0.0.2.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:38.999
(a / and 
      :op1 (e / efficient-01 
            :ARG0 (t / thing 
                  :name (n / name 
                        :op1 68 
                        :op2 (c / C) 
                        :op3 -5)) 
            :ARG1 (t2 / thing 
                  :name (n2 / name 
                        :op1 94 
                        :op2 (c2 / C) 
                        :op3 -30)) 
            :ARG2 (a3 / amplify-01 
                  :ARG0 (c3 / cycle-02 
                        :ARG1 (s2 / step-01 
                              :ARG1 (a2 / amplification) 
                              :ARG1-of (f / follow-01)) 
                        :quant 35) 
                  :ARG1 (d / DNA) 
                  :ARG1-of (r / recombine-01 
                        :ARG0 (h / homologou)))) 
      :op2 (s / s) 
      :op3 (m / min))

# ::snt The targeting efficiency of this construct was about 4 % .
# ::tok The targeting efficiency of this construct was about 4 % .
# ::alignments 9-10|0.0.0.0.0.0 8-9|0.0.0.0.0 7-8|0.0.0.0.0.0.0 5-6|0.0.0.0 4-5|0.0.0 2-3|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:39.118
(t2 / target-01 
      :ARG1 (e / efficient-01 
            :ARG1 (t / this 
                  :ARG0-of (c / construct-01 
                        :ARG1 (4 / 4 
                              :value-of (p / percentage-entity 
                                    :op1-of (a / about)))))))

# ::snt Correctly targeted ES clones were injected into fertilized ICR mouse eggs at the eight-cell stage .
# ::tok Correctly targeted ES clones were injected into fertilized ICR mouse eggs at the eight-cell stage .
# ::alignments 14-15|0.0.0.0 10-11|0.0.0.1.0 9-10|0.0.0.1.0.0 8-9|0.0.0.1.0.1 7-8|0.0.0.1 5-6|0.0.0.3 3-4|0.0.0 2-3|0.0.0.2 1-2|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:39.187
(c2 / correctly 
      :mod-of (t / target-01 
            :ARG1 (c / clone-01 
                  :ARG0 (s / stage) 
                  :ARG0-of (f / fertilize-01 
                        :ARG1 (e / egg 
                              :mod (m / mouse) 
                              :mod (i / ICR))) 
                  :ARG1 (e2 / e) 
                  :ARG2-of (i2 / inject-01))))

# ::snt The resulting male chimeras were mated with C57BL/6N females , and heterozygous male and female mice were interbred to generate homozygous mice .
# ::tok The resulting male chimeras were mated with C57BL/6N females , and heterozygous male and female mice were interbred to generate homozygous mice .
# ::alignments 21-22|0.0.0 20-21|0.0.0.0 19-20|0.0 15-16|0.2 14-15|0.2.0 13-14|0 12-13|0.1 11-12|0.2.1 10-11|0.0.2 8-9|0.0.2.0.0 5-6|0.0.2.0 3-4|0.0.2.0.1 2-3|0.0.1 1-2|0.0.2.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:39.622
(a / and 
      :ARG0-of (g / generate-01 
            :ARG1 (m / mouse 
                  :mod (h / homozygou)) 
            :ARG2 (m5 / male) 
            :op2-of (a2 / and 
                  :op1 (m4 / mate-01 
                        :ARG0 (f2 / female) 
                        :ARG1 (c / chimera 
                              :ARG1-of (r / result-01))))) 
      :op1 (m3 / male) 
      :op2 (m2 / mouse 
            :mod (f / female) 
            :mod (h2 / heterozygou)))

# ::snt The ataxic phenotypes of homozygous mice were observed in two independent lines .
# ::tok The ataxic phenotypes of homozygous mice were observed in two independent lines .
# ::alignments 11-12|0.0.1 10-11|0.0.1.0.0+0.0.1.0 9-10|0.0.1.1 7-8|0 5-6|0.0 4-5|0.0.0 2-3|0.0.2 1-2|0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:39.701
(o / observe-01 
      :ARG1 (m / mouse 
            :mod (h / homozygou) 
            :mod-of (l / line 
                  :ARG0-of (d / depend-01 
                        :polarity -) 
                  :quant 2) 
            :mod-of (p / phenotyp 
                  :mod (a / ataxic))))

# ::snt Mouse genomic DNA used for Southern blot analysis was extracted from the liver of each genotype .
# ::tok Mouse genomic DNA used for Southern blot analysis was extracted from the liver of each genotype .
# ::alignments 15-16|0.0.0.0.0.0 14-15|0.0.0.0.0.0.0 12-13|0.1 9-10|0 7-8|0.0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 3-4|0.0.0 2-3|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:39.788
(e2 / extract-01 
      :ARG1 (d / DNA 
            :ARG1-of (u / use-01 
                  :ARG2 (a / analyze-01 
                        :ARG1 (b / blot-01 
                              :ARG1 (g / genotype 
                                    :mod (e / each))) 
                        :manner (t / thing 
                              :name (n / name 
                                    :op1 "Southern")))) 
            :mod (m / mouse)) 
      :ARG2 (l / liver))

# ::snt BamHI-digested genomic DNA was probed with the [ 32P ] - labelled 0.4-kb SpeI-BamHI genomic fragment , which is located between exons 8 and 9 .
# ::tok BamHI-digested genomic DNA was probed with the [ 32P ] - labelled 0.4-kb SpeI-BamHI genomic fragment , which is located between exons 8 and 9 .
# ::alignments 24-25|0.0.0.0.0 23-24|0.1 22-23|0.0.0.0.2 21-22|0.0.0.0.1 19-20|0.1.0 15-16|0.0.0.0 11-12|0.0.0 4-5|0 2-3|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:39.963
(p / probe-01 
      :ARG0 (d / DNA 
            :ARG0-of (l2 / label-01 
                  :ARG1 (f / fragment-01 
                        :ARG0 9 
                        :ARG1 (e / exon) 
                        :ARG2 8)) 
            :mod (b / bamhi-digest)) 
      :ARG1 (a / and 
            :ARG0-of (l / locate-01)))

# ::snt His-tagged and MBP-fused recombinant protein containing cytoplasmic domain ( cp ) of human ADAM22 isoform 1 ( position : 756 -- 906 , 151 amino acids in length ) were produced in E. coli .
# ::tok His-tagged and MBP-fused recombinant protein containing cytoplasmic domain ( cp ) of human ADAM22 isoform 1 ( position : 756 -- 906 , 151 amino acids in length ) were produced in E. coli .
# ::alignments 32-34|0.3.2.1+0.3.2.0.1+0.3.2.0.0+0.3.2.0+0.3.2 30-31|0.3 27-28|0.0.2 25-26|0.0.2.0 24-25|0.0.3 17-18|0.3.0 15-16|0.3.1 14-15|0.0.1.1 12-13|0.0.1.1.0 7-8|0.0.1 6-7|0.0.1.0 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 2-3|0.2.0.0+0.2.0+0.2 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:41.799
(a3 / and 
      :ARG1-of (c2 / contain-01 
            :ARG0 (p3 / protein 
                  :mod (r / recombinant)) 
            :ARG2 (d2 / domain 
                  :mod (c / cytoplasmic) 
                  :poss (i / isoform 
                        :mod (h / human))) 
            :op1-of (l / length 
                  :location-of (a / acid)) 
            :op1-of (a2 / amino)) 
      :op1 (h2 / his-tagg) 
      :op2 (t / thing 
            :name (n2 / name 
                  :op1 "MBP-fused")) 
      :op3 (p / produce-01 
            :ARG1 (p2 / position) 
            :ARG2 1 
            :manner (d / disease 
                  :name (n / name 
                        :op1 "E." 
                        :op2 "coli") 
                  :wiki "Escherichia_coli")))

# ::snt His-tagged ADAM22-cp protein was purified in denatured condition using Ni-NTA resin ( Qiagen GmbH ) and dialysed in PBS .
# ::tok His-tagged ADAM22-cp protein was purified in denatured condition using Ni-NTA resin ( Qiagen GmbH ) and dialysed in PBS .
# ::alignments 18-19|0.2.2.0 15-16|0.2.2 12-14|0.0.0.1+0.0.0.0+0.0.0+0.0 10-11|0.2.1 9-10|0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 8-9|0.2 7-8|0.2.0 6-7|0.2.0.0 4-5|0 2-3|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:42.404
(p2 / purify-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "Qiagen" 
                  :op2 "GmbH")) 
      :ARG1 (p3 / protein 
            :mod (h / his-tagg)) 
      :ARG2 (u / use-01 
            :ARG0 (c / condition 
                  :mod (d / denature)) 
            :ARG1 (r / resin 
                  :mod (o2 / organization 
                        :name (n2 / name 
                              :op1 "Ni-NTA"))) 
            :op1-of (a / and 
                  :time (p / pb))))

# ::snt Precipitated protein was recovered and was mixed with Freund 's complete adjuvant ( Invitrogen ) , then , the mixture was used for immunization of rabbits .
# ::tok Precipitated protein was recovered and was mixed with Freund 's complete adjuvant ( Invitrogen ) , then , the mixture was used for immunization of rabbits .
# ::alignments 25-26|0.0.1 23-24|0.1.0.1.0.1 21-22|0.1.0.1.0 19-20|0.1.0.1.0.0 16-17|0.1.0.1.0.2 13-14|0.1.0.1.2.0.0+0.1.0.1.2.0+0.1.0.1.2 11-12|0.1.0 10-11|0.1.0.0 8-9|0.1.0.1.1.0+0.1.0.1.1+0.1.0.1 6-7|0.1 4-5|0 3-4|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:42.542
(a2 / and 
      :op1 (r2 / recover-02 
            :ARG1 (p2 / protein 
                  :ARG1-of (p3 / precipitate-01)) 
            :ARG1-of (r / rabbit-01)) 
      :op2 (m2 / mix-01 
            :ARG2 (a / adjuvant 
                  :ARG1-of (c / complete-02) 
                  :poss (p / person 
                        :ARG0-of (u / use-01 
                              :ARG1 (m / mixture) 
                              :ARG2 (i / immunization) 
                              :time (t / then)) 
                        :name (n2 / name 
                              :op1 "Freund") 
                        :poss-of (o / organization 
                              :name (n / name 
                                    :op1 "Invitrogen"))))))

# ::snt The antiserum raised against the His-tagged ADAM22-cp protein was incubated with MBP-fused ADAM22-cp protein coupled to Affi-Gel 10 beads ( Bio-Rad ) .
# ::tok The antiserum raised against the His-tagged ADAM22-cp protein was incubated with MBP-fused ADAM22-cp protein coupled to Affi-Gel 10 beads ( Bio-Rad ) .
# ::alignments 18-19|0 17-18|0.0.0.0 14-15|0.0.1.0.0 13-14|0.0.1.0 11-12|0.1.0.0+0.1.0+0.1 9-10|0.0.1 7-8|0.0.0.1 5-6|0.0.0.1.0 2-3|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:42.948
(b / bead-01 
      :ARG0 (a / antiserum 
            :ARG1-of (r / raise-01 
                  :ARG0 10 
                  :prep-against (p2 / protein 
                        :mod (h / his-tagg))) 
            :ARG1-of (i / incubate-01 
                  :ARG0 (p / protein 
                        :ARG1-of (c / couple-01)))) 
      :ARG1 (t / thing 
            :name (n / name 
                  :op1 "MBP-fused")))

# ::snt Beads with bound antibodies were washed in PBS , and the bound antibodies were eluted with 100 mM glycine , pH 3.0 , and neutralized immediately .
# ::tok Beads with bound antibodies were washed in PBS , and the bound antibodies were eluted with 100 mM glycine , pH 3.0 , and neutralized immediately .
# ::alignments 25-26|0.2.0.1 24-25|0.2.0 23-24|0.2 20-21|0.2.0.0.0.0 18-19|0.1.1 17-18|0.1.1.0 16-17|0.0.0.0.0 12-13|0.2.0.0 11-12|0.2.0.0.0 9-10|0 7-8|0.1.0 5-6|0.1 3-4|0.0.0 2-3|0.0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:43.317
(a3 / and 
      :ARG2-of (b3 / bead-01 
            :ARG1 (a4 / antibodi 
                  :ARG1-of (b2 / bind-01 
                        :ARG0 100))) 
      :op1 (w / wash-01 
            :ARG0 (p2 / pb) 
            :ARG1 (g / glycine 
                  :mod (m / mm))) 
      :op2 (a / and 
            :op1 (n / neutralize-01 
                  :ARG1 (a2 / antibodi 
                        :ARG1-of (b / bind-01 
                              :ARG0 (p / ph))) 
                  :time (i / immediate))))

# ::snt Using the affinity purified antibody , both human and mouse ADAM22 proteins were detected by Western blot analysis .
# ::tok Using the affinity purified antibody , both human and mouse ADAM22 proteins were detected by Western blot analysis .
# ::alignments 17-18|0.0.0.0.0 16-17|0.0.0.0.0.0 15-16|0.0.0.0.0.1.1+0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 13-14|0.0.0.0 11-12|0.0.0 10-11|0.0.0.1 9-10|0 8-9|0.0 7-8|0.0.0.0.0.0.0 6-7|0.0.0.2 4-5|0.0.0.0.1.0 3-4|0.0.0.0.1.0.0 2-3|0.0.0.0.1.0.1 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:43.851
(m / mouse 
      :op1-of (a3 / and 
            :op2 (p / protein 
                  :ARG1-of (d / detect-01 
                        :ARG0 (a / analyze-01 
                              :ARG1 (b / blot-01 
                                    :ARG1 (h / human)) 
                              :manner (w / world-region 
                                    :name (n / name 
                                          :op1 "West") 
                                    :wiki "Western_world")) 
                        :ARG0-of (u / use-01 
                              :ARG1 (a4 / antibody 
                                    :ARG1-of (p2 / purify-01) 
                                    :mod (a5 / affinity)))) 
                  :mod (a2 / ADAM22) 
                  :mod (b2 / both))))

# ::snt However , unfortunately the antibody was not suitable for immunohistochemical analysis of mouse tissues .
# ::tok However , unfortunately the antibody was not suitable for immunohistochemical analysis of mouse tissues .
# ::alignments 13-14|0.0 12-13|0 10-11|0.0.0 7-8|0.0.0.0 6-7|0.0.0.0.1 4-5|0.0.0.0.0 2-3|0.0.0.0.0.0.0+0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:43.937
(m / mouse 
      :mod-of (t / tissue 
            :ARG1-of (a / analyze-01 
                  :ARG2-of (s / suitable-04 
                        :ARG1 (a2 / antibody 
                              :ARG1-of (f / fortunate-01 
                                    :polarity -)) 
                        :polarity -))))

# ::snt The absence of ADAM22 protein in the Adam22 - / - mice was confirmed by Western blot analysis .
# ::tok The absence of ADAM22 protein in the Adam22 - / - mice was confirmed by Western blot analysis .
# ::alignments 17-18|0.0 16-17|0.0.0 15-16|0.0.1.1+0.0.1.0.0+0.0.1.0+0.0.1 13-14|0 11-12|0.0.0.0 9-10|0.0.0.1 4-5|0.1.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:44.119
(c / confirm-01 
      :ARG0 (a / analyze-01 
            :ARG1 (b / blot-01 
                  :ARG0 (m / mouse) 
                  :ARG1 (s / slash)) 
            :manner (w / world-region 
                  :name (n / name 
                        :op1 "West") 
                  :wiki "Western_world")) 
      :ARG1 (a2 / absent-01 
            :ARG1 (p / protein)))

# ::snt Briefly , the cerebellum was isolated from a P14 .5 mouse of each genotype and homogenized with a Polytron homogenizer in cell lysis buffer ( 50 mM Tris-HCl , pH 7.5 , 100 mM NaCl , 1 % NP-40 , Complete protease inhibitors [ Roche Diagnostics ] ) .
# ::tok Briefly , the cerebellum was isolated from a P14 .5 mouse of each genotype and homogenized with a Polytron homogenizer in cell lysis buffer ( 50 mM Tris-HCl , pH 7.5 , 100 mM NaCl , 1 % NP-40 , Complete protease inhibitors [ Roche Diagnostics ] ) .
# ::alignments 44-46|0.4.0.1+0.4.0.0+0.4.0+0.4 42-43|0.1.6.0 41-42|0.1.6 40-41|0.0 38-39|0.3.0.0+0.3.0+0.3 37-38|0.1.4.0 36-37|0.1.4 34-35|0.2.0.0+0.2.0+0.2 32-33|0.1.5 29-30|0.1.2 27-28|0.1.3.0.0.0+0.1.3.0.0+0.1.3.0 26-27|0.1.3 25-26|0.1.3.0.1 23-24|0.1.7 22-23|0.1.7.1 21-22|0.1.7.1.0 19-20|0.1.7.2 18-19|0.0.0.0.0+0.0.0.0+0.0.0 14-15|0 13-14|0.1.1.1 12-13|0.1.1.1.0 10-11|0.1.1 8-9|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 5-6|0.1 3-4|0.1.0 0-1|0.1.7.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:45.000
(a / and 
      :ARG1-of (c / complete-02 
            :ARG0 (t3 / thing 
                  :name (n5 / name 
                        :op1 "Polytron"))) 
      :op1 (i2 / isolate-01 
            :ARG1 (c4 / cerebellum) 
            :ARG2 (m2 / mouse 
                  :mod (t4 / thing 
                        :name (n6 / name 
                              :op1 "P14")) 
                  :poss (g / genotype 
                        :mod (e / each))) 
            :op1-of (p3 / ph) 
            :op1-of (m / mm 
                  :mod-of (t2 / thing 
                        :name (n4 / name 
                              :op1 "Tris-HCl") 
                        :quant 50)) 
            :op1-of (1 / 1 
                  :value-of (p2 / percentage-entity)) 
            :op1-of 100 
            :op1-of (p / protease 
                  :mod-of (i / inhibitor)) 
            :purpose-of (b / buffer-01 
                  :ARG0 (b2 / briefly) 
                  :ARG1 (l / lysi 
                        :mod (c3 / cell)) 
                  :beneficiary-of (h / homogeniz))) 
      :op2 (t / thing 
            :name (n3 / name 
                  :op1 "NaCl")) 
      :op3 (c2 / country 
            :name (n2 / name 
                  :op1 "NP-40")) 
      :op4 (o / organization 
            :name (n / name 
                  :op1 "Roche" 
                  :op2 "Diagnostics")))

# ::snt After removal of cell debris by centrifugation , the supernatant was separated on 10 % SDS-PAGE , and transferred to a nitrocellulose membrane .
# ::tok After removal of cell debris by centrifugation , the supernatant was separated on 10 % SDS-PAGE , and transferred to a nitrocellulose membrane .
# ::alignments 22-23|0.0.2 21-22|0.0.2.0 18-19|0.0 17-18|0 14-15|0.0.0.0 13-14|0.0.0 11-12|0.0.1.0 9-10|0.0.1 6-7|0.1.0.0 4-5|0.1.0.1 3-4|0.1.0.1.0 1-2|0.1.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:45.202
(a / and 
      :op1 (t / transfer-01 
            :ARG0 (1 / 10 
                  :value-of (p / percentage-entity)) 
            :ARG1 (s2 / supernatant 
                  :ARG1-of (s / separate-01)) 
            :ARG2 (m / membrane 
                  :mod (n / nitrocellulose))) 
      :time (a2 / after 
            :op1 (r / remove-01 
                  :ARG0 (c / centrifugation) 
                  :ARG1 (d / debris 
                        :mod (c2 / cell)))))

# ::snt The blot was then incubated with polyclonal antibody against the cytoplasmic domain of ADAM22 ( at 1:1,000 ) .
# ::tok The blot was then incubated with polyclonal antibody against the cytoplasmic domain of ADAM22 ( at 1:1,000 ) .
# ::alignments 11-12|0.0.0 10-11|0.0.0.0 7-8|0.1 4-5|0 3-4|0.2 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:45.266
(i / incubate-01 
      :ARG1 (b / blot-01 
            :ARG1 (d / domain 
                  :mod (c / cytoplasmic))) 
      :ARG2 (a / antibody) 
      :time (t / then))

# ::snt Bound antibodies were visualized with horseradish peroxidase-labelled second antibody and a ECL-plus chemiluminescence detection system ( Amersham Biosciences Corp. ) .
# ::tok Bound antibodies were visualized with horseradish peroxidase-labelled second antibody and a ECL-plus chemiluminescence detection system ( Amersham Biosciences Corp. ) .
# ::alignments 16-19|0.1.0.0.0.2+0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 14-15|0.0.0 13-14|0.0.0.0 12-13|0.0.0.0.0 11-12|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 9-10|0.0 8-9|0.2 6-7|0.2.0 5-6|0.2.1 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:45.500
(v / visualize-01 
      :ARG0 (a / and 
            :op1 (s / system 
                  :ARG0-of (d / detect-01 
                        :ARG1 (c / chemiluminescence)) 
                  :quant (t / thing 
                        :name (n2 / name 
                              :op1 "ECL-plus")))) 
      :ARG1 (a3 / antibodi 
            :ARG1-of (b / bound-01 
                  :ARG0 (o / organization 
                        :name (n / name 
                              :op1 "Amersham" 
                              :op2 "Biosciences" 
                              :op3 "Corp.")))) 
      :ARG2 (a2 / antibody 
            :mod (p / peroxidase-labell) 
            :mod (h / horseradish)))

# ::snt Primary Schwann cell culture .
# ::tok Primary Schwann cell culture .
# ::alignments 3-4|0.0.0.0 2-3|0.0.0.0.0 0-2|0+0.0.1+0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:45.522
(s / Schwann 
      :op2-of (n / name 
            :name-of (t / thing 
                  :mod-of (c / culture 
                        :mod (c2 / cell))) 
            :op1 (p / Primary)))

# ::snt Primary Schwann cells were prepared from 4-month-old C57BL/6 mice according to Manent 's protocol [ 32 ] with minor modifications .
# ::tok Primary Schwann cells were prepared from 4-month-old C57BL/6 mice according to Manent 's protocol [ 32 ] with minor modifications .
# ::alignments 19-20|0.2.0 18-19|0.2.0.0 15-16|0.1.1.0.0 13-14|0.0 11-12|0.2.1.0+0.2.1+0.2 9-10|0 8-9|0.1.0 4-5|0.1 2-3|0.1.1 1-2|0.1.1.0.1.0+0.1.1.0.1+0.1.1.0 0-1|0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:45.881
(s / say-01 
      :ARG0 (p / protocol) 
      :ARG1 (p3 / prepare-02 
            :ARG0 (m3 / mouse) 
            :ARG1 (c / cell 
                  :mod (t / thing 
                        :mod-of 32 
                        :name (n2 / name 
                              :op1 "Schwann")) 
                  :mod (p4 / primary))) 
      :ARG2 (p2 / person 
            :ARG0-of (m / modify-01 
                  :mod (m2 / minor)) 
            :name (n / name 
                  :op1 "Manent")))

# ::snt Briefly , sciatic nerves were removed and incubated for 7 days in the pre-treatment medium , which consisted of D-MEM ( high glucose ) supplemented with 10 % FCS , 50 mg/ml gentamicin ( Invitrogen Corp. ) , 2.5 g/ml fungizone ( Invitrogen Corp. ) , 2 M forskolin ( EMD Biosciences Inc. ) and 10 ng/ml recombinant heregulin-beta1 ( R&D Systems ) .
# ::tok Briefly , sciatic nerves were removed and incubated for 7 days in the pre-treatment medium , which consisted of D-MEM ( high glucose ) supplemented with 10 % FCS , 50 mg/ml gentamicin ( Invitrogen Corp. ) , 2.5 g/ml fungizone ( Invitrogen Corp. ) , 2 M forskolin ( EMD Biosciences Inc. ) and 10 ng/ml recombinant heregulin-beta1 ( R&D Systems ) .
# ::alignments 61-62|0.7 57-58|0.1.2 55-56|0.1.3 54-55|0 51-53|0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 48-49|0.6 47-48|0.6.0.1+0.6.0.0.0+0.6.0.0+0.6.0 46-47|0.6.1 42-44|0.5.0.1+0.5.0.0+0.5.0+0.5 40-41|0.4 38-39|0.0.0.0.0 34-36|0.3.0.1+0.3.0.0+0.3.0+0.3 32-33|0.2 30-31|0.2.0 28-29|0.0.1 27-28|0.0.0.0.1.0.0.0.0.0 26-27|0.0.0.0.1.0.0.0.0 24-25|0.0 22-23|0.1.1 21-22|0.1 19-20|0.0.0.1.0+0.0.0.1+0.0.0 17-18|0.0.0.0 14-15|0.0.0.0.1 10-11|0.0.0.2.1+0.0.0.2 9-10|0.0.0.2.0 7-8|0.0.0.0.1.0 6-7|0.0.0.0.1.0.1 5-6|0.0.0.0.1.0.0.0 3-4|0.0.0.0.1.0.0 2-3|0.0.0.0.1.0.0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:47.931
(a / and 
      :ARG1-of (s2 / supplement-01 
            :ARG0 (p2 / person 
                  :ARG2-of (c2 / consist-01 
                        :ARG0 2.5 
                        :ARG1 (m / medium 
                              :location-of (i3 / incubate-01 
                                    :ARG1 (n6 / nerve 
                                          :ARG1-of (r2 / remove-01 
                                                :ARG0 (12 / 10 
                                                      :value-of (p / percentage-entity))) 
                                          :mod (s3 / sciatic)) 
                                    :op1-of (a2 / and)))) 
                  :name (n5 / name 
                        :op1 "D-MEM") 
                  :quant (t3 / temporal-quantity 
                        :quant 7 
                        :unit (d / day))) 
            :ARG2 (f3 / fc) 
            :accompanier (t / thing 
                  :name (n / name 
                        :op1 (b / Biosciences) 
                        :op2 (i / Inc.)))) 
      :op1 (h / high-02 
            :ARG0 (b2 / briefly) 
            :ARG1 (g2 / glucose) 
            :op1-of (r / recombinant) 
            :op1-of 10) 
      :op2 (g / gentamicin 
            :quant 50) 
      :op3 (o / organization 
            :name (n4 / name 
                  :op1 "Invitrogen" 
                  :op2 "Corp.")) 
      :op4 (f2 / fungizone) 
      :op5 (t2 / thing 
            :name (n3 / name 
                  :op1 (i2 / Invitrogen) 
                  :op2 (c / Corp.))) 
      :op6 (f / forskolin 
            :mod (v / vehicle 
                  :name (n2 / name 
                        :op1 "M1") 
                  :wiki "M1_Abrams") 
            :quant 2) 
      :op7 (s / system))

# ::snt For dissociation , cultured sciatic nerves were cut into pieces and incubated at 37 C for 3 hours in Opti-MEM medium ( Invitrogen Corp. ) containing 130 U/ml collagenase type I ( Invitrogen Corp. ) and 0.4 U/ml dispase II ( Roche Diagnostics ) .
# ::tok For dissociation , cultured sciatic nerves were cut into pieces and incubated at 37 C for 3 hours in Opti-MEM medium ( Invitrogen Corp. ) containing 130 U/ml collagenase type I ( Invitrogen Corp. ) and 0.4 U/ml dispase II ( Roche Diagnostics ) .
# ::alignments 42-43|0.2.1.0.2.1.1 39-40|0.2.1.0.2.1.0.2+0.2.1.0.2.1.0.1.2+0.2.1.0.2.1.0.1.1+0.2.1.0.2.1.0.1.0+0.2.1.0.2.1.0.1+0.2.1.0.2.1.0 38-39|0.2.1.0.2.1.0.0 35-36|0.2.1.0.2.1 32-34|0.2.1.0.2.0.0.1+0.2.1.0.2.0.0.0+0.2.1.0.2.0.0+0.2.1.0.2.0 30-31|0.1.0 29-30|0.1 28-29|0.1.1 26-27|0.1.2 25-26|0 22-24|0.2.1.0.0.0.1+0.2.1.0.0.0.0+0.2.1.0.0.0+0.2.1.0.0 20-21|0.0 19-20|0.0.0.0.0+0.0.0.0+0.0.0 17-18|0.2.1.1.0.1+0.2.1.1.0 16-17|0.2.1.1.0.0 14-15|0.2.1.0.1 13-14|0.2.0 11-12|0.2.1.0 10-11|0.2.1.0.2 9-10|0.2.1.1.1 7-8|0.2.1.1 5-6|0.2.1 4-5|0.2.1.2 3-4|0.2 1-2|0.2.1.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:49.098
(c3 / contain-01 
      :ARG0 (m / medium 
            :mod (c4 / country 
                  :name (n4 / name 
                        :op1 "Opti-MEM"))) 
      :ARG1 (t2 / type 
            :domain (i2 / i) 
            :mod (c2 / collagenase) 
            :quant 130) 
      :ARG2 (c7 / culture-01 
            :ARG0 37 
            :ARG1 (n5 / nerve 
                  :ARG1-of (i3 / incubate-01 
                        :ARG0 (o / organization 
                              :name (n3 / name 
                                    :op1 "Invitrogen" 
                                    :op2 "Corp.")) 
                        :ARG2 (c5 / C) 
                        :op1-of (a2 / and 
                              :op2 (t / thing 
                                    :name (n2 / name 
                                          :op1 (i / Invitrogen) 
                                          :op2 (c / Corp.))) 
                              :op3 (a / and 
                                    :op1 (w / war 
                                          :mod (d2 / dispase) 
                                          :name (n / name 
                                                :op1 "World" 
                                                :op2 "War" 
                                                :op3 "II") 
                                          :wiki "World_War_II") 
                                    :op2 (d / diagnostic)))) 
                  :ARG1-of (c6 / cut-01 
                        :ARG0 (t3 / temporal-quantity 
                              :quant 3 
                              :unit (h / hour)) 
                        :ARG2 (p / piece) 
                        :purpose (d3 / dissociation)) 
                  :mod (s / sciatic))))

# ::snt Dissociated cells were resuspended in the pre-treatment medium and plated on Poly-D-Lysine/Laminin coated plate ( BD Biosciences ) .
# ::tok Dissociated cells were resuspended in the pre-treatment medium and plated on Poly-D-Lysine/Laminin coated plate ( BD Biosciences ) .
# ::alignments 15-17|0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 13-14|0.0.1 12-13|0.0.1.0 9-10|0.0 8-9|0 7-8|0.0.1.1 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:49.246
(a / and 
      :op1 (p2 / plate-01 
            :ARG0 (c2 / cell 
                  :ARG1-of (d / dissociate-01 
                        :ARG0 (o / organization 
                              :name (n / name 
                                    :op1 "BD" 
                                    :op2 "Biosciences")))) 
            :ARG1 (p / plate 
                  :ARG1-of (c / coat-01) 
                  :name-of (m / medium))))

# ::snt The purity of the cultured Schwann cells , as determined by indirect immunofluorescence analysis , approached 90 % .
# ::tok The purity of the cultured Schwann cells , as determined by indirect immunofluorescence analysis , approached 90 % .
# ::alignments 17-18|0.1 16-17|0.1.0 15-16|0 13-14|0.0.0.0 12-13|0.0.0.0.1 11-12|0.0.0.0.0 9-10|0.0.0 6-7|0.0.1 5-6|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 4-5|0.0.1.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:49.329
(a / approach-02 
      :ARG0 (p2 / purity 
            :ARG1-of (d2 / determined-02 
                  :ARG0 (a2 / analyze-01 
                        :ARG1-of (d / direct-02) 
                        :manner (i / immunofluorescence))) 
            :domain (c / cell 
                  :ARG1-of (c2 / culture-01) 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "Schwann")))) 
      :ARG1 (p / percentage-entity 
            :value 90))

# ::snt Adult C57BL/6 male mice were used in this study .
# ::tok Adult C57BL/6 male mice were used in this study .
# ::alignments 8-9|0.1 7-8|0.1.1 5-6|0 3-4|0.0 2-3|0.0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:22:49.360
(u / use-01 
      :ARG1 (m / mouse 
            :mod (m2 / male)) 
      :ARG2 (s / study-01 
            :ARG1 (a / adult) 
            :mod (t / this)))

# ::snt Total RNAs purified from the cerebellum , spinal cord , sciatic nerve , DRG and cultured Schwann cells using TRIzol ( Invitrogen Corp. ) and RNeasy kit ( Qiagen GmbH ) were analysed by RT-PCR using SuperScript II and random primer ( Invitrogen Corp. ) , and PCR amplification ( 40 cycles ; 94 C -30 s , 60 C -30 s and 68 C -5 min ) with Expand Hi-Fidelity DNA polymerase ( Roche Diagnostics ) and ADAM22-specific primers .
# ::tok Total RNAs purified from the cerebellum , spinal cord , sciatic nerve , DRG and cultured Schwann cells using TRIzol ( Invitrogen Corp. ) and RNeasy kit ( Qiagen GmbH ) were analysed by RT-PCR using SuperScript II and random primer ( Invitrogen Corp. ) , and PCR amplification ( 40 cycles ; 94 C -30 s , 60 C -30 s and 68 C -5 min ) with Expand Hi-Fidelity DNA polymerase ( Roche Diagnostics ) and ADAM22-specific primers .
# ::alignments 79-80|0.2.0.1.1.2 77-78|0.2.0.1.1 75-76|0.2.0.0.0 72-73|0.2.0.1.1.1 71-72|0.2.0.1.1.1.0 69-71|0.2.0.1.1.1.1.0.1+0.2.0.1.1.1.1.0.0+0.2.0.1.1.1.1.0+0.2.0.1.1.1.1 66-67|0.2.1 63-66|0.2.0.5.0.2+0.2.0.5.0.1+0.2.0.5.0.0+0.2.0.5.0+0.2.0.5 62-63|0.2 58-61|0.2.0.4.0.2+0.2.0.4.0.1+0.2.0.4.0.0+0.2.0.4.0+0.2.0.4 56-57|0.1 53-56|0.2.0.1.1.0.0.2+0.2.0.1.1.0.0.1+0.2.0.1.1.0.0.0+0.2.0.1.1.0.0+0.2.0.1.1.0 52-53|0 51-52|0.2.0.0 50-51|0.2.0.1.0.0.0.0.2 48-49|0.2.0.2.1.1 46-47|0.2.0.2.1 42-44|0.2.0.2.1.0.0.1+0.2.0.2.1.0.0.0+0.2.0.2.1.0.0+0.2.0.2.1.0 40-41|0.2.0.3 39-40|0.2.0.1.0.0.0.2.0.0.0 38-39|0.2.0 36-38|0.2.0.2.0.1+0.2.0.2.0.0+0.2.0.2.0+0.2.0.2 35-36|0.2.0.1 28-30|0.0.0.1+0.0.0.0+0.0.0+0.0 26-27|0.2.0.1.0.0.0.0.1.0 24-25|0.2.0.1.0.0.0.0.1 21-23|0.2.0.1.0.1.0.0.1+0.2.0.1.0.1.0.0.0+0.2.0.1.0.1.0.0+0.2.0.1.0.1.0 19-20|0.2.0.1.0.0.0.0.0.0.0+0.2.0.1.0.0.0.0.0.0+0.2.0.1.0.0.0.0.0 18-19|0.2.0.1.0.0.0.0 17-18|0.2.0.1.0.0.0.2.0 16-17|0.2.0.1.0.0.0.2.1.0+0.2.0.1.0.0.0.2.1+0.2.0.1.0.0.0.2 15-16|0.2.0.1.0.0.0.2.0.0 14-15|0.2.0.1.0.0.0 11-12|0.2.0.1.0.1.1 10-11|0.2.0.1.0.1.1.0 8-9|0.2.0.1.0.0.0.1 7-8|0.2.0.1.0.0.0.1.0 5-6|0.2.0.1.0.0.1 2-3|0.2.0.1.0.0 1-2|0.2.0.1.0 0-1|0.2.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:03.106
(a3 / and 
      :op1 (t7 / thing 
            :name (n7 / name 
                  :op1 (q / Qiagen) 
                  :op2 (g / GmbH))) 
      :op2 (s / s) 
      :op3 (a2 / and 
            :op1 (a6 / and 
                  :ARG0-of (c4 / cycle-02 
                        :ARG2 (d / diagnostic)) 
                  :ARG1-of (u / use-01 
                        :ARG0 (r2 / rna 
                              :ARG1-of (p5 / purify-01 
                                    :ARG0 (a8 / and 
                                          :ARG2-of (u2 / use-01 
                                                :ARG0 (p4 / person 
                                                      :name (n9 / name 
                                                            :op1 "TRIzol")) 
                                                :ARG1 (a7 / and 
                                                      :op1 (k / kit)) 
                                                :op1-of 40) 
                                          :op1 (c8 / cord 
                                                :mod (s4 / spinal)) 
                                          :op2 (t8 / thing 
                                                :mod-of (c6 / cell 
                                                      :ARG1-of (c7 / culture-01 
                                                            :ARG0 (r / random))) 
                                                :name (n10 / name 
                                                      :op1 "Schwann"))) 
                                    :ARG2 (c9 / cerebellum)) 
                              :ARG2-of (t9 / total-01 
                                    :ARG1 (o / organization 
                                          :name (n8 / name 
                                                :op1 "Invitrogen" 
                                                :op2 "Corp.")) 
                                    :op1-of (n11 / nerve 
                                          :mod (s3 / sciatic)))) 
                        :ARG2 (a / and 
                              :op1 (t4 / thing 
                                    :name (n4 / name 
                                          :op1 94 
                                          :op2 (c3 / C) 
                                          :op3 -30)) 
                              :op2 (p2 / polymerase 
                                    :mod (d2 / DNA) 
                                    :mod (t / thing 
                                          :name (n / name 
                                                :op1 (e / Expand) 
                                                :op2 (h / Hi-Fidelity)))) 
                              :op3 (p / primer))) 
                  :op1 (t6 / thing 
                        :name (n6 / name 
                              :op1 (s2 / SuperScript) 
                              :op2 (i2 / II)) 
                        :op1-of (a5 / and 
                              :op2 (t5 / thing 
                                    :name (n5 / name 
                                          :op1 (i / Invitrogen) 
                                          :op2 (c5 / Corp.))) 
                              :op3 (a4 / amplification))) 
                  :op2 (p3 / primer) 
                  :op3 (t3 / thing 
                        :name (n3 / name 
                              :op1 60 
                              :op2 (c2 / C) 
                              :op3 -30)) 
                  :op4 (t2 / thing 
                        :name (n2 / name 
                              :op1 68 
                              :op2 (c / C) 
                              :op3 -5))) 
            :op2 (m / min)))

# ::snt To detect splicing variants in the cytoplasmic domain , a forward primer was placed just upstream of the transmembrane domain and a reverse primer was set on the terminating exon .
# ::tok To detect splicing variants in the cytoplasmic domain , a forward primer was placed just upstream of the transmembrane domain and a reverse primer was set on the terminating exon .
# ::alignments 29-30|0.0.0.0.2.0 28-29|0.0.0.0.2 23-24|0.0.0.0.1.0 22-23|0.0.0.0.1 20-21|0 19-20|0.0.0.0.2.0.0 15-16|0.0.0.0.0.0 14-15|0.0.0.0.0 13-14|0.1 11-12|0.1.0 10-11|0.1.0.0 7-8|0.0.1 6-7|0.0.1.0 3-4|0.0.0 2-3|0.0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:03.498
(a / and 
      :condition (d3 / detect-01 
            :ARG1 (v / variant 
                  :ARG1-of (s / splice-01 
                        :ARG0 (j / just 
                              :mod-of (u / upstream)) 
                        :ARG0-of (r / reverse-01 
                              :ARG1 (p / primer)) 
                        :ARG0-of (t / terminate-01 
                              :ARG1 (e / exon 
                                    :part-of (d / domain))))) 
            :ARG2 (d2 / domain 
                  :mod (c / cytoplasmic))) 
      :op1 (p2 / place-01 
            :ARG1 (p3 / primer 
                  :mod (f / forward))))

# ::snt The primers used in this study were as follows .
# ::tok The primers used in this study were as follows .
# ::alignments 8-9|0 5-6|0.0.0.0 4-5|0.0.0.0.0 2-3|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:03.519
(f / follow-01 
      :ARG1 (p / primer 
            :ARG1-of (u / use-01 
                  :ARG2 (s / study-01 
                        :mod (t / this)))))

# ::snt ISH04-forward : 5 ' - AACAGGCACTGGACAGGGGCTGAC-3 ' and ISH04-reverse : 5 ' - AATGGATGTCTCCCATAGCCTGGC-3 ' .
# ::tok ISH04-forward : 5 ' - AACAGGCACTGGACAGGGGCTGAC-3 ' and ISH04-reverse : 5 ' - AATGGATGTCTCCCATAGCCTGGC-3 ' .
# ::alignments 10-11|0.0 7-8|0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:03.537
(a / and 
      :op2-of (5 / 5 
            :op1 5))

# ::snt Mice were anesthetized with ethyl ether .
# ::tok Mice were anesthetized with ethyl ether .
# ::alignments 5-6|0.1 4-5|0.1.0 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:03.562
(a / anesthetize-01 
      :ARG1 (m / mouse) 
      :ARG2 (e / eth 
            :mod (e2 / ethyl)))

# ::snt Whole-body perfusion by 2 % paraformaldehyde-glutaraldehyde solution followed by heparin-included saline was performed .
# ::tok Whole-body perfusion by 2 % paraformaldehyde-glutaraldehyde solution followed by heparin-included saline was performed .
# ::alignments 12-13|0.0.0.0.0 10-11|0 9-10|0.1 7-8|0.0 6-7|0.0.0 4-5|0.0.0.0.0.0.0 3-4|0.0.0.0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:03.630
(s / saline 
      :ARG1-of (f / follow-01 
            :ARG0 (s2 / solution 
                  :mod-of (p3 / perfusion 
                        :ARG1-of (p / perform-02 
                              :ARG0 (2 / 2 
                                    :value-of (p2 / percentage-entity)))))) 
      :mod (h / heparin-includ))

# ::snt Sciatic nerves , trigeminal nerves , brain and spinal cord were removed and fixed in 10 % neutral-buffered formalin .
# ::tok Sciatic nerves , trigeminal nerves , brain and spinal cord were removed and fixed in 10 % neutral-buffered formalin .
# ::alignments 18-19|0.1.2 17-18|0.1.2.0 16-17|0.1.0 15-16|0.1.0.0 13-14|0.2 12-13|0 11-12|0.1 9-10|0.1.1.1 8-9|0.1.1.1.0 7-8|0.1.1 6-7|0.1.1.0 4-5|0.0 3-4|0.0.0 1-2|0.2.0 0-1|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:04.020
(a / and 
      :op1 (n2 / nerve 
            :mod (t / trigeminal)) 
      :op2 (r / remove-01 
            :ARG0 (p / percentage-entity 
                  :value 10) 
            :ARG1 (a2 / and 
                  :op1 (b / brain) 
                  :op2 (c / cord 
                        :mod (s / spinal))) 
            :time (f / formalin 
                  :mod (n / neutral-buffer))) 
      :op3 (f2 / fix-03 
            :ARG1 (n3 / nerve 
                  :mod (s2 / sciatic))))

# ::snt The spinal cord and other nerve blocks were washed and postfixed with 2 % osmium tetroxide , and were dehydrated in ethanol and equilibrated in Epon .
# ::tok The spinal cord and other nerve blocks were washed and postfixed with 2 % osmium tetroxide , and were dehydrated in ethanol and equilibrated in Epon .
# ::alignments 25-26|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 23-24|0.1.1 22-23|0.1 21-22|0.1.0.1 19-20|0.1.0 17-18|0.1.0.2 15-16|0.1.0.2.0 14-15|0.1.0.2.0.0 13-14|0.1.0.2.0.0.0 12-13|0.1.0.2.0.0.0.0 9-10|0 8-9|0.0 6-7|0.0.0.0 5-6|0.1.1.0 4-5|0.0.0.0.0 3-4|0.0.0 2-3|0.1.0.0 1-2|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:04.332
(a3 / and 
      :op1 (w / wash-01 
            :ARG1 (a4 / and 
                  :op1 (b / block 
                        :mod (o2 / other)))) 
      :op2 (a / and 
            :op1 (d / dehydrate-01 
                  :ARG1 (c2 / cord 
                        :mod (s / spinal)) 
                  :location (e2 / ethanol) 
                  :op2-of (a2 / and 
                        :op1 (t / tetroxide 
                              :mod (o / osmium 
                                    :mod (p / percentage-entity 
                                          :value 2))))) 
            :op2 (e / equilibrate-01 
                  :ARG1 (n2 / nerve) 
                  :location (c / country 
                        :name (n / name 
                              :op1 "Epon")))))

# ::snt Epon embedded semithin sections were stained with toluidine blue and were subjected to light microscopic examination .
# ::tok Epon embedded semithin sections were stained with toluidine blue and were subjected to light microscopic examination .
# ::alignments 15-16|0.0.1 14-15|0.0.1.0 13-14|0.0.1.1 11-12|0.0 9-10|0 8-9|0.0.0.1.0 7-8|0.0.0.1.0.0 5-6|0.0.0.1 3-4|0.0.0 2-3|0.0.0.3 1-2|0.0.0.0 0-1|0.0.0.2.0.0+0.0.0.2.0+0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:04.458
(a / and 
      :op1 (s / subject-01 
            :ARG1 (s3 / section 
                  :ARG1-of (e2 / embed-01) 
                  :ARG1-of (s2 / stain-01 
                        :ARG2 (b / blue 
                              :mod (t / toluidine))) 
                  :mod (c / country 
                        :name (n / name 
                              :op1 "Epon")) 
                  :mod (s4 / semithin)) 
            :ARG2 (e / examine-01 
                  :ARG0 (m / microscopic) 
                  :ARG1-of (l / light-06))))

# ::snt For electron microscopic analysis , thin sections were cut using an ultramicrotome , stained with 1.5 % uranylacetate in 50 % ethanol and 0.8 % lead citrate , and analysed using electron microscope .
# ::tok For electron microscopic analysis , thin sections were cut using an ultramicrotome , stained with 1.5 % uranylacetate in 50 % ethanol and 0.8 % lead citrate , and analysed using electron microscope .
# ::alignments 32-33|0.1.0 31-32|0.1.0.0 30-31|0.1 28-29|0 26-27|0.0.0.0 25-26|0.0.0.0.0 24-25|0.0.1.0.1.0.0 23-24|0.0.1.0.1.0.0.0 22-23|0.0.0 21-22|0.0.1.1.0.0.0 20-21|0.0.1.1.0.0 19-20|0.0.1.1.0 17-18|0.0.2 16-17|0.0.0.0.1 15-16|0.0.0.0.1.0 13-14|0.0 11-12|0.0.1.0.0 9-10|0.0.1.0 8-9|0.0.1.0.1 6-7|0.0.1 5-6|0.0.1.1 3-4|0.0.1.0.1.0 2-3|0.0.1.0.1.0.1 1-2|0.0.1.0.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:05.640
(a / and 
      :op1 (s / stain-01 
            :ARG0 (a2 / and 
                  :op1 (c / citrate 
                        :ARG1-of (l / lead-02) 
                        :quant (p3 / percentage-entity 
                              :value 1.5))) 
            :ARG1 (s2 / section 
                  :ARG0-of (u4 / use-01 
                        :ARG1 (u3 / ultramicrotome) 
                        :ARG1-of (c2 / cut-01 
                              :purpose (a3 / analyze-01 
                                    :ARG0 (p / percentage-entity 
                                          :value 0.8) 
                                    :manner (m2 / microscopic) 
                                    :mod (e3 / electron)))) 
                  :ARG1-of (t / thin-03 
                        :ARG0 (5 / 50 
                              :value-of (p2 / percentage-entity 
                                    :mod-of (e2 / ethanol))))) 
            :ARG2 (u2 / uranylacetate)) 
      :op2 (u / use-01 
            :ARG1 (m / microscope 
                  :mod (e / electron))))

# ::snt All procedures were conducted according to the Eisai Animal Care Committee 's guidelines .
# ::tok All procedures were conducted according to the Eisai Animal Care Committee 's guidelines .
# ::alignments 12-13|0.0 7-11|0.0.0.0.3+0.0.0.0.2+0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 4-5|0 3-4|0.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:05.674
(s / say-01 
      :ARG0 (g / guideline 
            :poss (o / organization 
                  :name (n / name 
                        :op1 "Eisai" 
                        :op2 "Animal" 
                        :op3 "Care" 
                        :op4 "Committee"))) 
      :ARG1 (c / conduct-01 
            :ARG1 (p / procedure 
                  :quant (a / all))))

# ::snt Frozen sections were rinsed in 0.1 % Triton X-100 / PBS at room temperature for 1 hour , and were blocked in BLOCKACE solution ( Dai-nippon ) .
# ::tok Frozen sections were rinsed in 0.1 % Triton X-100 / PBS at room temperature for 1 hour , and were blocked in BLOCKACE solution ( Dai-nippon ) .
# ::alignments 23-24|0.1.0 20-21|0.1 18-19|0 16-17|0.0.3.1+0.0.3 15-16|0.0.3.0 13-14|0.0.2 12-13|0.0.2.0 10-11|0.0.0 9-10|0.0.0.0 7-9|0.0.0.0.0.1.1+0.0.0.0.0.1.0+0.0.0.0.0.1+0.0.0.0.0 6-7|0.0.0.0.0.0 5-6|0.0.0.0.0.0.0 3-4|0.0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:05.997
(a / and 
      :op1 (r2 / rinse-01 
            :ARG0 (p / pb 
                  :op2-of (s2 / slash 
                        :op1 (p2 / person 
                              :mod (p3 / percentage-entity 
                                    :value 0.1) 
                              :name (n / name 
                                    :op1 "Triton" 
                                    :op2 "X-100")))) 
            :ARG1 (s3 / section 
                  :ARG1-of (f / freeze-01)) 
            :ARG2 (t2 / temperature 
                  :consist-of (r / room)) 
            :duration (t / temporal-quantity 
                  :quant 1 
                  :unit (h / hour))) 
      :op2 (b / block-01 
            :ARG0 (s / solution)))

# ::snt The following antibodies were incubated overnight in 0.1 % BLOCKACE at 4 C : monoclonal mouse anti-calbindin 28 K ( Sigma , 1:200 ) ; monoclonal mouse anti-MBP ( SMI-99 , Sternberger Monoclonals Inc. , 1:50 ) ; monoclonal mouse anti-Neu N ( CHEMICON , 1:100 ) ; rabbit anti-S100 polyclonal ( DAKO , 1:200 ) .
# ::tok The following antibodies were incubated overnight in 0.1 % BLOCKACE at 4 C : monoclonal mouse anti-calbindin 28 K ( Sigma , 1:200 ) ; monoclonal mouse anti-MBP ( SMI-99 , Sternberger Monoclonals Inc. , 1:50 ) ; monoclonal mouse anti-Neu N ( CHEMICON , 1:100 ) ; rabbit anti-S100 polyclonal ( DAKO , 1:200 ) .
# ::alignments 52-53|0.3.1.0.0+0.3.1.0+0.3.1 48-49|0.0.0.0.1 41-42|0.0.0.0.3.0 39-40|0.0.0.0.5 38-39|0.0.0.0.3 31-34|0.3.0.2+0.3.0.1+0.3.0.0+0.3.0+0.3 26-27|0.0.0.0.4 25-26|0.2 24-25|0 20-21|0.1 18-19|0.0.0.0.2 17-18|0.0.1 15-16|0.0.2 14-15|0.0.0.0.2.0 12-13|0.0.0.0.0 11-12|0.0.0.0.0.0 8-9|0.0.0.1 7-8|0.0.0.1.0 5-6|0.0.0.0.6 4-5|0.0.0.0 2-3|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:06.535
(a / and 
      :ARG2-of (f / follow-01 
            :ARG1 (a2 / antibodi 
                  :ARG1-of (i / incubate-01 
                        :ARG0 (c / C 
                              :quant 4) 
                        :ARG1-of (r / rabbit-01) 
                        :op1-of (k / k 
                              :mod (m6 / monoclonal)) 
                        :op1-of (m2 / monoclonal 
                              :mod-of (n2 / N)) 
                        :op1-of (m3 / mouse) 
                        :op1-of (m / mouse) 
                        :time (o3 / overnight)) 
                  :duration (p / percentage-entity 
                        :value 0.1)) 
            :op1-of 28 
            :op1-of (m5 / mouse)) 
      :op1 (s / sigma) 
      :op2 (m4 / monoclonal) 
      :op3 (o2 / organization 
            :name (n3 / name 
                  :op1 "Sternberger" 
                  :op2 "Monoclonals" 
                  :op3 "Inc.") 
            :part (o / organization 
                  :name (n / name 
                        :op1 "DAKO"))))

# ::snt Nuclei were counterstained with 1 g/ml DAPI ( Sigma ) .
# ::tok Nuclei were counterstained with 1 g/ml DAPI ( Sigma ) .
# ::alignments 8-9|0 6-7|0.0.0.0.0+0.0.0.0+0.0.0 4-5|0.0.0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:06.555
(s / sigma 
      :domain (n2 / nucleus 
            :prep-with (p / person 
                  :name (n / name 
                        :op1 "DAPI") 
                  :quant 1)))

# ::snt MBP staining was performed after microwave epitope retrieval in 10 mmol/L citrate buffer ( pH 6 ) .
# ::tok MBP staining was performed after microwave epitope retrieval in 10 mmol/L citrate buffer ( pH 6 ) .
# ::alignments 15-16|0.0.0.0 14-15|0 12-13|0.0.0.1 11-12|0.0.0.1.0 9-10|0.0.2 7-8|0.0.1.0 6-7|0.0.1.0.1 5-6|0.0.1.0.0 4-5|0.0.1 3-4|0.0 1-2|0.0.0 0-1|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:06.666
(p / ph 
      :ARG0-of (p2 / perform-02 
            :ARG1 (s / stain-01 
                  :ARG0 6 
                  :ARG0-of (b / buffer-01 
                        :ARG1 (c / citrate)) 
                  :ARG1 (m2 / MBP)) 
            :time (a / after 
                  :op1 (r / retrieval 
                        :ARG1-of (m / microwave-01) 
                        :mod (e / epitope))) 
            :time 10))

# ::snt Sections were incubated for 1 hour with secondary antibodies : Cy3-labeled donkey anti-rabbit IgG ( Jackson Immuno Research , 1:200 ) , FITC-labelled donkey anti-mouse IgG ( Jackson Immuno Research , 1:200 ) .
# ::tok Sections were incubated for 1 hour with secondary antibodies : Cy3-labeled donkey anti-rabbit IgG ( Jackson Immuno Research , 1:200 ) , FITC-labelled donkey anti-mouse IgG ( Jackson Immuno Research , 1:200 ) .
# ::alignments 27-30|0.0.2.0.2+0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 23-24|0 22-23|0.0.0.3 15-18|0.0.0.4.0.2+0.0.0.4.0.1+0.0.0.4.0.0+0.0.0.4.0+0.0.0.4 13-14|0.0.0.5.1.0+0.0.0.5.1+0.0.0.5 11-12|0.0.0.5.0 10-11|0.0.0.2.0.0+0.0.0.2.0+0.0.0.2 8-9|0.0.0.0 7-8|0.0.0.1 5-6|0.0.1.1+0.0.1 4-5|0.0.1.0 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:06.990
(d / donkey 
      :ARG2-of (i / incubate-01 
            :ARG1 (s2 / section-01 
                  :ARG0 (a / antibodi) 
                  :ARG2 (s / secondary) 
                  :op1-of (t / thing 
                        :name (n4 / name 
                              :op1 "Cy3-labeled")) 
                  :op1-of (f / fitc-labell) 
                  :op1-of (o2 / organization 
                        :name (n2 / name 
                              :op1 "Jackson" 
                              :op2 "Immuno" 
                              :op3 "Research")) 
                  :op1-of (p / person 
                        :mod (d2 / donkey) 
                        :name (n3 / name 
                              :op1 "IgG"))) 
            :duration (t2 / temporal-quantity 
                  :quant 1 
                  :unit (h / hour)) 
            :op1-of (o / organization 
                  :name (n / name 
                        :op1 "Jackson" 
                        :op2 "Immuno" 
                        :op3 "Research"))))

# ::snt Sections were photographed with an Olympus microscope ( Olympus IX71 ) equipped with a high-resolution CCD camera .
# ::tok Sections were photographed with an Olympus microscope ( Olympus IX71 ) equipped with a high-resolution CCD camera .
# ::alignments 16-17|0.1.0.1 15-16|0.1.0.1.0 14-15|0.0.0 11-12|0.1.0 8-10|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 6-7|0.1 5-6|0.1.1.0.0+0.1.1.0+0.1.1 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:07.260
(p / photograph-01 
      :ARG1 (s / section-01 
            :ARG1 (h / high-resolution)) 
      :ARG2 (m / microscope 
            :ARG1-of (e / equip-01 
                  :ARG0 (t / thing 
                        :name (n / name 
                              :op1 (o / Olympus) 
                              :op2 (i / IX71))) 
                  :ARG2 (c / camera 
                        :mod (c2 / CCD))) 
            :mod (o2 / organization 
                  :name (n2 / name 
                        :op1 "Olympus"))))

# ::snt RNA in situ hybridisation .
# ::tok RNA in situ hybridisation .
# ::alignments 3-4|0.1 0-1|0.0.0+0.0+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:07.271
(o / organization 
      :name (n / name 
            :op1 "RNA") 
      :part-of (h / hybridisation))

# ::snt In situ hybridisation on frozen sections were carried out using 35S-labelled RNA probes .
# ::tok In situ hybridisation on frozen sections were carried out using 35S-labelled RNA probes .
# ::alignments 12-13|0.1.0 11-12|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 10-11|0.1.0.1 9-10|0.1 7-8|0 5-6|0.0.0 4-5|0.0.0.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:07.414
(c / carry-out-03 
      :ARG1 (h / hybridisation 
            :topic (s / section 
                  :ARG1-of (f / freeze-01))) 
      :ARG2 (u / use-01 
            :ARG1 (p / probe 
                  :mod (o / organization 
                        :name (n / name 
                              :op1 "RNA")) 
                  :mod 35s-labell)))

# ::snt Briefly , 610 bp of mouse ADAM22 cDNA ( position : 1351 -- 1960 from initiating ATG ) was cloned into the pBluescript II SK ( + ) or the pBluescript II KS ( + ) vector .
# ::tok Briefly , 610 bp of mouse ADAM22 cDNA ( position : 1351 -- 1960 from initiating ATG ) was cloned into the pBluescript II SK ( + ) or the pBluescript II KS ( + ) vector .
# ::alignments 36-37|0.2.2 31-33|0.2.2.0.0.1+0.2.2.0.0.0+0.2.2.0.0+0.2.2.0 28-29|0.2 23-25|0.2.1.0.1+0.2.1.0.0+0.2.1.0+0.2.1 19-20|0 16-17|0.3.1.0.0+0.3.1.0+0.3.1 15-16|0.3 13-14|0.3.0.0+0.3.0 11-12|0.2.0.0+0.2.0 9-10|0.0 7-8|0.1 6-7|0.1.0 5-6|0.1.0.0 0-1|0.3.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:07.885
(c / clone-01 
      :ARG0 (p / position) 
      :ARG1 (c3 / cdna 
            :mod (a / ADAM22 
                  :mod (m / mouse))) 
      :ARG2 (o2 / or 
            :op1 (d2 / date-entity 
                  :year 1351) 
            :op2 (o3 / organization 
                  :name (n2 / name 
                        :op1 "II" 
                        :op2 "SK")) 
            :op3 (v / vector 
                  :mod (o / organization 
                        :name (n / name 
                              :op1 "II" 
                              :op2 "KS")))) 
      :ARG2-of (i / initiate-01 
            :ARG0 (d / date-entity 
                  :year 1960) 
            :ARG1 (c2 / country 
                  :name (n3 / name 
                        :op1 "ATG")) 
            :op1-of (b / briefly)))

# ::snt Using these plasmids as templates , sense and antisense labelled RNA probes were generated by T7 RNA polymerase and [ 35S ] UTP .
# ::tok Using these plasmids as templates , sense and antisense labelled RNA probes were generated by T7 RNA polymerase and [ 35S ] UTP .
# ::alignments 20-21|0.0 18-19|0.1.0.0.0.0.0 17-18|0.1.0.0.0.0.0.0 15-17|0.1.0.0.0.0.0.0.0.0.1+0.1.0.0.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0.0 13-14|0.1.0.0.0.0 11-12|0.1.0.0.0 10-11|0.1.0.0.0.1.0.0+0.1.0.0.0.1.0+0.1.0.0.0.1 9-10|0.1.0.0 8-9|0.1.1 7-8|0.1 6-7|0 4-5|0.1.0.2 2-3|0.1.0.1 1-2|0.1.0.1.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:08.337
(s / sense-02 
      :ARG1 35 
      :op1-of (a3 / and 
            :ARG0-of (u / use-01 
                  :ARG0-of (l / label-01 
                        :ARG1 (p2 / probe 
                              :ARG1-of (g / generate-01 
                                    :ARG0 (a / and 
                                          :op1 (p / polymerase 
                                                :mod (t / thing 
                                                      :name (n / name 
                                                            :op1 (t2 / T7) 
                                                            :op2 (r / RNA)))))) 
                              :mod (o / organization 
                                    :name (n2 / name 
                                          :op1 "RNA")))) 
                  :ARG1 (p3 / plasmid 
                        :mod (t4 / this)) 
                  :ARG2 (t3 / templat)) 
            :op2 (a2 / antisense)))

# ::snt Frozen brain and spinal cord from 2 month-old C57BL/6 female mice were used in this analysis .
# ::tok Frozen brain and spinal cord from 2 month-old C57BL/6 female mice were used in this analysis .
# ::alignments 15-16|0.1 14-15|0.1.1 12-13|0 10-11|0.1.0 9-10|0.1.0.0 6-7|0.1.0.1 4-5|0.0.1 3-4|0.0.1.0 2-3|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:08.519
(u / use-01 
      :ARG1 (a2 / and 
            :op1 (b / brain 
                  :ARG1-of (f2 / freeze-01)) 
            :op2 (c / cord 
                  :mod (s / spinal))) 
      :ARG2 (a / analyze-01 
            :ARG0 (m / mouse 
                  :mod (f / female) 
                  :quant 2) 
            :mod (t / this)))

# ::snt Pretreatment , hybridisation , RNase treatment and washing was carried out following the protocol described in the literature [ 33 ] .
# ::tok Pretreatment , hybridisation , RNase treatment and washing was carried out following the protocol described in the literature [ 33 ] .
# ::alignments 19-20|0.0.1.1.0 17-18|0 14-15|0.0.1.0.0.0.0 13-14|0.0.1.0.0.0 11-12|0.0.1.0.0 9-10|0.0.1.0 7-8|0.0.1.1 6-7|0.0.1 5-6|0.0 4-5|0.0.0 2-3|0.0.1.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:08.606
(l / literature 
      :ARG1-of (t / treat-03 
            :ARG3 (r / rnase) 
            :op1-of (a / and 
                  :ARG1-of (c / carry-out-03 
                        :ARG1-of (f / follow-01 
                              :ARG2 (p / protocol 
                                    :ARG1-of (d / describe-01 
                                          :ARG0 (h / hybridisation))))) 
                  :op2 (w / wash-01 
                        :ARG1 33))))

# ::snt Dehydrated slides were attached to imaging plates for 48 hours and the autoradiograms were analysed using a Bio-Image Analyser ( BAS3000 , Fuji Photo Film ) .
# ::tok Dehydrated slides were attached to imaging plates for 48 hours and the autoradiograms were analysed using a Bio-Image Analyser ( BAS3000 , Fuji Photo Film ) .
# ::alignments 22-25|0.0.0.0.0.2+0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 20-21|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 17-19|0.2.1.0.1+0.2.1.0.0+0.2.1.0+0.2.1 15-16|0.2 12-13|0.2.0 10-11|0 9-10|0.0.2.1+0.0.2 8-9|0.0.2.0 6-7|0.0.1 5-6|0.1 3-4|0.0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:09.240
(a2 / and 
      :op1 (a3 / attach-01 
            :ARG1 (s / slide-01 
                  :ARG0 (o / organization 
                        :name (n / name 
                              :op1 "Fuji" 
                              :op2 "Photo" 
                              :op3 "Film")) 
                  :ARG1-of (d / dehydrate-01 
                        :ARG0 (o2 / organization 
                              :name (n2 / name 
                                    :op1 "BAS3000")))) 
            :ARG2 (p2 / plate) 
            :duration (t / temporal-quantity 
                  :quant 48 
                  :unit (h / hour))) 
      :op2 (i / image) 
      :op3 (u / use-01 
            :ARG0 (a / autoradiogram) 
            :ARG1 (p / person 
                  :name (n3 / name 
                        :op1 "Bio-Image" 
                        :op2 "Analyser"))))

# ::snt KS is leading this project , and performed cDNA cloning , plasmid construction , antibody production , immunohistochemical study , and wrote the manuscript .
# ::tok KS is leading this project , and performed cDNA cloning , plasmid construction , antibody production , immunohistochemical study , and wrote the manuscript .
# ::alignments 23-24|0.3.0 21-22|0.3 20-21|0 18-19|0.2 15-16|0.0.0.0.0.0 14-15|0.0.0.0.0.0.0 12-13|0.1 11-12|0.1.0 9-10|0.0.1 8-9|0.0.1.0 7-8|0.0 6-7|0.0.2 4-5|0.0.0.0.0 3-4|0.0.0.0.0.1 2-3|0.0.0.0 0-1|0.0.0.1.0+0.0.0.1+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:09.433
(a / and 
      :op1 (p3 / perform-02 
            :ARG0 (c4 / country 
                  :ARG0-of (l / lead-01 
                        :ARG1 (p4 / project 
                              :ARG0-of (p / produce-01 
                                    :ARG1 (a2 / antibody)) 
                              :mod (t / this))) 
                  :name (n / name 
                        :op1 "KS")) 
            :ARG1 (c2 / clone-01 
                  :ARG1 (c3 / cdna)) 
            :op1-of (a3 / and)) 
      :op2 (c / construct-01 
            :mod (p2 / plasmid)) 
      :op3 (s / study-01) 
      :op4 (w / write-01 
            :ARG1 (m / manuscript)))

# ::snt KH and JK conducted histopathological experiments .
# ::tok KH and JK conducted histopathological experiments .
# ::alignments 5-6|0.1 4-5|0.1.0 3-4|0 2-3|0.0.0.0.0+0.0.0.0+0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:09.455
(c / conduct-01 
      :ARG0 (a / and 
            :op1 (p / person 
                  :name (n / name 
                        :op1 "JK"))) 
      :ARG1 (e / experiment-01 
            :ARG1 (h / histopathological)))

# ::snt TH analysed mRNA distribution by in situ hybridisation .
# ::tok TH analysed mRNA distribution by in situ hybridisation .
# ::alignments 7-8|0.0.1 3-4|0.0 2-3|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:09.487
(t / th 
      :ARG0-of (d / distribute-01 
            :ARG1 (m / mrna) 
            :ARG2 (h / hybridisation)))

# ::snt ET , NM , MI , TO and KY contributed to the generation of knockout mice .
# ::tok ET , NM , MI , TO and KY contributed to the generation of knockout mice .
# ::alignments 15-16|0.1.0 14-15|0.1.0.0 12-13|0.1 9-10|0 8-9|0.0.2.0.0+0.0.2.0+0.0.2 7-8|0.0 4-5|0.0.1.1+0.0.1.0.0+0.0.1.0+0.0.1 2-3|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:09.553
(c / contribute-01 
      :ARG0 (a / and 
            :op1 (c3 / country 
                  :name (n3 / name 
                        :op1 "NM")) 
            :op2 (o / organization 
                  :name (n2 / name 
                        :op1 "MI6") 
                  :wiki "Secret_Intelligence_Service") 
            :op3 (c2 / country 
                  :name (n / name 
                        :op1 "KY"))) 
      :ARG2 (g / generation 
            :consist-of (m / mouse 
                  :mod (k / knockout))))

# ::snt TN supervised the project .
# ::tok TN supervised the project .
# ::alignments 3-4|0.1 1-2|0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:09.566
(s / supervise-01 
      :ARG0 (c / country 
            :name (n / name 
                  :op1 "TN")) 
      :ARG1 (p / project))

# ::snt All authors read and approved the manuscript .
# ::tok All authors read and approved the manuscript .
# ::alignments 6-7|0.1.0.0 4-5|0.1.0 3-4|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:09.631
(r / read-01 
      :ARG1 (a3 / author-01 
            :mod (a4 / all)) 
      :op1-of (a2 / and 
            :ARG0-of (a / approve-01 
                  :ARG1 (m / manuscript))))

# ::snt We are grateful to Isao Tanaka , Masayuki Okada , Yoshiharu Mizui , Kappei Tsukahara , Hiroyuki Kato , Hiroo Ogura and Junro Kuromitsu ( Eisai Co. , Ltd. ) , and Shin-ichi Murase ( Virginia University ) for the fruitful discussions and advice .
# ::tok We are grateful to Isao Tanaka , Masayuki Okada , Yoshiharu Mizui , Kappei Tsukahara , Hiroyuki Kato , Hiroo Ogura and Junro Kuromitsu ( Eisai Co. , Ltd. ) , and Shin-ichi Murase ( Virginia University ) for the fruitful discussions and advice .
# ::alignments 43-44|0.0.2.0 42-43|0.0.2 41-42|0.0 40-41|0.0.1 35-37|0.0.2.0.0.0.1+0.0.2.0.0.0.0+0.0.2.0.0.0+0.0.2.0.0 32-34|0.2.1.0.0.1+0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 31-32|0.2.1 25-27|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 22-24|0.7.0.1+0.7.0.0+0.7.0+0.7 21-22|0 19-21|0.6.0.1+0.6.0.0+0.6.0+0.6 16-18|0.5.0.1+0.5.0.0+0.5.0+0.5 13-15|0.4.0.1+0.4.0.0+0.4.0+0.4 10-12|0.3.0.1+0.3.0.0+0.3.0+0.3 7-9|0.2.0.1+0.2.0.0+0.2.0+0.2 4-6|0.1.0.1+0.1.0.0+0.1.0+0.1 2-3|0.1.1 0-1|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:10.578
(a4 / and 
      :ARG1-of (d / discuss-01 
            :ARG0 (o / organization 
                  :name (n3 / name 
                        :op1 "Eisai" 
                        :op2 "Co.")) 
            :ARG1-of (f / fruitful) 
            :op1-of (a2 / and 
                  :op2 (a / advise-01 
                        :ARG0 (t / thing 
                              :name (n / name 
                                    :op1 (v / Virginia) 
                                    :op2 (u / University)))))) 
      :op1 (p7 / person 
            :name (n10 / name 
                  :op1 "Isao" 
                  :op2 "Tanaka") 
            :prep-to-of (g / grateful 
                  :domain (w / we))) 
      :op2 (p6 / person 
            :name (n9 / name 
                  :op1 "Masayuki" 
                  :op2 "Okada") 
            :op1-of (a3 / and 
                  :op2 (t2 / thing 
                        :name (n2 / name 
                              :op1 (s / Shin-ichi) 
                              :op2 (m / Murase))))) 
      :op3 (p5 / person 
            :name (n8 / name 
                  :op1 "Yoshiharu" 
                  :op2 "Mizui")) 
      :op4 (p4 / person 
            :name (n7 / name 
                  :op1 "Kappei" 
                  :op2 "Tsukahara")) 
      :op5 (p3 / person 
            :name (n6 / name 
                  :op1 "Hiroyuki" 
                  :op2 "Kato")) 
      :op6 (p2 / person 
            :name (n5 / name 
                  :op1 "Hiroo" 
                  :op2 "Ogura")) 
      :op7 (p / person 
            :name (n4 / name 
                  :op1 "Junro" 
                  :op2 "Kuromitsu")))

# ::snt Targeted mutation of Adam22 .
# ::tok Targeted mutation of Adam22 .
# ::alignments 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:10.584
(m / mutation 
      :ARG1-of (t / target-01))

# ::snt ( A ) The genomic structure of the wild-type Adam22 allele ( top ) , the targeting construct ( middle ) and the disrupted allele ( bottom ) are shown .
# ::tok ( A ) The genomic structure of the wild-type Adam22 allele ( top ) , the targeting construct ( middle ) and the disrupted allele ( bottom ) are shown .
# ::alignments 29-30|0 26-27|0.1.1.1.1.0 24-25|0.1 23-24|0.1.0 21-22|0.1.1 19-20|0.2 17-18|0.1.1.1 16-17|0.1.1.1.1 12-13|0.1.1.1.0 10-11|0.1.1.0 9-10|0.0.0.0+0.0.0+0.0 5-6|0.1.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:10.822
(s / show-01 
      :ARG0 (t3 / thing 
            :name (n / name 
                  :op1 "Adam22")) 
      :ARG1 (a / allele 
            :ARG1-of (d / disrupt-01) 
            :op3-of (a2 / and 
                  :op1 (a3 / allele) 
                  :op2 (c / construct-01 
                        :ARG0 (t2 / top) 
                        :ARG1-of (t / target-01 
                              :ARG0 (b / bottom))) 
                  :time (s2 / structure))) 
      :ARG2 (m / middle))

# ::snt ADAM22 expression was disrupted by the insertion of a termination codon and a PGKneo cassette into exon 8 .
# ::tok ADAM22 expression was disrupted by the insertion of a termination codon and a PGKneo cassette into exon 8 .
# ::alignments 17-18|0.0.1.0.1 16-17|0 14-15|0.0.0.0 13-14|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 11-12|0.0.0 10-11|0.0.2 9-10|0.0.2.0 6-7|0.0 3-4|0.0.1 1-2|0.0.1.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:11.011
(e / exon 
      :ARG2-of (i / insert-01 
            :ARG0 (a / and 
                  :op1 (c / cassette 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "PGKneo")))) 
            :ARG0-of (d / disrupt-01 
                  :ARG1 (e2 / express-01 
                        :ARG0 (a2 / ADAM22) 
                        :ARG1 8)) 
            :ARG1 (c2 / codon 
                  :ARG1-of (t2 / terminate-01))))

# ::snt An MC1/TK cassette at the end of the targeting vector allows for negative selection .
# ::tok An MC1/TK cassette at the end of the targeting vector allows for negative selection .
# ::alignments 13-14|0.0.0 12-13|0.0.0.0 10-11|0.0.0.1 9-10|0.0 8-9|0 5-6|0.0.1 2-3|0.0.0.1.0 1-2|0.0.0.1.0.0.0.0+0.0.0.1.0.0.0+0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:11.231
(t / target-01 
      :ARG1 (v / vector 
            :ARG0-of (s / select-01 
                  :mod (n / negative) 
                  :purpose-of (a / allow-01 
                        :ARG0 (c / cassette 
                              :mod (t2 / thing 
                                    :name (n2 / name 
                                          :op1 "MC1/TK"))))) 
            :ARG1-of (e / end-01)))

# ::snt The 3 ' probe represents the position of the external probe used for Southern blot analysis , and expected BamHI [ B ] fragments are indicated by arrows .
# ::tok The 3 ' probe represents the position of the external probe used for Southern blot analysis , and expected BamHI [ B ] fragments are indicated by arrows .
# ::alignments 27-28|0.1.0.0 25-26|0.1.0 23-24|0.1.0.1 21-22|0.1.0.1.0.1+0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 19-20|0.2.0.0+0.2.0+0.2 18-19|0.1 17-18|0 15-16|0.0.1.0.0.0 14-15|0.0.1.0.0.0.0 13-14|0.0.1.0.0.0.1.0.0+0.0.1.0.0.0.1.0+0.0.1.0.0.0.1 11-12|0.0.1.0.0 10-11|0.0.1.0 9-10|0.0.1.0.1 6-7|0.0.1 4-5|0.0 3-4|0.0.0 1-2|0.0.1.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:12.019
(a2 / and 
      :op1 (r / represent-01 
            :ARG0 (p3 / probe-01) 
            :ARG1 (p2 / position 
                  :poss (p / probe-01 
                        :ARG1-of (u / use-01 
                              :ARG2 (a3 / analyze-01 
                                    :ARG1 (b / blot-01 
                                          :ARG1 3) 
                                    :manner (t2 / thing 
                                          :name (n3 / name 
                                                :op1 "Southern")))) 
                        :mod (e2 / external)))) 
      :op2 (e / expect-01 
            :ARG1 (i / indicate-01 
                  :ARG0 (a / arrow) 
                  :ARG1 (f / fragment-01 
                        :ARG1 (l / location 
                              :name (n / name 
                                    :op1 "B") 
                              :wiki -)))) 
      :op3 (t / thing 
            :name (n2 / name 
                  :op1 "BamHI")))

# ::snt ( B ) Southern blot analysis of mouse genomic DNA .
# ::tok ( B ) Southern blot analysis of mouse genomic DNA .
# ::alignments 9-10|0.0.0.1 7-8|0.0.0.1.0 5-6|0.0.0 4-5|0.0 3-4|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0.2+0.1.0+0.1+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:12.228
(l / location 
      :ARG0-of (b / blot-01 
            :ARG1 (a / analyze-01 
                  :ARG0 (t / thing 
                        :name (n / name 
                              :op1 "Southern")) 
                  :ARG1 (d / DNA 
                        :mod (m / mouse)))) 
      :name (n2 / name 
            :op1 "B") 
      :wiki -)

# ::snt The expected DNA fragments for the wild-type allele and disrupted allele are 7.5-kb and 2.5-kb , respectively .
# ::tok The expected DNA fragments for the wild-type allele and disrupted allele are 7.5-kb and 2.5-kb , respectively .
# ::alignments 16-17|0.1.0.0.0 13-14|0.1.1 10-11|0.0.0 9-10|0.1 8-9|0 7-8|0.0.1 3-4|0.0 2-3|0.1.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:12.299
(a3 / and 
      :op1 (f / fragment-01 
            :ARG0 (a2 / allele) 
            :ARG1 (a4 / allele)) 
      :op2 (d / disrupt-01 
            :ARG0 (d2 / DNA 
                  :ARG1-of (e / expect-01 
                        :ARG0 (r / respective))) 
            :ARG1 (a / and)))

# ::snt + / + , wild-type ; + / - , heterozygote ; - / - , homozygote .
# ::tok + / + , wild-type ; + / - , heterozygote ; - / - , homozygote .
# ::alignments 16-17|0.0.1 13-14|0.0.2 10-11|0 7-8|0.0.0.0 5-6|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:12.326
(h2 / heterozygote 
      :op2-of (s3 / slash 
            :op1 (a / and 
                  :op1 (s2 / slash)) 
            :op3 (h / homozygote) 
            :poss (s / slash)))

# ::snt ( C ) Western blot analysis of ADAM22 expression in the mouse cerebellum .
# ::tok ( C ) Western blot analysis of ADAM22 expression in the mouse cerebellum .
# ::alignments 12-13|0.1.0.0 11-12|0.1.0.0.0 8-9|0.1.0 5-6|0.1 4-5|0 3-4|0.0.2+0.0.0.0+0.0.0+0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:12.435
(b / blot-01 
      :ARG0 (w / world-region 
            :name (n / name 
                  :op1 "West") 
            :op1-of (c2 / C) 
            :wiki "Western_world") 
      :ARG1 (a / analyze-01 
            :ARG1 (e / express-01 
                  :ARG1 (c / cerebellum 
                        :mod (m / mouse)))))

# ::snt Absence of ADAM22 protein in the Adam22 ( - / - ) mutant cerebellum was shown using anti-ADAM22-cp ( cytoplasmic domain ) polyclonal antibody .
# ::tok Absence of ADAM22 protein in the Adam22 ( - / - ) mutant cerebellum was shown using anti-ADAM22-cp ( cytoplasmic domain ) polyclonal antibody .
# ::alignments 23-24|0.1.1 20-21|0.2.0 19-20|0.2 16-17|0.1 15-16|0 13-14|0.0 12-13|0.0.0 9-10|0.1.3 6-7|0.1.0.0.0+0.1.0.0+0.1.0 3-4|0.1.2.0 0-1|0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:12.748
(s / show-01 
      :ARG0 (c2 / cerebellum 
            :mod (m / mutant)) 
      :ARG1 (u / use-01 
            :ARG0 (t / thing 
                  :name (n / name 
                        :op1 "Adam22")) 
            :ARG1 (a / antibody) 
            :ARG2 (a2 / absence 
                  :consist-of (p / protein)) 
            :manner (s2 / slash)) 
      :ARG2 (c / cytoplasmic 
            :mod-of (d / domain)))

# ::snt Uncoordinated movements in the Adam22 ( - / - ) mice at postnatal day 18 ( P18 ) .
# ::tok Uncoordinated movements in the Adam22 ( - / - ) mice at postnatal day 18 ( P18 ) .
# ::alignments 14-15|0.2.0 13-14|0.1.0.0 12-13|0.1.0 10-11|0.1 7-8|0.0 4-5|0.2.1.0+0.2.1+0.2 1-2|0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:12.833
(m2 / move-01 
      :ARG0 (s / slash) 
      :ARG1 (m / mouse 
            :location (p / postnatal 
                  :mod-of (d / day))) 
      :ARG2 (t / thing 
            :mod 18 
            :name (n / name 
                  :op1 "Adam22")) 
      :mod (u / uncoordinat))

# ::snt ( A ) Adam22 ( - / - ) mice were smaller than their wild-type ( + / + ) littermates .
# ::tok ( A ) Adam22 ( - / - ) mice were smaller than their wild-type ( + / + ) littermates .
# ::alignments 20-21|0 17-18|0.0.0.0.0 11-12|0.0 9-10|0.0.0 6-7|0.0.0.0 3-4|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:12.868
(l / littermat 
      :compared-to-of (s2 / small 
            :domain (m / mouse 
                  :mod (s3 / slash 
                        :poss (s / slash 
                              :mod (a / Adam22))))))

# ::snt ( B , C ) Adam22 ( - / - ) mice at P18 were unable to support themselves on their hindlimbs .
# ::tok ( B , C ) Adam22 ( - / - ) mice at P18 were unable to support themselves on their hindlimbs .
# ::alignments 21-22|0.0.1 17-18|0.0 11-12|0 8-9|0.0.1.0 5-6|0.0.0 3-4|0.0.1.1.0 1-2|0.0.1.1.2+0.0.1.1.1.0+0.0.1.1.1+0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:12.993
(m / mouse 
      :ARG1-of (s / support-01 
            :ARG0 (a / Adam22) 
            :ARG2 (h / hindlimb 
                  :poss (s2 / slash) 
                  :poss-of (l / location 
                        :location (c / C) 
                        :name (n / name 
                              :op1 "B") 
                        :wiki -))))

# ::snt Neuronal ADAM22 mRNA expression in the CNS .
# ::tok Neuronal ADAM22 mRNA expression in the CNS .
# ::alignments 6-7|0.1.0.0+0.1.0+0.1 3-4|0 2-3|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:13.016
(e / express-01 
      :ARG0 (n2 / neuronal) 
      :ARG1 (o / organization 
            :name (n / name 
                  :op1 "CNS")) 
      :mod (m / mrna))

# ::snt To determine the ADAM22 mRNA distribution , in situ hybridisation analysis using 35S-labeled probe was performed .
# ::tok To determine the ADAM22 mRNA distribution , in situ hybridisation analysis using 35S-labeled probe was performed .
# ::alignments 15-16|0.1.0.0 13-14|0.1.1 12-13|0.1.1.0 11-12|0.1 10-11|0.1.0 9-10|0.1.0.1 5-6|0.0 3-5|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:13.218
(d2 / determine-01 
      :ARG1 (d / distribute-01 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 (a2 / ADAM22) 
                        :op2 (m / mRNA)))) 
      :manner (u / use-01 
            :ARG0 (a / analyze-01 
                  :ARG0 (p / perform-02) 
                  :ARG1 (h / hybridisation)) 
            :ARG1 (p2 / probe-01 
                  :mod 35s-label)))

# ::snt Coronal ( A , B ) and sagittal ( C , D ) sections of the mouse brain and spinal cord ( E ) were shown .
# ::tok Coronal ( A , B ) and sagittal ( C , D ) sections of the mouse brain and spinal cord ( E ) were shown .
# ::alignments 25-26|0.1.0 22-23|0.1.2 20-21|0.4 19-20|0.4.0 18-19|0 17-18|0.3 16-17|0.3.0 13-14|0.2 11-12|0.1.0.1 9-10|0.1.0.0 7-8|0.2.0 6-7|0.1 4-5|0.0.1+0.0.0.0+0.0.0+0.0 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:13.561
(a / and 
      :op1 (l / location 
            :name (n / name 
                  :op1 "B") 
            :wiki -) 
      :op2 (a2 / and 
            :ARG1-of (s / show-01 
                  :ARG0 (c2 / C) 
                  :op1-of (d / D)) 
            :op1 (c3 / coronal) 
            :op2 (e / E)) 
      :op3 (s3 / section 
            :mod (s4 / sagittal)) 
      :op4 (b / brain 
            :part-of (m / mouse)) 
      :op5 (c / cord 
            :mod (s2 / spinal)))

# ::snt Using the antisense probe ( A , C ) , strong signals were obtained , especially in the hippocampus and the cerebellum , while no signals was detected by the sense probe ( B , D ) .
# ::tok Using the antisense probe ( A , C ) , strong signals were obtained , especially in the hippocampus and the cerebellum , while no signals was detected by the sense probe ( B , D ) .
# ::alignments 35-36|0.0.1.0 33-34|0.2+0.1.0+0.1+0 31-32|0.0.1.1.2.0 30-31|0.0.1.1.2.0.1 27-28|0.0.1.1.2 25-26|0.0.1.1.2.1 24-25|0.0.0 21-22|0.0.1.1.0.1 19-20|0.0.1.1.0 18-19|0.0.1.1.0.0 15-16|0.0.1.1.2.0.0 13-14|0.0.1.1 11-12|0.0.1.1.1 10-11|0.0.1.1.1.0 7-8|0.0.1.1.2.0.1.0 3-4|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:14.013
(l / location 
      :ARG0-of (p2 / probe-01 
            :ARG1 - 
            :ARG1-of (u / use-01 
                  :ARG0 (d / D) 
                  :purpose-of (o / obtain-01 
                        :ARG0 (a / and 
                              :op1 (h / hippocampu) 
                              :op2 (c / cerebellum)) 
                        :ARG1 (s3 / signal 
                              :ARG1-of (s4 / strong-02)) 
                        :condition (d2 / detect-01 
                              :ARG0 (p / probe-01 
                                    :ARG0 (e / especially) 
                                    :ARG1 (s / sense-02 
                                          :ARG0 (c2 / C))) 
                              :ARG1 (s2 / signal))))) 
      :name (n / name 
            :op1 "B") 
      :wiki -)

# ::snt In the spinal cord , autoradiograms of ADAM22 mRNA was detected in the grey matter ( E ) .
# ::tok In the spinal cord , autoradiograms of ADAM22 mRNA was detected in the grey matter ( E ) .
# ::alignments 16-17|0.0 14-15|0.2 13-14|0.2.0 10-11|0 7-9|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 5-6|0.1 3-4|0.3 2-3|0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:14.135
(d / detect-01 
      :ARG0 (e / E) 
      :ARG1 (a2 / autoradiogram 
            :poss (t / thing 
                  :name (n / name 
                        :op1 (a / ADAM22) 
                        :op2 (m2 / mRNA)))) 
      :ARG2 (m / matter 
            :mod (g / grey)) 
      :location (c / cord 
            :mod (s / spinal)))

# ::snt Normal neurodevelopment in the CNS of ADAM22-deficient mice .
# ::tok Normal neurodevelopment in the CNS of ADAM22-deficient mice .
# ::alignments 7-8|0.0.1 4-5|0.0.0.0+0.0.0+0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:14.149
(n2 / neurodevelopment 
      :location (o / organization 
            :name (n / name 
                  :op1 "CNS") 
            :part-of (m / mouse)))

# ::snt Sagittal sections of the cerebellum from wild-type mice ( A , C , E , G ) and homozygous mutants ( B , D , F , H ) at postnatal day 13 were stained for calbindin ( C and D ; green ) or MBP ( G and H ; green ) , and were counterstained with DAPI ( A , B , E , F ; blue ) .
# ::tok Sagittal sections of the cerebellum from wild-type mice ( A , C , E , G ) and homozygous mutants ( B , D , F , H ) at postnatal day 13 were stained for calbindin ( C and D ; green ) or MBP ( G and H ; green ) , and were counterstained with DAPI ( A , B , E , F ; blue ) .
# ::alignments 68-69|0.3.2.4.0.0 66-67|0.3.2.4.2.1+0.3.2.4.2.0.0+0.3.2.4.2.0+0.3.2.4.2 64-65|0.3.2.4.0.1 62-63|0.3.2.4.1.1+0.3.2.4.1.0.0+0.3.2.4.1.0+0.3.2.4.1 58-59|0.3.2.2.0.1.0.0.0+0.3.2.2.0.1.0.0+0.3.2.2.0.1.0 54-55|0.3.2.2.0.1 51-52|0.3.2.2.0.0 48-49|0 47-48|0.2.1+0.2.0.0+0.2.0+0.2 44-45|0.3.2.2 42-43|0.3.2.4.0 41-42|0.3.2.4 40-41|0.3.2.3 39-40|0.3.2 38-39|0.3.2.1 36-37|0.3.2.2.1 34-35|0.3.2.2.0 32-33|0.3.2.2.0.0.1 31-32|0.3.2.2.0.0.3.0 30-31|0.3.2.2.0.0.3 27-28|0.3.2.2.0.0.0 25-26|0.1.1+0.1.0.0+0.1.0+0.1 23-24|0.3.2.2.0.0.2 21-22|0.0.1+0.0.0.0+0.0.0+0.0 19-20|0.3.1 18-19|0.3.1.0 17-18|0.3 15-16|0.3.2.0.1+0.3.2.0.0.0+0.3.2.0.0+0.3.2.0 13-14|0.3.2.2.0.3 11-12|0.3.2.2.0.2 7-8|0.3.0 4-5|0.3.0.0 1-2|0.3.0.0.0 0-1|0.3.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:15.504
(a3 / and 
      :op1 (l2 / location 
            :name (n6 / name 
                  :op1 "B") 
            :wiki -) 
      :op2 (a6 / aircraft-type 
            :name (n5 / name 
                  :op1 "F22") 
            :wiki "Lockheed_Martin_F-22_Raptor") 
      :op3 (o / organization 
            :name (n4 / name 
                  :op1 "G-8") 
            :wiki "G8") 
      :op4-of (a7 / and 
            :op1 (m2 / mouse 
                  :source-of (c4 / cerebellum 
                        :part (s2 / section 
                              :mod (s3 / sagittal)))) 
            :op2 (m / mutant 
                  :mod (h2 / homozygou)) 
            :op3 (a5 / and 
                  :op1 (o3 / organization 
                        :name (n7 / name 
                              :op1 "G-8") 
                        :wiki "G8") 
                  :op2 (c / C) 
                  :op2-of (o2 / or 
                        :ARG1-of (s / stain-01 
                              :manner (g / green-02 
                                    :op1-of (h / h) 
                                    :op1-of 13 
                                    :op1-of (d3 / D) 
                                    :op1-of (p2 / postnatal 
                                          :time (d2 / day))) 
                              :op1-of (a2 / and 
                                    :op2 (p / person 
                                          :name (n3 / name 
                                                :op1 "DAPI"))) 
                              :op1-of (c3 / C) 
                              :op1-of (e2 / E)) 
                        :op1 (c2 / calbindin)) 
                  :op3 (d / D) 
                  :op4 (a4 / and 
                        :op1 (g2 / green-02 
                              :op1-of (b / blue) 
                              :op1-of (e / E)) 
                        :op2 (l / location 
                              :name (n2 / name 
                                    :op1 "B") 
                              :wiki -) 
                        :op3 (a / aircraft-type 
                              :name (n / name 
                                    :op1 "F22") 
                              :wiki "Lockheed_Martin_F-22_Raptor")))))

# ::snt Significant abnormalities were not observed in the homozygotes .
# ::tok Significant abnormalities were not observed in the homozygotes .
# ::alignments 7-8|0.1 4-5|0 3-4|0.2 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:15.536
(o / observe-01 
      :ARG1 (a / abnormaliti 
            :ARG1-of (s / significant-02)) 
      :ARG2 (h / homozygot) 
      :polarity -)

# ::snt Hippocampal neurons were stained by anti-Neu N antibody ( I and J ) .
# ::tok Hippocampal neurons were stained by anti-Neu N antibody ( I and J ) .
# ::alignments 11-12|0.2.1+0.2.0.0+0.2.0+0.2 10-11|0 9-10|0.1 7-8|0.0 6-7|0.0.1 3-4|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:15.647
(a2 / and 
      :op1 (a3 / antibody 
            :ARG0-of (s / stain-01 
                  :ARG1 (n3 / neuron)) 
            :mod (n2 / N)) 
      :op2 (i / i) 
      :op3 (a / aircraft-type 
            :name (n / name 
                  :op1 "J-10") 
            :wiki "Chengdu_J-10"))

# ::snt Spinal myelin was analysed by MBP staining ( K and L ) .
# ::tok Spinal myelin was analysed by MBP staining ( K and L ) .
# ::alignments 10-11|0.2 9-10|0 8-9|0.1 6-7|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:15.673
(a / and 
      :op1 (s / stain-01 
            :ARG0 (m / myelin 
                  :mod (s2 / spinal))) 
      :op2 (k / k) 
      :op3 (l / L))

# ::snt These analyses showed no obvious differences between homozygotes ( J , L ) and wild-type littermates ( I , K ) .
# ::tok These analyses showed no obvious differences between homozygotes ( J , L ) and wild-type littermates ( I , K ) .
# ::alignments 19-20|0.1.2.0 17-18|0.1.0 15-16|0.1.1 13-14|0.1.1.0 11-12|0.1.2.1 9-10|0.1.1.0.1.1+0.1.1.0.1.0.0+0.1.1.0.1.0+0.1.1.0.1 7-8|0.1.1.0.0 5-6|0.1 4-5|0.1.2 3-4|0.2 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:15.929
(s / show-01 
      :ARG0 (a3 / analysis 
            :mod (t / this)) 
      :ARG1 (d / differ-01 
            :ARG0 (i / i) 
            :ARG1 (l / littermat 
                  :op3-of (a / and 
                        :op1 (h / homozygot) 
                        :op2 (a2 / aircraft-type 
                              :name (n / name 
                                    :op1 "J-10") 
                              :wiki "Chengdu_J-10"))) 
            :ARG1-of (o / obvious-01 
                  :ARG0 (k / k) 
                  :ARG2 (l2 / L))) 
      :polarity -)

# ::snt Bar : ( A , B , E , F ) 100 m , ( K , L ) 250 m .
# ::tok Bar : ( A , B , E , F ) 100 m , ( K , L ) 250 m .
# ::alignments 19-20|0.1 17-18|0.2 15-16|0.3 12-13|0.4.0 11-12|0.4 9-10|0.1.0.1+0.1.0.0.0+0.1.0.0+0.1.0 7-8|0.1.1 5-6|0.0.1+0.0.0.0+0.0.0+0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:16.112
(b / bar-01 
      :ARG1 (l2 / location 
            :name (n2 / name 
                  :op1 "B") 
            :wiki -) 
      :ARG2 (2 / 250 
            :op1 (a / aircraft-type 
                  :name (n / name 
                        :op1 "F22") 
                  :wiki "Lockheed_Martin_F-22_Raptor") 
            :poss (e / E)) 
      :manner (l / L) 
      :manner (k / k) 
      :time (1 / 100 
            :quant-of (m / m)))

# ::snt Hypomyelination of peripheral nerves in ADAM22-deficient mice .
# ::tok Hypomyelination of peripheral nerves in ADAM22-deficient mice .
# ::alignments 6-7|0.0.0 3-4|0.0 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:16.125
(p / peripheral 
      :mod-of (n / nerve 
            :source (m / mouse)))

# ::snt Epon embedded semithin cross-sections of the sciatic nerves ( A , B ) , the trigeminal nerves ( C , D ) and the spinal cord [ lateral funiculus ] ( E , F ) of the indicated genotypes at postnatal day 10 were stained with toluidine blue .
# ::tok Epon embedded semithin cross-sections of the sciatic nerves ( A , B ) , the trigeminal nerves ( C , D ) and the spinal cord [ lateral funiculus ] ( E , F ) of the indicated genotypes at postnatal day 10 were stained with toluidine blue .
# ::alignments 47-48|0.2.0.1.0.0 46-47|0.2.0.1.0.0.0 44-45|0.2.0.1.0 42-43|0.2.0.1.0.2.0 41-42|0.0.0 40-41|0.0.0.0 38-39|0.0 37-38|0 33-34|0.2.0.5.1+0.2.0.5.0.0+0.2.0.5.0+0.2.0.5 31-32|0.2.2 28-29|0.2.0.2 27-28|0.2.0.4 25-26|0.2.0.6 24-25|0.2.0.3 22-23|0.2 20-21|0.2.0.1.0.2 18-19|0.2.0.1.0.1 16-17|0.2.1 15-16|0.2.1.0 11-12|0.1.1+0.1.0.0+0.1.0+0.1 7-8|0.2.0.0.1 6-7|0.2.0.0.1.0 3-4|0.2.0.0 2-3|0.2.0.0.0 1-2|0.2.0 0-1|0.2.0.1.1.0+0.2.0.1.1+0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:19.289
(i / indicate-01 
      :ARG1 (g / genotyp 
            :poss (d / day 
                  :time-of (p / postnatal))) 
      :ARG2 (l2 / location 
            :name (n3 / name 
                  :op1 "B") 
            :wiki -) 
      :op3-of (a2 / and 
            :ARG0-of (e2 / embed-01 
                  :ARG1 (c3 / cross-section 
                        :mod (s4 / semithin) 
                        :poss (n4 / nerve 
                              :mod (s3 / sciatic))) 
                  :ARG3 (t3 / thing 
                        :ARG1-of (s / stain-01 
                              :ARG2 (b / blue 
                                    :mod (t / toluidine)) 
                              :op1-of (c2 / C) 
                              :op1-of (d2 / D 
                                    :mod-of 10)) 
                        :name (n5 / name 
                              :op1 "Epon")) 
                  :op1-of (f / funiculu) 
                  :op1-of (s2 / spinal) 
                  :op1-of (l / lateral) 
                  :op1-of (a / aircraft-type 
                        :name (n / name 
                              :op1 "F22") 
                        :wiki "Lockheed_Martin_F-22_Raptor") 
                  :op1-of (c / cord)) 
            :op1 (n2 / nerve 
                  :mod (t2 / trigeminal)) 
            :op2 (e / E)))

# ::snt Note that the ADAM22-deficient mouse shows thin myelin or lack of myelin in the peripheral nerve fibres ( B , D ) , but the spinal myelinated fibres are intact ( F ) .
# ::tok Note that the ADAM22-deficient mouse shows thin myelin or lack of myelin in the peripheral nerve fibres ( B , D ) , but the spinal myelinated fibres are intact ( F ) .
# ::alignments 31-32|0.1.1.1.0.1+0.1.1.1.0.0.0+0.1.1.1.0.0+0.1.1.1.0 29-30|0.1.2.0 27-28|0.1.2.0.0 26-27|0.1.2.0.0.0 25-26|0.1.2.0.0.1 23-24|0.1.2 20-21|0.1.1.0.0.0 18-19|0.0.1+0.0.0.0+0.0.0+0.0 16-17|0.1.3 15-16|0.1.1.1.2 14-15|0.1.3.0 11-12|0.1.1.1.1 9-10|0.1.1.1 8-9|0.1.1 7-8|0.1.1.0 6-7|0.1.1.0.0 5-6|0.1 4-5|0.1.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:20.105
(n4 / note-01 
      :ARG0 (l / location 
            :name (n2 / name 
                  :op1 "B") 
            :wiki -) 
      :ARG1 (s2 / show-01 
            :ARG0 (m4 / mouse) 
            :ARG1 (o / or 
                  :op1 (m3 / myelin 
                        :ARG1-of (t / thin-03 
                              :ARG0 (d / D))) 
                  :op2 (l2 / lack-01 
                        :ARG0 (a / aircraft-type 
                              :name (n / name 
                                    :op1 "F22") 
                              :wiki "Lockheed_Martin_F-22_Raptor") 
                        :ARG1 (m2 / myelin) 
                        :topic (n3 / nerve))) 
            :ARG1-of (c / contrast-01 
                  :ARG2 (i / intact 
                        :domain (f / fibr 
                              :mod (m / myelinat) 
                              :mod (s / spinal)))) 
            :time (f2 / fibr 
                  :mod (p / peripheral))))

# ::snt Electron microscopic analysis of sciatic nerves .
# ::tok Electron microscopic analysis of sciatic nerves .
# ::alignments 5-6|0.0.0 4-5|0.0.0.0 2-3|0.0 1-2|0.0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:20.157
(e / electron 
      :mod-of (a / analyze-01 
            :ARG1 (n / nerve 
                  :mod (s / sciatic)) 
            :manner (m / microscopic)))

# ::snt Electron micrographs of the sciatic nerves from Adam22 + / - ( A ) and Adam22 - / - ( B ) mice at postnatal day 10 are shown .
# ::tok Electron micrographs of the sciatic nerves from Adam22 + / - ( A ) and Adam22 - / - ( B ) mice at postnatal day 10 are shown .
# ::alignments 28-29|0 26-27|0.2.0.1 25-26|0.2.0.0.0 24-25|0.2.0.0.0.1 22-23|0.2.0.0.0.0 20-21|0.0.1+0.0.0.0+0.0.0+0.0 17-18|0.1 14-15|0.2 9-10|0.2.0.3 5-6|0.2.0 4-5|0.2.0.0 1-2|0.2.0.2 0-1|0.2.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:20.918
(s / show-01 
      :ARG0 (l / location 
            :name (n / name 
                  :op1 "B") 
            :wiki -) 
      :ARG2 (s2 / slash) 
      :op1-of (a / and 
            :poss-of (n2 / nerve 
                  :mod (s4 / sciatic 
                        :mod (d / day 
                              :poss-of (m / mouse) 
                              :time-of (p / postnatal))) 
                  :mod-of 10 
                  :poss-of (m2 / micrograph 
                        :mod (e / electron)) 
                  :source (s3 / slash))))

# ::snt In the heterozygote ( A ) , thick myelin was formed , while no myelin was formed in the ADAM22-deficient mouse ( B ) .
# ::tok In the heterozygote ( A ) , thick myelin was formed , while no myelin was formed in the ADAM22-deficient mouse ( B ) .
# ::alignments 22-23|0.0.1+0.0.0.0+0.0.0+0.0 20-21|0.2.1 16-17|0.2 14-15|0.2.0 13-14|0.2.0.0 10-11|0 8-9|0.1 7-8|0.1.0 2-3|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:21.050
(f2 / form-01 
      :ARG0 (l / location 
            :name (n / name 
                  :op1 "B") 
            :wiki -) 
      :ARG1 (m3 / myelin 
            :ARG1-of (t / thick-03 
                  :ARG2 (h / heterozygote))) 
      :condition (f / form-01 
            :ARG1 (m2 / myelin 
                  :polarity -) 
            :location (m / mouse)))

# ::snt The axons looked normal in each genotype .
# ::tok The axons looked normal in each genotype .
# ::alignments 6-7|0.0 5-6|0.0.0 3-4|0.1 2-3|0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:21.067
(l / look-01 
      :ARG1 (g / genotype 
            :mod (e / each)) 
      :ARG2 (n / normal-02 
            :ARG1 (a / axon)))

# ::snt Marked delay in differentiation of the mutant Schwann cells .
# ::tok Marked delay in differentiation of the mutant Schwann cells .
# ::alignments 8-9|0.1.0 6-8|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 3-4|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:21.141
(d2 / delay-01 
      :ARG1 (m2 / mark-01) 
      :location (d / differentiation 
            :domain (c / cell 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 (m / mutant) 
                              :op2 (s / Schwann))))))

# ::snt Transverse sections of the sciatic nerves of the indicated genotypes at postnatal day 13 were stained for MBP ( C and D ; green ) or S100 ( E and F ; red ) , and were counterstained with DAPI ( A , B ; blue ) .
# ::tok Transverse sections of the sciatic nerves of the indicated genotypes at postnatal day 13 were stained for MBP ( C and D ; green ) or S100 ( E and F ; red ) , and were counterstained with DAPI ( A , B ; blue ) .
# ::alignments 45-46|0.0.0 43-44|0.1.1+0.1.0.0+0.1.0+0.1 39-40|0.2.1.0.1.0.0.0+0.2.1.0.1.0.0+0.2.1.0.1.0 35-36|0.2.1.0.1 32-33|0.2.3.1.0.0 30-31|0.2.3.2+0.2.3.0.0+0.2.3.0+0.2.3 29-30|0.2.3.1 28-29|0.2.3.1.1 25-26|0.2.1 23-24|0.0 22-23|0 21-22|0.2.2 20-21|0.2 19-20|0.2.0 15-16|0.2.1.0 13-14|0.0.1 12-13|0.2.1.0.0.1.0 11-12|0.2.1.0.0.1 9-10|0.2.3.1.0.1 8-9|0.2.3.1.0 5-6|0.2.3.1.0.1.0 4-5|0.2.3.1.0.1.0.0 1-2|0.2.1.0.0 0-1|0.2.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.014
(a4 / and 
      :op1 (g / green-02 
            :ARG0 (b / blue) 
            :ARG1 13) 
      :op2 (l / location 
            :name (n / name 
                  :op1 "B") 
            :wiki -) 
      :op3-of (a5 / and 
            :op1 (c / C) 
            :op1-of (o / or 
                  :ARG2-of (s / stain-01 
                        :ARG1 (s3 / section 
                              :mod (t / transverse) 
                              :poss (p2 / postnatal 
                                    :time (d2 / day))) 
                        :op1-of (a / and 
                              :op2 (p / person 
                                    :name (n2 / name 
                                          :op1 "DAPI"))))) 
            :op2 (d / D) 
            :op4 (a2 / aircraft-type 
                  :name (n3 / name 
                        :op1 "F22") 
                  :op3-of (a3 / and 
                        :op1 (i / indicate-01 
                              :ARG0 (r / red) 
                              :ARG1 (g2 / genotyp 
                                    :poss-of (n4 / nerve 
                                          :mod (s2 / sciatic)))) 
                        :op2 (e / E)) 
                  :wiki "Lockheed_Martin_F-22_Raptor")))

# ::snt In the mutant sciatic nerve , density of DAPI-signals were greatly increased ( B ) compared with those of the wild-type ( A ) .
# ::tok In the mutant sciatic nerve , density of DAPI-signals were greatly increased ( B ) compared with those of the wild-type ( A ) .
# ::alignments 15-16|0.1 13-14|0.2.1+0.2.0.0+0.2.0+0.2 11-12|0 10-11|0.3 8-9|0.0.0 6-7|0.0 4-5|0.4 3-4|0.4.0 2-3|0.4.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.235
(i / increase-01 
      :ARG1 (d2 / density 
            :mod (d / dapi-signal)) 
      :ARG1-of (c / compare-01) 
      :ARG2 (l / location 
            :name (n / name 
                  :op1 "B") 
            :wiki -) 
      :mod (g / great) 
      :time (n2 / nerve 
            :mod (s / sciatic) 
            :mod (m / mutant)))

# ::snt Bar : ( A , B ) = 50 m .
# ::tok Bar : ( A , B ) = 50 m .
# ::alignments 9-10|0.1.0 8-9|0.1 5-6|0.0.1+0.0.0.0+0.0.0+0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.254
(b / bar-01 
      :ARG0 (l / location 
            :name (n / name 
                  :op1 "B") 
            :wiki -) 
      :ARG1 (5 / 50 
            :quant-of (m / m)))

# ::snt Adam22 gene structure and tissue specific transcripts .
# ::tok Adam22 gene structure and tissue specific transcripts .
# ::alignments 6-7|0 5-6|0.0 4-5|0.0.0.1 3-4|0.0.0 2-3|0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.335
(t / transcript 
      :ARG1-of (s / specific-02 
            :ARG0 (a / and 
                  :op1 (s2 / structure 
                        :mod (g / gene)) 
                  :op2 (t2 / tissue))))

# ::snt ( A ) RT-PCR analysis .
# ::tok ( A ) RT-PCR analysis .
# ::alignments 4-5|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.340
(a / analyze-01)

# ::snt Amplified DNA fragments were analysed by 1 % agarose gel electrophoresis .
# ::tok Amplified DNA fragments were analysed by 1 % agarose gel electrophoresis .
# ::alignments 10-11|0.2.0 9-10|0.2 7-8|0.0 6-7|0.0.0 2-3|0.1 1-2|0.1.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.403
(a / amplify-01 
      :ARG0 (p / percentage-entity 
            :value 1) 
      :ARG1 (f / fragment-01 
            :ARG1 (d / DNA)) 
      :op1-of (g / gel 
            :mod-of (e / electrophoresi)))

# ::snt Lanes 1 .
# ::tok Lanes 1 .
# ::alignments 1-2|0.0 0-1|0.1.0+0.1+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.411
(o / organization 
      :mod 1 
      :name (n / name 
            :op1 "Lanes"))

# ::snt 100 bp DNA ladder ; 2 .
# ::tok 100 bp DNA ladder ; 2 .
# ::alignments 5-6|0.1 4-5|0 3-4|0.0 2-3|0.0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.428
(a / and 
      :op1 (l / ladder 
            :mod (d / DNA)) 
      :op2 (2 / 2 
            :op1-of 100))

# ::snt cerebellum ; 3 .
# ::tok cerebellum ; 3 .
# ::alignments 2-3|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.437
(a / and 
      :op1 (c / cerebellum) 
      :op2 3)

# ::snt spinal cord ; 4 .
# ::tok spinal cord ; 4 .
# ::alignments 3-4|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.448
(a / and 
      :op1 (c / cord 
            :mod (s / spinal)) 
      :op2 4)

# ::snt dorsal root ganglion ; 5 .
# ::tok dorsal root ganglion ; 5 .
# ::alignments 4-5|0.1 3-4|0 2-3|0.0 1-2|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.464
(a / and 
      :op1 (g / ganglion 
            :mod (r / root) 
            :mod (d / dorsal)) 
      :op2 5)

# ::snt sciatic nerve ; 6 .
# ::tok sciatic nerve ; 6 .
# ::alignments 3-4|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.475
(a / and 
      :op1 (n / nerve 
            :mod (s / sciatic)) 
      :op2 6)

# ::snt cultured Schwann cells ; 7 .
# ::tok cultured Schwann cells ; 7 .
# ::alignments 4-5|0.0.0.0 3-4|0 2-3|0.0 1-2|0.0.1.0.0+0.0.1.0+0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.514
(a / and 
      :op1 (c / cell 
            :ARG1-of (c2 / culture-01 
                  :ARG0 7) 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "Schwann"))))

# ::snt distilled water ( B ) Exon organization of the mouse Adam22 gene is illustrated .
# ::tok distilled water ( B ) Exon organization of the mouse Adam22 gene is illustrated .
# ::alignments 13-14|0 11-12|0.0 10-11|0.0.0 9-10|0.0.0.0 6-7|0.1 5-6|0.1.0 3-4|0.1.1.2+0.1.1.1.0+0.1.1.1+0.1.1 1-2|0.1.1.0.0 0-1|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.604
(i / illustrate-01 
      :ARG1 (g / gene 
            :mod (a / Adam22 
                  :mod (m / mouse))) 
      :ARG2 (o / organization 
            :mod (e / exon) 
            :mod-of (l / location 
                  :ARG0-of (d / distil-01 
                        :ARG1 (w / water)) 
                  :name (n / name 
                        :op1 "B") 
                  :wiki -)))

# ::snt Boxes indicate exons .
# ::tok Boxes indicate exons .
# ::alignments 2-3|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.615
(i / indicate-01 
      :ARG0 (b / box-01) 
      :ARG1 (e / exon))

# ::snt The G01 transcript ( orthologous to the human ADAM22 isoform 1 transcript ) is composed of grey boxes .
# ::tok The G01 transcript ( orthologous to the human ADAM22 isoform 1 transcript ) is composed of grey boxes .
# ::alignments 17-18|0.2 16-17|0.2.0 14-15|0 11-12|0.0.1+0.0.1.0 10-11|0.0.1.0.1 9-10|0.0.0 8-9|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 7-8|0.0 4-5|0.0.1.0.0 2-3|0.1.0+0.1 1-2|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.842
(c / compose-01 
      :ARG0 (h / human 
            :mod-of (i / isoform) 
            :mod-of (t2 / transcribe-01 
                  :ARG1 (t / thing 
                        :beneficiary-of (o / orthologou) 
                        :quant 1) 
                  :ARG2 (t3 / thing 
                        :name (n / name 
                              :op1 "ADAM22")))) 
      :ARG1 (t4 / thing 
            :ARG1-of (t5 / transcribe-01 
                  :ARG2 (t6 / thing 
                        :name (n2 / name 
                              :op1 "G01")))) 
      :ARG2 (b / box 
            :mod (g / grey)))

# ::snt Boxes in black indicate non-coding region .
# ::tok Boxes in black indicate non-coding region .
# ::alignments 5-6|0.1 4-5|0.1.0 3-4|0 2-3|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.870
(i / indicate-01 
      :ARG0 (b2 / box-01 
            :ARG1 (b / black-04)) 
      :ARG1 (r / region 
            :mod (n / non-cod)))

# ::snt ( C ) Summary of the isolated clones .
# ::tok ( C ) Summary of the isolated clones .
# ::alignments 7-8|0.0 6-7|0.0.1 3-4|0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:22.891
(s / summary 
      :poss (c / clone-01 
            :ARG1 (c2 / C) 
            :ARG1-of (i / isolate-01)))

# ::snt The nucleotide sequence data have been deposited with the DDBJ/EMBL/GenBank Data Libraries under the accession numbers described in the table .
# ::tok The nucleotide sequence data have been deposited with the DDBJ/EMBL/GenBank Data Libraries under the accession numbers described in the table .
# ::alignments 19-20|0.1.0.1 16-17|0.1.0 15-16|0.1.0.0 14-15|0.1.0.0.0 9-12|0.1.1.2+0.1.1.1+0.1.1.0+0.1.1+0.1 6-7|0 3-4|0.0 2-3|0.0.1 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:23.067
(d2 / deposit-01 
      :ARG1 (d3 / data 
            :mod (n3 / nucleotide) 
            :source (s / sequence)) 
      :ARG2 (o / organization 
            :ARG0-of (d / describe-01 
                  :ARG1 (n / number 
                        :mod (a / accession)) 
                  :ARG2 (t / table)) 
            :name (n2 / name 
                  :op1 "DDBJ/EMBL/GenBank" 
                  :op2 "Data" 
                  :op3 "Libraries")))

# ::snt ( D ) Number of clones isolated from each tissue is summarized .
# ::tok ( D ) Number of clones isolated from each tissue is summarized .
# ::alignments 11-12|0 9-10|0.0.0.0.1 8-9|0.0.0.0.1.0 6-7|0.0.0.0 5-6|0.0.0 3-4|0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:23.153
(s / summarize-01 
      :ARG1 (n / number-01 
            :ARG1 (c / clone-01 
                  :ARG1-of (i / isolate-01 
                        :ARG0 (d / D) 
                        :ARG2 (t / tissue 
                              :mod (e / each))))))

# ::snt Cb ; cerebellum , Sp ; spinal cord , DRG ; dorsal root ganglion , SN ; sciatic nerve , cSC ; cultured Schwann cells .
# ::tok Cb ; cerebellum , Sp ; spinal cord , DRG ; dorsal root ganglion , SN ; sciatic nerve , cSC ; cultured Schwann cells .
# ::alignments 24-25|0.0.0.3 23-24|0.0.0.3.1.0.0+0.0.0.3.1.0+0.0.0.3.1 22-23|0.0.0.3.0 20-21|0.0.0.3.0.1 18-19|0.0 17-18|0 15-16|0.0.0.3.0.0 13-14|0.0.0.2 12-13|0.0.0.2.0 11-12|0.0.0.2.1 7-8|0.0.0.1 6-7|0.0.0.1.0 2-3|0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:23.328
(s / sciatic 
      :mod-of (n2 / nerve 
            :op4-of (a / and 
                  :op1 (c5 / cerebellum) 
                  :op2 (c4 / cord 
                        :mod (s3 / spinal)) 
                  :op3 (g / ganglion 
                        :mod (r / root) 
                        :mod (d / dorsal)) 
                  :op5 (c / cell 
                        :ARG1-of (c2 / culture-01 
                              :ARG0 (s2 / sn) 
                              :ARG2 (c3 / cSC)) 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "Schwann"))))))

# ::snt Genotyping of the progeny of Adam22 heterozygous intercrosses .
# ::tok Genotyping of the progeny of Adam22 heterozygous intercrosses .
# ::alignments 7-8|0.0.0 6-7|0.0.0.0 5-6|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:23.349
(g / genotyp 
      :poss (p / progeny 
            :mod (i / intercross 
                  :mod (h / heterozygou 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "Adam22"))))))

# ::snt From heterozygous intercrosses , 78 mice were produced .
# ::tok From heterozygous intercrosses , 78 mice were produced .
# ::alignments 7-8|0 5-6|0.0 4-5|0.0.0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:23.367
(p / produce-01 
      :ARG1 (m / mouse 
            :quant 78) 
      :ARG2 (i / intercross 
            :mod (h / heterozygou)))

# ::snt Numbers of mice in each genotype were counted on postnatal day 10 , 15 and 20 .
# ::tok Numbers of mice in each genotype were counted on postnatal day 10 , 15 and 20 .
# ::alignments 15-16|0.1.1 14-15|0 13-14|0.1.0.0 11-12|0.0 10-11|0.1.0.1.0 9-10|0.1.0.1.0.0 7-8|0.1.0.1 5-6|0.1.0.2 4-5|0.1.0.2.0 2-3|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:23.621
(a / and 
      :op1 10 
      :poss-of (m / mouse 
            :ARG1-of (n / number-01 
                  :ARG0 15 
                  :ARG1-of (c / count-02 
                        :time (d / day 
                              :mod (p / postnatal))) 
                  :location (g / genotype 
                        :mod (e / each))) 
            :poss-of 20))

# ::snt No homozygotes were survived more than postnatal day 20 .
# ::tok No homozygotes were survived more than postnatal day 20 .
# ::alignments 8-9|0.0.0 7-8|0.1 6-7|0 4-5|0.0.2 3-4|0.0 1-2|0.0.1 0-1|0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:23.688
(p / postnatal 
      :ARG2-of (s / survive-01 
            :ARG0 20 
            :ARG1 (h / homozygot) 
            :degree (m / more) 
            :polarity -) 
      :time (d / day))

# ::snt + / + , wild-type ; + / - , heterozygote ; - / - , homozygote .
# ::tok + / + , wild-type ; + / - , heterozygote ; - / - , homozygote .
# ::alignments 16-17|0.0.1 13-14|0.0.2 10-11|0 7-8|0.0.0.0 5-6|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:23.714
(h2 / heterozygote 
      :op2-of (s3 / slash 
            :op1 (a / and 
                  :op1 (s2 / slash)) 
            :op3 (h / homozygote) 
            :poss (s / slash)))

# ::snt Body weight of progeny at postnatal day 10.5 + / + , wild-type ; + / - , heterozygote ; - / - , homozygote .
# ::tok Body weight of progeny at postnatal day 10.5 + / + , wild-type ; + / - , heterozygote ; - / - , homozygote .
# ::alignments 24-25|0.0.0.0.1 21-22|0.4 18-19|0.3 15-16|0.2 13-14|0 9-10|0.1 7-8|0.0.0.0.2.0 6-7|0.0.0.0.2 5-6|0.0.0.0.0 3-4|0.0.0.0 1-2|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T01:23:23.794
(a / and 
      :op1 (b / body 
            :part (w / weight 
                  :mod (p2 / progeny 
                        :location (p / postnatal) 
                        :poss (h / homozygote) 
                        :source (d / day 
                              :mod 10.5)))) 
      :op2 (s3 / slash) 
      :op3 (s2 / slash) 
      :op4 (h2 / heterozygote) 
      :op5 (s / slash))

